Publications and communications of Cavalier, Etienne

Cavalier, E. (In press). Long-term stability of 25-hydroxyvitamin D: importance of the analytical method and of the patient matrix. Clinical Chemistry and Laboratory Medicine. doi:10.1515/cclm-2021-0382

Jørgensen, H. S., Behets, G., Viaene, L., Bammens, B., Claes, K., Meijers, B., Naesens, M., Sprangers, B., Kuypers, D., Cavalier, E., D'Haese, P., & Evenepoel, P. (In press). Diagnostic Accuracy of Noninvasive Bone Turnover Markers in Renal Osteodystrophy. American journal of kidney diseases : the official journal of the National Kidney Foundation. doi:10.1053/j.ajkd.2021.07.027

Vasikaran, S. D., Miura, M., Pikner, R., Bhattoa, H. P., & Cavalier, E. (In press). Practical Considerations for the Clinical Application of Bone Turnover Markers in Osteoporosis. Calcified Tissue International. doi:10.1007/s00223-021-00930-4

CAVALIER, E. (17 March 2022). Update on recommendations for measurement and clinical use of vitamin D and PTH. Paper presented at 65 Deutscher Kongress für endokrinologie gemeinsam mit der Jahrestagung des Dachverbands OSTEOLOGIE (online).

ROUSSEAU, A.-F., schmitz, S., CAVALIER, E., Misset, B., & BOEMER, F. (07 March 2022). Altered Serum Acylcarnitines Profile after a Prolonged Stay in Intensive Care. Nutrients, 14 (5), 1122. doi:10.3390/nu14051122

LE GOFF, C., Gergelé, L., SEIDEL, L., CAVALIER, E., & KAUX, J.-F. (March 2022). Mountain Ultra-Marathon (UTMB) Impact on Usual and Emerging Cardiac Biomarkers. Frontiers in Cardiovascular Medicine, 9, 856223. doi:10.3389/fcvm.2022.856223

LE GOFF, C., Viallon, M., KAUX, J.-F., Andonian, P., Moulin, K., Seidel, L., Giardini, G., Gergelé, L., Croisille, P., CAVALIER, E., & Millet, G. P. (March 2022). Kinetics of Cardiac Remodeling and Fibrosis Biomarkers During an Extreme Mountain Ultramarathon. Frontiers in Cardiovascular Medicine, 9, 790551. doi:10.3389/fcvm.2022.790551

Vermeersch, P., Cotton, F., De Smet, D., Martens, G., Oyaert, M., & Cavalier, E. (February 2022). Lessons from the Belgian experience with regulatory control during the COVID-19 pandemic for the implementation of the European IVD regulation 2017/746. Acta Clinica Belgica, 77 (1), 1-3. doi:10.1080/17843286.2020.1787659

Cavalier, E., LUKAS, P., & DELANAYE, P. (2022). Analytical evaluation of the Nittobo Medical tartrate resistant acid phosphatase isoform 5b (TRACP-5b) EIA and comparison with IDS iSYS in different clinically defined populations. Clinical Chemistry and Laboratory Medicine, 60 (3), 394-400. doi:10.1515/cclm-2021-1190

Curtis, E. M., Reginster, J.-Y., Al-Daghri, N., Biver, E., Brandi, M. L., CAVALIER, E., Hadji, P., Halbout, P., Harvey, N. C., Hiligsmann, M., Javaid, M. K., Kanis, J. A., Kaufman, J.-M., Lamy, O., Matijevic, R., Perez, A. D., RADERMECKER, R., Rosa, M. M., Thomas, T., & Cooper, C. (2022). Management of patients at very high risk of osteoporotic fractures through sequential treatments. Aging Clinical and Experimental Research, 34, 695-714. doi:10.1007/s40520-022-02100-4

DELANAYE, P., Cavalier, E., & Bouquegneau, A. (2022). The ideal drug dosage adaptation through estimated glomerular filtration rate in obese patients? Measuring GFR is the key. British Journal of Clinical Pharmacology. doi:10.1111/bcp.15255

DELANAYE, P., DUBOIS, B., CAVALIER, E., & JOURET, F. (2022). Vignette diagnostique de l’étudiant : approche diagnostique de la maladie rénale chronique. Revue Médicale de Liège, 7 (4), 249-252.

DELANAYE, P., Gaillard, F., van der Weijden, J., Mjøen, G., Ferhman-Ekholm, I., Dubourg, L., Ebert, N., Schaeffner, E., Åkerfeldt, T., Goffin, K., Couzi, L., Garrouste, C., Rostaing, L., Courbebaisse, M., Legendre, C., Hourmant, M., Kamar, N., Cavalier, E., WEEKERS, L., & van Londen, M. (2022). Age-adapted percentiles of measured glomerular filtration in healthy individuals: extrapolation to living kidney donors over 65 years. Clinical Chemistry and Laboratory Medicine, 60 (3), 401-407. doi:10.1515/cclm-2021-1011

Frisee, V., Rigaux, G., Dufour, P., Barbato, O., Brutinel, F., Egyptien, S., Bossaert, P., Deleuze, S., Cavalier, E., & Ponthier, J. (January 2022). American Bison (Bison bison) reproductive endocrinology: serum Pregnancy Associated Glycoproteins (PAG), Progesterone, Estrone and Estrone-Sulfate in non pregnant animals and during gestation. Domestic Animal Endocrinology, 78, 106684. doi:10.1016/j.domaniend.2021.106684

Ladang, A., Kovacs, S., Lengele, L., Locquet, M., Reginster, J.-Y., Bruyère, O., & Cavalier, E. (2022). Neurofilament light chain concentration in an aging population. Aging Clinical and Experimental Research, 34 (2), 331-339. doi:10.1007/s40520-021-02054-z

MALAISE, O., SEIDEL, L., BONVOISIN, C., WEEKERS, L., JOURET, F., MALAISE, M., CAVALIER, E., DELANAYE, P., & BOUQUEGNEAU, A. (2022). BONE MINERAL DENSITY AND BONE MICRO-ARCHITECTURE EVOLUTION AFTER KIDNEY TRANSPLANTATION: 3-MONTHS RESULTS OF A PROSPECTIVE COHORT STUDY. Osteoporosis International.

Sempos, C. T., Williams, E. L., Carter, G. D., Jones, J., Camara, J. E., Burdette, C. Q., Hahm, G., Nalin, F., Duewer, D. L., Kuszak, A. J., Merkel, J., Hoofnagle, A. N., LUKAS, P., Cavalier, E., Durazo-Arvizu, R. A., Crump, P. M., Popp, C., Beckert, C., Schultess, J., & Wise, S. A. (2022). Assessment of serum total 25-hydroxyvitamin D assays for Vitamin D External Quality Assessment Scheme (DEQAS) materials distributed at ambient and frozen conditions. Analytical and Bioanalytical Chemistry. doi:10.1007/s00216-021-03742-5

Willers, C., Norton, N., Harvey, N. C., Jacobson, T., Johansson, H., Lorentzon, M., McCloskey, E. V., Borgström, F., Kanis, J. A., Kaux, J.-F. (Other coll.), Reginster, J.-Y. (Other coll.), Bruyère, O. (Other coll.), Cavalier, E. (Other coll.), & LECART, M.-P. (Other coll.). (January 2022). Osteoporosis in Europe: a compendium of country-specific reports. Archives of Osteoporosis, 17 (1), 23. doi:10.1007/s11657-021-00969-8

Wise, S. A., Camara, J. E., Burdette, C. Q., Hahm, G., Nalin, F., Kuszak, A. J., Merkel, J., Durazo-Arvizu, R. A., Williams, E. L., Hoofnagle, A. N., Ivison, F., Fischer, R., van den Ouweland, J. M. W., Ho, C. S., Law, E. W. K., Simard, J.-N., Gonthier, R., Holmquist, B., Meadows, S., & Sempos, C. T. (January 2022). Interlaboratory comparison of 25-hydroxyvitamin D assays: Vitamin D Standardization Program (VDSP) Intercomparison Study 2 - Part 1 liquid chromatography - tandem mass spectrometry (LC-MS/MS) assays - impact of 3-epi-25-hydroxyvitamin D(3) on assay performance. Analytical and Bioanalytical Chemistry, 414 (1), 333-349. doi:10.1007/s00216-021-03576-1

schmitz, S., BOEMER, F., FARRAUTO, L., CAVALIER, E., Misset, B., & ROUSSEAU, A.-F. (December 2021). Acylcarnitines profile in survivors of a prolonged ICU stay. European Journal of Anaesthesiology, 38 (e-Suppl 39), 169.

CASTIGLIONE, V., CAVALIER, E., LUTTERI, L., LUKAS, P., & BERODES, M. (19 November 2021). NEW FAECAL CALPROTECTIN ASSAY BY IDS: VALIDATION AND COMPARISON TO DIASORIN METHOD. Paper presented at RBSLM Annual Meeting, Brussels, Belgium.

Le Goff, C., Cavalier, E., & Kaux, J.-F. (November 2021). Le point sur le sport intense et les marqueurs cardiaques. Vaisseaux, Coeur, Poumons, 26 (6), 18-21.

Le Goff, C., Kaux, J.-F., SEIDEL, L., Gergelé, L., Millet, G., Viallon, M., Martens, G., Croisille, P., & Cavalier, E. (November 2021). CARDIAC FIBROSIS MARKERS: GALECTIN-3 AND SUPPRESSION OF TUMORIGENICITY 2 MEASUREMENT IN PARTICIPANT AT THE TOR DES GÉANTS. British Journal of Sports Medicine, 55 (S1), 115.

ROUSSEAU, A.-F., schmitz, S., COLSON, C., FARRAUTO, L., MINGUET, P., CAVALIER, E., Misset, B., & BOEMER, F. (November 2021). Etude du profil en acylcarnitines après séjour prolongé aux soins intensifs. Poster session presented at Journées Francophones de Nutrition, Lille, France.

Zelzer, S., Le Goff, C., PEETERS, S., Calaprice, C., Meinitzer, A., Enko, D., Goessler, W., Herrmann, M., & Cavalier, E. (November 2021). Comparison of two LC-MS/MS methods for the quantification of 24,25-dihydroxyvitamin D3 in patients and external quality assurance samples. Clinical Chemistry and Laboratory Medicine, 60 (1), 74-81. doi:10.1515/cclm-2021-0792

CAVALIER, E. (09 October 2021). Quale metodo di dosaggio del PTH, quali target di PTH. Paper presented at 62é congresso nazional SIN, Rimini.

Chevalley, T., Brandi, M., Cavalier, E., Harvey, N., Iolascon, G., Cooper, C., Hannouche, D., Kaux, J.-F., Kurth, A., Maggi, S., Maier, G., Papavasiliou, K., Al-Daghri, N., Sosa-Henriquez, M., Suhm, N., Tarantino, U., Reginster, J.-Y., & Rizzoli, R. (October 2021). How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture? Osteoporosis International, 32 (10), 1921-1935. doi:10.1007/s00198-021-05957-9

Parotte, M. C., VALDES SOCIN, H. G., & CAVALIER, E. (01 October 2021). Hypercalcémie aggravée par l’administration de vitamine D chez un patient adulte révélant une mutation hétérozygote composite CYP24A1 : réponse et traitement à long terme par rifampicine. Annales d'Endocrinologie, 82, 311.

CAVALIER, E. (23 September 2021). Can biomarkers of bone turnover help in the choice of the most appropriate sequence? Paper presented at ESCEO Workshop - Management of patients at veryhigh risk of osteoporotic fractures throughsequential treatments.

Demeuse, J., CALAPRICE, C., Huyghebaert, L., Rechchad, M., Le Goff, C., & Cavalier, E. (16 September 2021). TROUBLESHOOTING : Development of a LC-MS/MS method for trace-level analysis of salivary melatonin. Paper presented at MSACL 2021 EU.

LE GOFF, C., Kaux, J.-F., DULGHERU, R. E., SEIDEL, L., PINCEMAIL, J., Cavalier, E., & MELON, P. (September 2021). The impact of an ultra-trail on the dynamic of cardiac, inflammatory, renal and oxidative stress biological markers correlated with electrocardiogram and echocardiogram. Acta Cardiologica, 76 (7), 739-747. doi:10.1080/00015385.2020.1778871

Wise, S. A., Camara, J. E., Sempos, C. T., LUKAS, P., Le Goff, C., PEETERS, S., Burdette, C. Q., Nalin, F., Hahm, G., Durazo-Arvizu, R. A., Kuszak, A. J., Merkel, J., & Cavalier, E. (September 2021). Vitamin D Standardization Program (VDSP) Intralaboratory Study for the Assessment of 25-Hydroxyvitamin D Assay Variability and Bias. The Journal of steroid biochemistry and molecular biology, 212, 105917. doi:10.1016/j.jsbmb.2021.105917

CAVALIER, E. (28 August 2021). How to warrant reliable data for calciotropic hormones & bone turnover markers assays. Paper presented at World congress on osteoporosis, osteoarthritis & musculoskeletal diseases : WCO, IOF, ESCEO, Londres, United Kingdom.

Camara, J. E., Wise, S. A., Hoofnagle, A. N., Williams, E. L., Carter, G. D., Jones, J., Burdette, C. Q., Hahm, G., Nalin, F., Kuszak, A. J., Merkel, J., Durazo-Arvizu, R. A., LUKAS, P., Cavalier, E., Popp, C., Beckert, C., Schultess, J., Van Slooten, G., Tourneur, C., & Sempos, C. T. (August 2021). Assessment of serum total 25-hydroxyvitamin D assay commutability of Standard Reference Materials and College of American Pathologists Accuracy-Based Vitamin D (ABVD) Scheme and Vitamin D External Quality Assessment Scheme (DEQAS) materials: Vitamin D Standardization Program (VDSP) Commutability Study 2. Analytical and Bioanalytical Chemistry, 413 (20), 5067-5084. doi:10.1007/s00216-021-03470-w

LADANG, A., Rigaud, L., Sqalli, G., & Cavalier, E. (July 2021). Effects of various pre-analytical conditions on blood-based biomarkers of Alzheimer's disease. Clinical Chemistry and Laboratory Medicine, 59 (12), 435-e437. doi:10.1515/cclm-2021-0637

Nyssen, L., Fillet, M., CAVALIER, E., & Servais, A.-C. (July 2021). Analytical strategies for the quality control of parathyroid hormone standards. Poster session presented at 37th International Symposium on Microscale Separations and Bioanalysis - Virtual edition, Boston, United States - Massachusetts.

ROUSSEAU, A.-F., MINGUET, P., COLSON, C., KELLENS, I., Chaabane, S., DELANAYE, P., Cavalier, E., Chase, J. G., LAMBERMONT, B., & Misset, B. (July 2021). Post-intensive care syndrome after a critical COVID-19: cohort study from a Belgian follow-up clinic. Annals of Intensive Care, 11 (1), 118. doi:10.1186/s13613-021-00910-9

CAVALIER, E. (10 June 2021). Bone biomarkers in CKD: what do they add to clinical management. Paper presented at ECTS - ERA-EDTA CKD MBD Workshop: Session 2 - Chronic Inflammation in CKD: Bone or Kidney.

CAVALIER, E. (19 May 2021). Vitamin D measurement: pitfalls and practical implications. Paper presented at ECTS Congress (Virtual).

Laurent, M. R., De Schepper, J., Trouet, D., Godefroid, N., Boros, E., Heinrichs, C., Bravenboer, B., Velkeniers, B., Lammens, J., Harvengt, P., Cavalier, E., KAUX, J.-F., LOMBET, J., De Waele, K., Verroken, C., van Hoeck, K., Mortier, G. R., Levtchenko, E., & Vande Walle, J. (May 2021). Corrigendum: Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium. Frontiers in Endocrinology, 12, 686401. doi:10.3389/fendo.2021.686401

Sqalli, G., Cavalier, E., & LADANG, A. (May 2021). Dosage au laboratoire de chimie clinique des biomarqueurs circulants oncologiques : limites et perspectives. Revue Médicale de Liège, 76 (5-6), 352-357.

CAVALIER, E. (28 April 2021). PTH from the clinical laboratory perspective. Paper presented at Belgian Thyroid Club spring meeting 2021.

Lefever, S., Indevuyst, C., Cuypers, L., Dewaele, K., Yin, N., Cotton, F., Padalko, E., Oyaert, M., Descy, J., Cavalier, E., Van Ranst, M., André, E., Lagrou, K., & Vermeersch, P. (2021). Comparison of the quantitative DiaSorin Liaison antigen test to RT-PCR for the diagnosis of COVID-19 in symptomatic and asymptomatic outpatients. Journal of Clinical Microbiology. doi:10.1128/JCM.00374-21

CAVALIER, E. (19 March 2021). Actualités de la vitamine D. Paper presented at 106ème journée française de médecine - Paris SMHP (Visio).

Cavalier, E. (March 2021). What does a PTH of 300 pg/mL actually mean? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 36 (3), 426-427. doi:10.1093/ndt/gfz163

Cavalier, E., Guiot, J., Lechner, K., Dutsch, A., Eccleston, M., Herzog, M., Bygott, T., Schomburg, A., Kelly, T., & Holdenrieder, S. (March 2021). Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression. Frontiers in Molecular Biosciences, 8, 600881. doi:10.3389/fmolb.2021.600881

Laurent, M., De Schepper, J., Trouet, D., Godefroid, N., Boros, E., Heinrichs, C., Bravenboer, B., Velkeniers, B., Lammens, J., Harvengt, P., Cavalier, E., Kaux, J.-F., LOMBET, J., De Waele, K., Verroken, C., van Hoeck, K., Mortier, G., Levtchenko, E., & Vande Walle, J. (March 2021). Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium. Frontiers in Endocrinology, 12, 641543. doi:10.3389/fendo.2021.641543

Makris, K., Bhattoa, H. P., Cavalier, E., Phinney, K., Sempos, C. T., Ulmer, C. Z., Vasikaran, S. D., Vesper, H., & Heijboer, A. C. (2021). Recommendations on the measurement and theclinical useof vitamin D metabolites and vitamin D binding protein - A position paper from the IFCC Committee on Bone Metabolism. Clinica Chimica Acta. doi:10.1016/j.cca.2021.03.002

PINCEMAIL, J., CAVALIER, E., CHARLIER, C., CHERAMY-BIEN, J.-P., BREVERS, E., COURTOIS, A., FADEUR, M., Meziane, S., LE GOFF, C., Misset, B., Albert, A., DEFRAIGNE, J., & ROUSSEAU, A.-F. (07 February 2021). Oxidative Stress Status in COVID-19 Patients Hospitalized in Intensive Care Unit for Severe Pneumonia. A Pilot Study. Antioxidants, 10 (257). doi:10.3390/antiox10020257

CAVALIER, E. (02 February 2021). Laboratory assessment of phosphate wasting disorders. Paper presented at workshop ESCEO « Laboratory assessment of phosphate wasting syndromes".

Schoneveld, L., LADANG, A., HENKET, M., Frix, A.-N., Cavalier, E., Guiot, J., & MALAISE, O. (Other coll.). (February 2021). YKL-40 as a new promising prognostic marker of severity in COVID infection. Critical care (London, England), 25 (1), 66. doi:10.1186/s13054-020-03383-7

HUART, J., BOUQUEGNEAU, A., Lutteri, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., BOVY, C., Krzesinski, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., Mariat, C., CAVALIER, E., Burtey, S., Jouret, F., & DELANAYE, P. (23 January 2021). Proteinuria in COVID‑19: prevalence, characterization and prognostic role. Journal of Nephrology, 34 (3), 355-364. doi:10.1007/s40620-020-00931-w

Annweiler, C., BRUYERE, O., CAVALIER, E., young, J., & Souberbielle, C. (January 2021). Assurer un statut satisfaisant en vitamine D dans la population générale est particulièrement important dans le contexte de la Covid-19. Revue du Praticien, 71 (1), 7-11.

BOUQUEGNEAU, A., HUART, J., LUTTERI, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., ROUSSEAU, A.-F., BOVY, C., KRZESINSKI, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., DARCIS, G., CAVALIER, E., JOURET, F., & DELANAYE, P. (2021). Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. Journal of Nephrology, 34 (4), 967-969. doi:10.1007/s40620-021-01075-1

Cavalier, E., Eastell, R., Jørgensen, N. R., Makris, K., Tournis, S., Vasikaran, S., Kanis, J. A., Cooper, C., Pottel, H., & Morris, H. A. (2021). A Multicenter Study to Evaluate Harmonization of Assays for C-Terminal Telopeptides of Type I Collagen (ß-CTX): A Report from the IFCC-IOF Committee for Bone Metabolism (C-BM). Calcified Tissue International. doi:10.1007/s00223-021-00816-5

Cavalier, E., Fraser, C. G., Bhattoa, H. P., Heijboer, A. C., Makris, K., Ulmer, C. Z., Vesper, H. W., Vasikaran, S., LUKAS, P., DELANAYE, P., Carobene, A., & On Behalf Of The Ifcc-Iof Committee For Bone Metabolism. (January 2021). Analytical Performance Specifications for 25-Hydroxyvitamin D Examinations. Nutrients, 13 (2). doi:10.3390/nu13020431

Cavalier, E., Vasikaran, S., Bhattoa, H. P., Heijboer, A. C., Makris, K., & Ulmer, C. Z. (January 2021). The path to the standardization of PTH: Is this a realistic possibility? a position paper of the IFCC C-BM. Clinica Chimica Acta, 515, 44-51. doi:10.1016/j.cca.2020.12.022

DELANAYE, P., & CAVALIER, E. (2021). Arguments for an age-adapted definition of chronic kidney disease. Portuguese Journal of nephrology and hypertension, 35 (4), 261-262.

DELANAYE, P., Mariat, C., Cavalier, E., Glassock, R. J., Gemenne, F., & Pottel, H. (2021). The « race » correction in estimating glomerular filtration rate: an European point of view. Current Opinion in Nephrology and Hypertension, 30 (6), 525-530. doi:10.1097/MNH.0000000000000739

DELANAYE, P., Melsom, T., CAVALIER, E., Pottel, H., Eriksen, B., & Dubourg, L. (2021). Iohexol plasma clearance: impact of weighing the syringe. Kidney International Reports, 6 (9), 2478-2480. doi:10.1016/j.ekir.2021.05.038

DELANAYE, P., Vidal-Petiot, Stehlé, T., Dubourg, Gaillard, F., Sterner, G., White, C., Lemoine, S., Audard, V., Prié, D., CAVALIER, E., Courbebaisse, M., Pottel, H., & Flamant, M. (2021). Comparison of plasma clearance with early-compartment correction equations and urinary clearance in high GFR ranges. Kidney International Reports, 6 (6), 1622-1628. doi:10.1016/j.ekir.2021.03.886

Dufour, P., Courtois, J., SEYNAEVE, Y., PEETERS, S., LE GOFF, C., CAVALIER, E., & Ponthier, J. (2021). Development and validation of a liquid chromatography coupled to mass spectrometer (LC-MS) method for the simultaneous quantification of estrone-3-sulfate, progesterone, estrone and estradiol in serum of mares and American bisons. Research in Veterinary Science, 136, 343-350. doi:10.1016/j.rvsc.2021.03.014

Farre Segura, J., Fabregat Cabello, N., CALAPRICE, C., Nyssen, L., PEETERS, S., Le Goff, C., & Cavalier, E. (2021). Development and validation of a fast and reliable method for the quantification of glucagon by liquid chromatography and tandem mass spectrometry. Clinica Chimica Acta. doi:10.1016/j.cca.2020.11.004

Résimont, G., Piéroni, L., Bigot‑Corbel, E., CAVALIER, E., & DELANAYE, P. (2021). Urinary strips for protein assays: easy to do but difficult to interpret! Journal of Nephrology, 34 (3), 411-432. doi:10.1007/s40620-020-00735-y

Résimont, G., VRANKEN, L., CAVALIER, E., & DELANAYE, P. (2021). Estimation d’un ratio Albumine/Créatinine urinaire à partir d’un ratio Protéine/Créatinine urinaire au départ de mesures réalisées sur un même échantillon : validation d’équations. Paper presented at VI congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT), Toulouse, France.

Sanchez Rodriguez, M. D. C., Locquet, M., Bruyère, O., Lengele, L., CAVALIER, E., Reginster, J.-Y., & Beaudart, C. (2021). Prediction of 5-year mortality risk by malnutrition according to the GLIM format using seven pragmatic approaches to define the criterion of loss of muscle mass. Clinical Nutrition, 40 (4), 2188-2199. doi:10.1016/j.clnu.2020.09.047

Schoneveld, L., CAVALIER, E., VALDES SOCIN, H. G., GRANDFILS, S., & LADANG, A. (January 2021). Étude rétrospective du bilan thyroïdien chez les femmes enceintes : définition des valeurs de référence de TSH et FT4. Revue Médicale de Liège, 46 (1), 44-49.

Ursem, S. R., Heijboer, A. C., D'Haese, P. C., Behets, G. J., Cavalier, E., Vervloet, M. G., & Evenepoel, P. (2021). Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney disease. Kidney International. doi:10.1016/j.kint.2020.12.024

Wise, S. A., Camara, J. E., Burdette, C. Q., Hahm, G., Nalin, F., Kuszak, A. J., Merkel, J., Durazo-Arvizu, R. A., Williams, E. L., Popp, C., Beckert, C., Schultess, J., Van Slooten, G., Tourneur, C., Pease, C., Kaul, R., Villarreal, A., Batista, M. C., Pham, H., & Sempos, C. T. (2021). Interlaboratory comparison of 25-hydroxyvitamin D assays: Vitamin D Standardization Program (VDSP) Intercomparison Study 2 - Part 2 ligand binding assays - impact of 25-hydroxyvitamin D(2) and 24R,25-dihydroxyvitamin D(3) on assay performance. Analytical and Bioanalytical Chemistry. doi:10.1007/s00216-021-03577-0

Wozolek, A., Jaquet, O., Donneau, A.-F., Lancellotti, P., Le Goff, C., Cavalier, E., Radermecker, M., Lavigne, J.-P., Durieux, R., Roediger, L., Senard, M., Hubert, M. B., Brichant, J.-F., Amabili, P., & Hans, G. (2021). Cardiac Biomarkers and Prediction of Early Outcome After Heart Valve Surgery: A Prospective Observational Study. Journal of Cardiothoracic and Vascular Anesthesia. doi:10.1053/j.jvca.2021.06.028

Zhang, Z., Huang, C., Cao, Y., Mu, R., Zhang, M. C., Xing, D., Fan, D., Ding, Y., Guo, J., Hou, Y., Jianhao, L., Veronese, N., Reginster, J.-Y., Bruyère, O., Cavalier, E., & Zhang, H. (2021). 2021 revised algorithm for the management of knee osteoarthritis-the Chinese viewpoint. Aging Clinical and Experimental Research, 33 (8), 2141-2147. doi:10.1007/s40520-021-01906-y

Bhattoa, H. P., Cavalier, E., Eastell, R., Heijboer, A. C., Jørgensen, N. R., Makris, K., Ulmer, C. Z., Kanis, J. A., Cooper, C., Silverman, S. L., & Vasikaran, S. D. (December 2020). Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood. Clinica Chimica Acta, 515, 16-20. doi:10.1016/j.cca.2020.12.023

CAVALIER, E. (December 2020). Vitamine D et ostéoporose. Revue du Praticien, 70 (10), 1096.

Dufour, P., Courtois, J., SEYNAEVE, Y., PEETERS, S., LE GOFF, C., CAVALIER, E., & Ponthier, J. (20 November 2020). Development and validation of a LC-MS method for the simultaneous quantification of estrone-3-sulfate, progesterone, estroneand estradiol in serum of mares and American bisons. Poster session presented at 2020 annual meeting of the Royal Belgian Society of Laboratory Medecine, Bruxelles, Belgium.

Schoneveld, L., LUKAS, P., CAVALIER, E., & GADISSEUR, R. (20 November 2020). CA19.9 assays provide clinically different results for the patients. Poster session presented at 2020 Annual Royal Belgian Society of Laboratory Medicine Meeting.

Schoneveld, L., LUKAS, P., CAVALIER, E., & GADISSEUR, R. (20 November 2020). CA19.9 assays provide clinically different results for the patients. Paper presented at 2020 Annual Royal Belgian Society of Laboratory Medicine Meeting.

Courbebaisse, M., & Cavalier, E. (Eds.). (2020). Vitamin D in 2020: Stop or Not Yet? Switzerland: MDPI. doi:10.3390/nu12113378

Courbebaisse, M., & CAVALIER, E. (2020). Vitamin D in 2020: An Old Pro-Hormone with Potential Effects beyond Mineral Metabolism. In M. Courbebaisse & E. Cavalier (Eds.), Special Issue "Vitamin D in 2020: Stop or Not Yet?" (pp. 3378). Switzerland: MDPI. doi:10.3390/nu12113378

Frix, A.-N., Schoneveld, L., LADANG, A., HENKET, M., DUYSINX, B., VAILLANT, F., Misset, B., Moutschen, M., Louis, R., Cavalier, E., & Guiot, J. (November 2020). Could KL-6 levels in COVID-19 help to predict lung disease? Respiratory Research, 21 (309). doi:10.1186/s12931-020-01560-4

Radermecker, C., Detrembleur, N., Guiot, J., Cavalier, E., HENKET, M., D'Emal, C., Vanwinge, C., Cataldo, D., Oury, C., Delvenne, P., & Marichal, T. (November 2020). Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19. Journal of Experimental Medicine, 217 (12). doi:10.1084/jem.20201012

Wieringa, G., Queraltó, J., Homšak, E., Jassam, N., Cavalier, E., Svinarov, D., Krleža, J. L., Christou, S., Pikner, R., Larsen, T. R., Tomberg, K., Linko-Parvinen, A., Sapin, V., Baum, H., Kroupis, C., Bagoly, Z., Costelloe, S., Sciacovelli, L., Stasulans, J., & Simundic, A.-M. (November 2020). A proposed Common Training Framework for Specialists in Laboratory Medicine under EU Directive 2013/55/EC (The Recognition of Professional Qualifications). Clinical Chemistry and Laboratory Medicine, 59 (3), 505-512. doi:10.1515/cclm-2020-1504

Zelzer, S., Meinitzer, A., Enko, D., Simstich, S., Le Goff, C., Cavalier, E., Herrmann, M., & Goessler, W. (November 2020). Simultaneous determination of 24,25- and 25,26-dihydroxyvitamin D3 in serum samples with liquid-chromatography mass spectrometry - A useful tool for the assessment of vitamin D metabolism. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 1158, 122394. doi:10.1016/j.jchromb.2020.122394

LAMBERT, V.* , hansen, S.* , Schoumacher, M.* , Lecomte, J., Leenders, J., Hubert, P., Herfs, M., Blacher, S., Carnet, O., Yip, C., BLAISE, P., DUCHATEAU, E., LOCHT, B., THYS, M., CAVALIER, E., GOTHOT, A., Govaerts, B., RAKIC, J.-M., Noël, A.* , & De Tullio, P.*. (2020). Pyruvate dehydrogenase kinase/lactate axis: a therapeutic target for neovascular age-related macular degeneration identified by metabolomics. Journal of Molecular Medicine. doi:10.1007/s00109-020-01994-9

Le Goff, C., Kaux, J.-F., SEIDEL, L., BREVERS, E., PINCEMAIL, J., CAVALIER, E., & MELON, P. (2020). BIOLOGICAL IMPACT OF AN ENDURANCE RACE OF 64 KM IN COMPARISON WITH SEMI-MARATHON, MARATHON AND A CONTROL GROUP. In F. Dela, E. Muller, & E. Tsolakidis, Book of abstracts - 25th anniversary congress - ECSS (pp. 528).

Pelaez, A., Dinic, M., Roche, F., Barthélémy, J., Alamartine, E., Cavalier, E., DELANAYE, P., Maillard, N., & Mariat, C. (October 2020). Cystatine C, inflammation et dysfonctionnement autonomique: un "ménage à trois" caché? Poster session presented at Société Française de Néphrologie (SFNDT), E-congrès, France.

DELANNOY, P., VRANKEN, L., CAVALIER, E., & VALDES SOCIN, H. G. (2020). Carence en vitamine B12 : diagnostic et prise en charge. Tempo Médical, 24-28.

Perić, M., Maiter, D., Cavalier, E., Lasserre, J. F., & Toma, S. (September 2020). The Effects of 6-Month Vitamin D Supplementation during the Non-Surgical Treatment of Periodontitis in Vitamin-D-Deficient Patients: A Randomized Double-Blind Placebo-Controlled Study. Nutrients, 12 (10). doi:10.3390/nu12102940

Zemb, P., Bergman, P., Camargo, C. A. J., Cavalier, E., Cormier, C., Courbebaisse, M., Hollis, B., Joulia, F., Minisola, S., Pilz, S., Pludowski, P., Schmitt, F., Zdrenghea, M., & Souberbielle, J.-C. (September 2020). Vitamin D deficiency and the COVID-19 pandemic. Journal of Global Antimicrobial Resistance, 22, 133-134. doi:10.1016/j.jgar.2020.05.006

Jørgensen, H. S., Cavalier, E., & Evenepoel, P. (August 2020). Clinical evidence of direct bone effects of cinacalcet [letter to the editor]. Kidney International, 98 (2), 514-515. doi:10.1016/j.kint.2020.04.013

Khalil, R., Antonio, L., Laurent, M. R., David, K., Kim, N. R., Evenepoel, P., Eisenhauer, A., Heuser, A., Cavalier, E., Khosla, S., Claessens, F., Vanderschueren, D., & Decallonne, B. (August 2020). Early effects of androgen deprivation on bone and mineral homeostasis in adult men: a prospective cohort study. European Journal of Endocrinology, 183 (2), 181-189. doi:10.1530/EJE-20-0348

Cavalier, E., DELANAYE, P., & Delanghe, J. (Eds.). (2020). Bone markers and CKD-MBD. Elsevier.

Bidlingmaier, M., Valcour, A., Chun, K. Y., Schilbach, K., Kühnle, T., Diederich, S., Rogge, T., Cavalier, E., & Katayev, A. (June 2020). SUN-LB46 Differences in IGF-I Concentrations Between European and US Populations - Consequences for Reference Intervals. Journal of the Endocrine Society, 4 (Supplement_1), 1092-A1093. doi:10.1210/jendso/bvaa046.2165

Cavalier, E., & Le Goff, C. (May 2020). La chromatographie liquide couplée à un spectromètre de masse en tandem (LC-MS/MS) : une révolution dans le laboratoire de chimie clinique. Revue Médicale de Liège, 75 (5-6), 457-459.

LADANG, A., ROUSSELLE, O., Huyghebaert, L., BEKAERT, A.-C., KOVACS, S., Le Goff, C., & Cavalier, E. (2020). Parathormone, bone alkaline phosphatase and 25-hydroxyvitamin D status in a large cohort of 1200 children and teenagers. Acta Clinica Belgica, 1-6. doi:10.1080/17843286.2020.1769285

LE GOFF, C., Farre Segura, J., Dufour, P., KAUX, J.-F., & CAVALIER, E. (May 2020). Intense sport practices and cardiac biomarkers. Clinical Biochemistry, 79, 1-8. doi:10.1016/j.clinbiochem.2020.02.008

CAVALIER, E. (06 March 2020). Steroid hormone measurements in clinical routine – promises and pitfalls of today’s analytical techniques - Vitamin D – problems with assays and standardization efforts. Paper presented at „Neue Chemie“ Campus Naturwissenschaften der Justus-Liebig-Universität Gießen Heinrich, Giessen, Germany.

Altieri, B., Cavalier, E., Bhattoa, H. P., Perez-Lopez, F. R., Lopez-Baena, M. T., Perez-Roncero, G. R., Chedraui, P., Annweiler, C., Della Casa, S., Zelzer, S., Herrmann, M., Faggiano, A., Colao, A., & Holick, M. F. (February 2020). Vitamin D testing: advantages and limits of the current assays. European Journal of Clinical Nutrition, 74 (2), 231-247. doi:10.1038/s41430-019-0553-3

Carter, G. D., Berry, J., Cavalier, E., Durazo-Arvizu, R., Gunter, E., Jones, G., Jones, J., Phinney, K., Sempos, C. T., Twomey, P. J., & Williams, E. L. (February 2020). Biotin supplementation causes erroneous elevations of results in some commercial serum 25-hydroxyvitamin d (25OHD) assays. The Journal of steroid biochemistry and molecular biology, 200, 105639. doi:10.1016/j.jsbmb.2020.105639

Evenepoel, P., Cavalier, E., & D'Haese, P. C. (February 2020). Bone biomarkers in de novo renal transplant recipients. Clinica Chimica Acta, 501, 179 - 185. doi:10.1016/j.cca.2019.10.035

CAVALIER, E. (31 January 2020). PTH and 25(OH)-vitamin D on Fujirebio Lumipulse: a great couple. Paper presented at Advanced Topics in Decision-making in Medicine [EWP02], Rotterdam, Netherlands.

CAVALIER, E. (22 January 2020). Issues in analysis of biomarkers. Paper presented at KSA University, Riyadh, Saudi Arabia.

LE GOFF, C.* , Farre Segura, J.* , STOJKOVIC, V., Dufour, P., PEETERS, S., Courtois, J., NIZET, A., De Vos, N., & CAVALIER, E. (2020). The pathway through LC-MS method development: in-house or ready-to-use kit-based methods? Clinical Chemistry and Laboratory Medicine. doi:10.1515/cclm-2019-0916

CAVALIER, E. (18 January 2020). When and how should monitoring of treatment of osteoporosis be performed in postmenopausal women? Paper presented at 2020 Clinical update symposium - Multidisciplinary management of postmenopausal osteoporosis: BBC 2020 guidelines.

Barguil, Y., Chiaradia, L., Sicard, D., Duhin, M., Sebat, C., Abdi, S., Alomar, Y., Blondeel, N., Bonnet, C., Bouberi-Niava, B., Bourgoin-Rousset, E., CAVALIER, E., Cisse, F., Combe, P., de Guire, V., Devaud, F., De Wulf, A., Dialo Agne, F., Dumas-Chastang, E., & Beauvieux, M.-C. (2020). Gestion d’une crise sanitaire mondiale : premiers retours d’expérience de biologistes médicaux d’Outre-mer et de francophonie face au COVID-19. Annales de Biologie Clinique, 78 (5), 499-518. doi:10.1684/abc.2020.1586

CAVALIER, E. (2020). PTH Measurement in CKD. In A. Covic, D. Goldsmith, & P. A. Ureña Torres, Parathyroid Glands in Chronic Kidney Disease (pp. 93-102). Springer.

Cavalier, E., & Bruyère, O. (2020). Vitamin D for the older patient: From hype to hope? Current Opinion in Clinical Nutrition and Metabolic Care, 23 (1), 4-7. doi:10.1097/MCO.0000000000000616

Cavalier, E., Huyghebaert, L., ROUSSELLE, O., BEKAERT, A.-C., KOVACS, S., VRANKEN, L., PEETERS, S., Le Goff, C., & LADANG, A. (2020). Simultaneous measurement of 25(OH)-vitamin D and 24,25(OH)2-vitamin D to define cut-offs for CYP24A1 mutation and vitamin D deficiency in a population of 1200 young subjects. Clinical Chemistry and Laboratory Medicine, 58 (2), 197-201. doi:10.1515/cclm-2019-0996

Cavalier, E., LUKAS, P., Bottani, M., Aarsand, A. K., Ceriotti, F., Coşkun, A., Díaz-Garzón, J., Fernàndez-Calle, P., Guerra, E., Locatelli, M., Sandberg, S., Carobene, A., Åkesson, K., Bhattoa, H. P., Bruyère, O., Cooper, C., Eastell, R., Garnero, P., Heijboer, A., & on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine Working Group on Biological Variation and IOF-IFCC Committee on Bone Metabolism. (2020). European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein—a cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism. Osteoporosis International, 31 (8), 1461-1470. doi:10.1007/s00198-020-05362-8

CAVALIER, E., LUKAS, P., Warling, X., Moonen, M., Smelten, N., & DELANAYE, P. (2020). The percentage of non-oxidized PTH concentration remains stable over a period of 1 year in hemodialyzed patients. Clinica Chimica Acta, 506, 107-109. doi:10.1016/j.cca.2020.03.025

Cebeci, A. N., Zou, M., BinEssa, H. A., Alzahrani, A. S., Al-Rijjal, R. A., Al-Enazi, A. F., Al-Mohanna, F. A., Cavalier, E., Meyer, B. F., & Shi, Y. (2020). Mutation of SGK3, a novel regulator of renal phosphate transport, causes autosomal dominant hypophosphatemic rickets. The Journal of clinical endocrinology and metabolism. doi:10.1210/clinem/dgz260

Courtois, J., BERTHOLET, C., Tollenaere, S., Van der Brempt, X., Cavalier, E., El Guendi, S., Gillard, N., Gadisseur, R., & Quintig, B. (2020). Detection of wheat allergens using 2D Western blot and mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 178. doi:10.1016/j.jpba.2019.112907

DELANAYE, P., BOUQUEGNEAU, A., Moranne, O., & Cavalier, E. (2020). Comment estimer la filtration glomérulaire dans le contexte de l’adaptation posologique de médicaments ? Revue Médicale Suisse, 16 (703), 1489-1493.

DELANAYE, P., Dubourg, L., Flamant, M., Yayo, E., Bukabau, J., Vidal-Petiot, E., Lemoine, S., CAVALIER, E., Schaeffner, E., Monnet, D., Sumaili, E., Ebert, N., & Pottel, H. (2020). Comparison of early-compartment correction equations for GFR measurements. Kidney International Reports, 5 (7), 1079-1081. doi:10.1016/j.ekir.2020.04.015

Evenepoel, P., Claes, K., Meijers, B., Laurent, M. R., Bammens, B., Naesens, M., Sprangers, B., Cavalier, E., & Kuypers, D. (2020). Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol. Nephrology Dialysis Transplantation. doi:10.1093/ndt/gfy306

LE GOFF, C., Kaux, J.-F., Farre Segura, J., STOJKOVIC, V., ANCION, A., SEIDEL, L., Lancellotti, P., & Cavalier, E. (January 2020). Evolution of the slopes of ST2 and galectin-3 during marathon and ultratrail running compared to a control group. Clinical Chemistry and Laboratory Medicine, 58 (2), 314-321. doi:10.1515/cclm-2019-0555

Lorentzon, M., Branco, J., Brandi, M. L., Bruyère, O., Chapurlat, R., Cooper, C., Cortet, B., Diez-Perez, A., Ferrari, S., Gasparik, A., Herrman, M., Jorgensen, N. R., Kanis, J. A., Kaufman, J. M., Laslop, A., Locquet, M., Matijevic, R., McCloskey, E. V., Minisola, S., & CAVALIER, E. (2020). Clinical application of bone turnover markers in postmenopausal osteoporosis. Osteoporosis International, 31 (S1), 65-66.

Makris, K., Sempos, C., & Cavalier, E. (2020). The measurement of vitamin D metabolites part II-the measurement of the various vitamin D metabolites. Hormones (Athens, Greece), 19 (2), 97-107. doi:10.1007/s42000-020-00188-9

Makris, K., Sempos, C., & Cavalier, E. (2020). The measurement of vitamin D metabolites: part I-metabolism of vitamin D and the measurement of 25-hydroxyvitamin D. Hormones (Athens, Greece). doi:10.1007/s42000-019-00169-7

Rozenberg, S., Bruyère, O., Bergmann, P., Cavalier, E., Gielen, E., Goemaere, S., Kaufman, J. M., Lapauw, B., Laurent, M. R., De Schepper, J., & Body, J. J. (2020). How to manage osteoporosis before the age of 50. Maturitas, 138, 14-25. doi:10.1016/j.maturitas.2020.05.004

Sanchez Rodriguez, M. D. C., Bergmann, P., Body, J. J., Cavalier, E., Gielen, E., Goemaere, S., Lapauw, B., Laurent, M. R., Rozenberg, S., Honvo, G., Beaudart, C., & Bruyère, O. (2020). The Belgian Bone Club 2020 guidelines for the management of osteoporosis in postmenopausal women. Maturitas, 139, 69 - 89. doi:10.1016/j.maturitas.2020.05.006

Sanchez Rodriguez, M. D. C., Locquet, M., Reginster, J.-Y., Cavalier, E., Bruyère, O., & Beaudart, C. (2020). Mortality in malnourished older adults diagnosed by ESPEN and GLIM criteria in the SarcoPhAge study. Journal of Cachexia, Sarcopenia and Muscle, 11 (5), 1200-1211. doi:10.1002/jcsm.12574

Sanchez Rodriguez, M. D. C., Locquet, M., Reginster, J.-Y., CAVALIER, E., Bruyère, O., & Beaudart, C. (2020). Diagnosis of malnutrition using GLIM criteria : validity of 7 pragmatic approaches which do not require the measurement of muscle mass. Osteoporosis International, 31 (S1), 618.

Tournis, S., Makris, K., Cavalier, E., & Trovas, G. (2020). Cardiovascular Risk in Patients with Primary Hyperparathyroidism. Current Pharmaceutical Design, 26 (43), 5628-5636. doi:10.2174/1381612824999201105165642

Vasikaran, S., Bhattoa, H. P., Eastell, R., Heijboer, A. C., Jørgensen, N. R., Makris, K., Ulmer, C., Kanis, J. A., Cooper, C., Silverman, S. S., & Cavalier, E. (2020). Harmonization of commercial assays for PINP; the way forward. Osteoporosis International. doi:10.1007/s00198-020-05310-6

De Maré, A., Verhulst, A., CAVALIER, E., DELANAYE, P., Behets, G. J., Meijers, B., Kuypers, D., D'Haese, P., & Evenepoel, P. (December 2019). Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease. Journal of Clinical Medicine, 8 (12), 2027. doi:10.3390/jcm8122027

LE GOFF, C., Nascimento, H., Disecare, M., PEETERS, S., & CAVALIER, E. (15 November 2019). SERUM FREE CORTISOL QUANTIFICATION BY LC-MSMS. Poster session presented at RBSLM.

LE GOFF, C., NIX, C., Huyghebaert, L., & CAVALIER, E. (15 November 2019). COMPARATIVE EVALUATION OF 4 DIFFERENT BD VACUTAINER® BLOOD COLLECTION TUBES TO STUDY THE STABILITY OF 15 STEROIDS. Poster session presented at RBSLM.

LE GOFF, C., PEETERS, S., DELEERSNYDER, J., COLLARD, G., FERRANTE, N., NIX, C., & CAVALIER, E. (15 November 2019). VALIDATION OF A NEW MAGNETIC BEAD-BASED SAMPLE PREPARATION KITS FOR URINARY CORTISOL and comparison with a home method used routinely in the lab. Poster session presented at RBSLM annual congres.

LUTTERI, L., CARLISI, I., STOJKOVIC, V., & CAVALIER, E. (15 November 2019). WHEN THE REFERENCE VALUES OF APOLIPOPROTEINS A AND B HAVE TO BE REVIEWED… Poster session presented at Annual Meeting of the Royal Belgian Society of Laboratory Medicine.

LUTTERI, L., CARLISI, I., STOJKOVIC, V., & CAVALIER, E. (15 November 2019). Evaluation of inflammatory proteins tests using Optilite Analyzer. Poster session presented at Annual Meeting of the Royal Belgian Society of Laboratory Medicine.

NIZET, A., DELEERSNYDER, J., Demeuse, J., BREVERS, E., PEETERS, S., CAVALIER, E., & LE GOFF, C. (15 November 2019). Establishment of first morning urinary free cortisol-creatinine ratio reference values. Poster session presented at Annual Joint Meeting of the Royal Belgian Society of Laboratory Medicine and the Belgian Pediatric Society, Bruxelles, Belgium.

NIZET, A., DELEERSNYDER, J., PEETERS, S., CAVALIER, E., & LE GOFF, C. (15 November 2019). The diagnosis power of urinary cortisol corrected by creatinine is it better than 24-hours urinary cortisol measurement? Poster session presented at Annual Joint Meeting of the Royal Belgian Society of Laboratory Medicine and the Belgian Pediatric Society, Bruxelles, Belgium.

STOJKOVIC, V., LUTTERI, L., & CAVALIER, E. (15 November 2019). One year of follow-up of the index for negative/positive discrimination of ANA detection on G-Sight microscope. Poster session presented at Annual Meeting of the Royal Belgian Society of Laboratory Medicine.

STOJKOVIC, V., LUTTERI, L., & CAVALIER, E. (15 November 2019). Evaluation of Quantiferon TB Gold Plus Test Using Liaison XL Analyzer. Poster session presented at Annual Meeting of the Royal Belgian Society of Laboratory Medicine.

STOJKOVIC, V., LUTTERI, L., & CAVALIER, E. (15 November 2019). Evaluation of free light chains Elisa test using AP22 Elite instrument and comparison with freelite test on SPA plus. Poster session presented at Annual Meeting of the Royal Belgian Society of Laboratory Medicine.

VRANKEN, L., BERTHOLET, C., LUKAS, P., & CAVALIER, E. (15 November 2019). Comparison of two automated assays for the determination of cobalaminin serum. Poster session presented at Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019.

VRANKEN, L., FONTAINE, C., LUKAS, P., & CAVALIER, E. (15 November 2019). Unexpected high levels of Cobalamin (Vitamin B12). Is PEG treatment useful? Poster session presented at Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019.

VRANKEN, L., FONTAINE, C., VALDES SOCIN, H. G., LUKAS, P., LE GOFF, C., Huyghebaert, L., & CAVALIER, E. (15 November 2019). Impact of Metformin on vitamin B12 status. Poster session presented at Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019.

VRANKEN, L., PIELTAIN, C., & CAVALIER, E. (15 November 2019). Evaluation of neonatal bilirubin method on GEM 5000 blood gas analyzer. Poster session presented at Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019.

NIZET, A., CAVALIER, E., STENVINKEL, P., HAARHAUS, M., & MAGNUSSON, P. (2019). Bone alkaline phosphatase : An important biomarker in chronic kidney disease - mineral and bone disorder. Clinica Chimica Acta. doi:10.1016/j.cca.2019.11.012

Mouraux, C., Van Egroo, M., Chylinski, D., Narbutas, J., LE GOFF, C., CAVALIER, E., Luxen, A., Salmon, E., Phillips, C., Maquet, P., Bastin, C., Collette, F., & Vandewalle, G. (November 2019). Effort as a sensitive variable of wakefulness extension and its impact on cognitive performance. Paper presented at BASS Annual meeting 2019, Ghent, Belgium.

CAVALIER, E. (02 October 2019). La supplémentation en vitamine D augmente-t-elle le risque de lithiase ? Paper presented at SFNDT, Nancy, France.

CAVALIER, E. (2019). Vitamine D, arthrose et ostéoporose. La Lettre du Rhumatologue, (455), 32-35.

CAVALIER, E. (October 2019). Vitamin D determination: Perspectives from the IFCC committee on bone metabolism. Paper presented at Vitamin D – minimum, maximum, optimum” 4th edition conference in Warsaw.

Cavalier, E., Souberbielle, J.-C., & Delanaye, P. (2019). PTH determination in hemodialyzed patients—A laboratory perspective. Seminars in Dialysis. doi:10.1111/sdi.12844

DELANAYE, P., VRANKEN, L., Pottel, H., & CAVALIER, E. (2019). Impact du choix de l’équation basée sur la créatinine sur la classification de la maladie rénale chronique dans une base de données de laboratoire. Néphrologie et Thérapeutique.

DELANAYE, P., VRANKEN, L., Schoneveld, L., LAMBERMONT, B., & CAVALIER, E. (2019). Prévalence de l’atteinte rénale aigue chez le patient hospitalisé en fonction du critère de variation de la créatinine utilisée. Néphrologie et Thérapeutique.

Radišić Biljak, V. R., Grubb, A., Guerra, I. C., Cavalier, E., Raymondo, S., Sierra-Amor, R., Mussap, M., Kamathan, S. N., Yucel, D., Datta, P., Wada, T., & Alcantara, F. F. (October 2019). The first step in creating national Chronic Kidney Disease (CKD) guidelines - a questionnaire. Biochemia Medica, 29 (3), 030301. doi:10.11613/BM.2019.030301

CAVALIER, E. (27 September 2019). Standardization of PTH assays: methodological and analytical challenges. Paper presented at 6th African Congress of Clinical Biology and 19th Moroccan congress of clinical Biology, Marrakech, Morocco.

Nyssen, L., Fillet, M., CAVALIER, E., & Servais, A.-C. (26 September 2019). Separation of Intact Parathyroid Hormone and Variants Using a Highly Sensitive Sheathless CE-ESI-MS/MS Method. Poster session presented at MSACL 2019 EU.

CAVALIER, E. (23 September 2019). Vitamin D determination: analytical and (some) clinical considerations and perspectives. Paper presented at XIVth Congress of Czech Society of Clinical Biochemistry, Pilsen, Cracovie, Poland.

Bargnoux, A.-S., Barguil, Y., Cavalier, E., & Cristol, J.-P. (August 2019). Estimation du débit de filtration glomérulaire par la cystatine C. Annales de Biologie Clinique, 77 (4), 375-380. doi:10.1684/abc.2019.1456

Ion, V., Le Goff, C., Cavalier, E., Delanaye, P., Servais, A.-C., Muntean, D.-L., & Fillet, M. (August 2019). Determination of iohexol by capillary blood microsampling and UHPLC-MS/MS. Journal of Pharmaceutical Analysis, 9 (4), 259-265. doi:10.1016/j.jpha.2019.06.003

LADANG, A., Beaudart, C., Locquet, M., Reginster, J.-Y., Bruyère, O., & Cavalier, E. (July 2019). Fragility fracture risk prediction in elderly people based on a micro RNA panel. Osteoporosis International, 30 (S2), 299-S300.

Le Goff, C., Marguerit, K., Kaux, J.-F., Millet, G., Viallon, M., Croisille, P., Cavalier, E., & Ladang, A. (2019). Impact of participating to a 330 km long ultra-trail versus a 67 km short ultra-trail on muscular and cardiac genetic regulation by microRNAs. In V. Bunc & E. Tsolakidis, Book of abstracts - 24th Annual Congress of the European College of Sport Science (pp. 255).

CASTIGLIONE, V., Pottel, H., Lieske, J. C., LUKAS, P., CAVALIER, E., DELANAYE, P., & Rule, A. (2019). Evaluation of inactive Matrix-Gla-Protein (MGP) as a biomarker for incident and recurrent kidney stones. Journal of Nephrology. doi:10.1007/s40620-019-00623-0

GADISSEUR, R., HAMIDOU, T., Cavalier, E. (Other coll.), Courtois, J. (Other coll.), vanderbrempt, X. (Other coll.), Tollenaere, S. (Other coll.), Maizoumbou (Other coll.), Jacquier (Other coll.), & Laouali (Other coll.). (03 June 2019). Sensitization profile of cricket food-allergic or cricket tolerant patients in an entomophagous population in Niamey, Niger. Allergy, 74.

GADISSEUR, R., LUKAS, P., & Cavalier, E. (03 June 2019). Phleum pratense may be taken as a marker allergen for Gx3 grass mix. Allergy, 74 (106), 101-331.

GADISSEUR, R., LUKAS, P., & Cavalier, E. (03 June 2019). Betula verrucosa may be taken as a marker allergen for Tx5 tree mix. Allergy, 74 (106), 130-331.

Bouchard-Lovighi, G., Veillet, A., Tsoumperi, D., Pages, J., Favre, C., Brossault, L., Dromenq, L., Tessonneau, M., Mougin, B., Priolo, G., Martinasso, G., Mengozzi, G., LUKAS, P., & CAVALIER, E. (June 2019). VIDAS PTH(1-84) ASSAY: Reference limits and comparison with three other third generation PTH assays. Clinica Chimica Acta, 493 (Supplement 1), 331.

STOJKOVIC, V., LUTTERI, L., & CAVALIER, E. (June 2019). Evaluation of the Sebia free light chains ELISA using the AP22 Elite instrument. Poster session presented at Euromedlab, Barcelone, Spain.

STOJKOVIC, V., LUTTERI, L., & CAVALIER, E. (June 2019). Evaluation of Diasorin Quantiferon-TB Gold Plus test using Liaison XL. Poster session presented at Euromedlab, Barcelone, Spain.

STOJKOVIC, V., LUTTERI, L., & CAVALIER, E. (June 2019). Evaluation and perspectives of the index for negative/positive discrimination of ANA detection on G-Sight microscope. Poster session presented at Euromedlab, Barcelone, Spain.

LE GOFF, C., BECKERS, P., LUKAS, P., NIX, C., PEETERS, S., & CAVALIER, E. (21 May 2019). The new Diasorin Androstenedione immunoassay: analytical performances,comparison with a LC-MS/MS and establishment of the reference range values. Poster session presented at Euromedlab, Barcelone, Spain.

LE GOFF, C., Gilson, M., Lahr, M., CAVALIER, E., & LEBRETHON, M.-C. (21 May 2019). Premature adrenarche : DHEA Sulfate by Immunoassay or LC-MS/MS ? Poster session presented at Euromedlab, Barcelone, Spain.

LE GOFF, C., NIX, C., & CAVALIER, E. (21 May 2019). Comparative evaluation of 4 different BD Vacutainer® blood collection tubes to study the stability of 15 steroid hormones detremined by LC-MS/MS. Poster session presented at Euromedlab, Barcelone, Spain.

LE GOFF, C., Nyssen, L., FERRANTE, N., PEETERS, S., & CAVALIER, E. (21 May 2019). Validation of the serum iohexol LC-MS/MS method using iohexol deuterated (D5) as internal standard. Poster session presented at Euromedlab, Barcelone, Spain.

LE GOFF, C., PEETERS, S., DELEERSNYDER, J., GENDEBIEN, A.-S., NIX, C., & CAVALIER, E. (21 May 2019). Validation of a new magnetic bead-based biological sample preparation kits for urinary cortisol and comparison with a home method used routinely in the lab. Poster session presented at Euromedlab, Barcelone, Spain.

LE GOFF, C., PEETERS, S., GENDEBIEN, A.-S., & CAVALIER, E. (21 May 2019). Evaluation of a new magnetic bead-based biological sample preparation kits for vitamin D analysis by LC-MS/MS. Poster session presented at Euromedlab, Barcelone, Spain.

LE GOFF, C., PEETERS, S., GENDEBIEN, A.-S., NIX, C., & CAVALIER, E. (21 May 2019). Evaluation of a new magnetic bead-based biological sample preparation kits for a panel of 11 steroides determined by LC-MS/MS. Poster session presented at Euromedlab, Barcelone, Spain.

LE GOFF, C., VRANKEN, L., PEETERS, S., GENDEBIEN, A.-S., Huyghebaert, L., Fabregat Cabello, N., & CAVALIER, E. (21 May 2019). Determination of serum androstanediol glucuronide reference range intervals in a cohort of heathy Belgian subjects. Poster session presented at Euromedlab IFCC.

LE GOFF, C., Zelzer, S., Huyghebaert, L., Farre Segura, J., Fabregat Cabello, N., Hermann, M., & CAVALIER, E. (21 May 2019). Method comparison of the 24,25(OH)2D3 measurement with two different LCMS/MS assays. Poster session presented at Euromedlab, Barcelone, Spain.

CAVALIER, E. (20 May 2019). Old and new biomarkers for kidney disease. Paper presented at 23rd IFCC-EFLM European Congress, Barcelone, Spain.

CAVALIER, E. (2019). Vitamin D: from bone and beyond. Paper presented at Diasorin Test the future, Lingotto, Turin, Italy.

BERTHOLET, C., Lamtiri-Laarif, M., VRANKEN, L., GADISSEUR, R., DELCOUR, S., & CAVALIER, E. (May 2019). Verification of the reference intervals proposed by Abbott on Alinity ci in a population of healthy subjects from Liege, Belgium. Poster session presented at Euromedlab IFCC.

DE VOEGHT, A., Godon, E., Chachati, A., CAVALIER, E., & Buysschaert, B. (2019). HYPERCALCÉMIE SUR INTOXICATION À LA VITAMINE D : VIGNETTE CLINIQUE ET REVUE DE LA LITTÉRATURE. Louvain Medical.

LADANG, A., BERTHOLET, C., VRANKEN, L., & CAVALIER, E. (May 2019). GLOBAL STRATEGY OF IMPLEMENTATION OF CALIPER PEDIATRIC REFERENCE VALUES IN A BELGIAN INSTITUTE. Poster session presented at Euromedlab 2019.

LADANG, A., ROUSSELLE, O., BEKAERT, A.-C., KOVACS, S., & CAVALIER, E. (May 2019). PEDIATRIC REFERENCE INTERVALS FOR BONE ALKALINE PHOSPHATASE ON LIAISON° XL. Poster session presented at Euromedlab 2019.

LADANG, A., ROUSSELLE, O., Huyghebaert, L., BEKAERT, A.-C., KOVACS, S., LE GOFF, C., & CAVALIER, E. (May 2019). EVALUATION OF PARATHORMONE AND 25-HYDROXYVITAMIN D STATUS IN A LARGE. Poster session presented at Euromedlab 2019.

LADANG, A., ROUSSELLE, O., Huyghebaert, L., BEKAERT, A.-C., KOVACS, S., LE GOFF, C., & CAVALIER, E. (May 2019). 24,25(OH)2D AS A MARKER OF VITAMIN D DEFICIENCY IN CHILDREN: A RETROSPECTIVE. Poster session presented at Euromedlab 2019.

LADANG, A., Seynaeve, Y., & CAVALIER, E. (May 2019). DIAGNOSTIC POTENTIAL OF MIRNAS IN PARATHYROID CARCINOMAS. Poster session presented at Euromedlab 2019.

Senterre, Y., Fombellida, K., CAVALIER, E., PAQUOT, N., & DELANAYE, P. (May 2019). Are variations of glycated hemoglobin given by the freestyle device accurate? Poster session presented at XXIII IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, Barcelone, Spain.

VALDES SOCIN, H. G., VRANKEN, L., Schoneveld, L., DELANNOY, P., Le Goff, C., Beckers, A., & CAVALIER, E. (2019). Vitamin B12 deficiency prevalence and associated biomarkers in type 2 Diabetes (T2DM) treated with metformin : biochemical assessment in a series of 106 patients. In Endocrine Abstracts - ECE 2019.

VRANKEN, L., BERTHOLET, C., LUKAS, P., & CAVALIER, E. (May 2019). Comparison of two automated assays for the determination of cobalamin in serum. Which one to choose? Poster session presented at 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Barcelona 2019.

VRANKEN, L., FONTAINE, C., LUKAS, P., & CAVALIER, E. (May 2019). Unexpected high levels of Cobalamin(Vitamin B12). Is PEG treatment a solution? Poster session presented at 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Barcelona 2019.

VRANKEN, L., FONTAINE, C., LUKAS, P., LE GOFF, C., Huyghebaert, L., CAVALIER, E., & VALDES SOCIN, H. G. (May 2019). Evaluation of Metformin impact on vitamin B12 status. Poster session presented at 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Barcelona 2019, Barcelone, Spain.

CAVALIER, E. (04 April 2019). Vitamine D, arthrose et ostéoporose. Paper presented at WCO (IOF ESCEO), Paris, France.

LADANG, A., Beaudart, C., Locquet, M., Reginster, J.-Y., Bruyère, O., & CAVALIER, E. (April 2019). Risk-fracture prediction in elderly people based on a microRNA panel. Poster session presented at IOF-WHO osteoporosis congress.

CAVALIER, E. (26 March 2019). Considérations pratiques sur l’hormone parathyroïdienne et son dosage. Paper presented at Bien vieillir avec PTH et Vitamine D, Lyon, France.

Carter, G. D., Ahmed, F., Berry, J., Cavalier, E., Durazo-Arvizu, R., Gunter, E., Jones, G., Jones, J., Phinney, K., Sempos, C. T., Twomey, P. J., Williams, E. L., & Wise, S. A. (March 2019). External Quality Assessment of 24,25-dihydroxyvitamin D3 (24,25(OH)2D3) assays. Journal of Steroid Biochemistry and Molecular Biology, 187, 130-133. doi:10.1016/j.jsbmb.2018.11.010

CAVALIER, E. (February 2019). A new 3rd generation PTH is born: insights on the bioMérieux Vidas Assays. Paper presented at Medlab Middle East Exhibition and Congress 2019.

Le Goff, C., Lennartz, L., VRANKEN, L., Kaux, J.-F., & Cavalier, E. (February 2019). Comparison of cardiac biomarker dynamics in marathon, semimarathon and untrained runners: what is the impact on results interpretation? Journal of Laboratory and Precision Medicine, 4 (6), 10. doi:10.21037/jlpm.2019.01.04

DELANAYE, P., Bataille, S., Quinonez, K., Buckinx, F., Warling, X., KRZESINSKI, J.-M., Pottel, H., Burtey, S., Bruyère, O., & CAVALIER, E. (25 January 2019). Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis. Journal of Renal Nutrition, 29 (6), 511-520. doi:10.1053/j.jrn.2018.11.010

Biver, E., Berenbaum, F., Valdes, A. M., Araujo de Carvalho, I., Bindels, L. B., Brandi, M. L., Calder, P. C., Castronovo, V., Cavalier, E., Cherubini, A., Cooper, C., Dennison, E., Franceschi, C., Fuggle, N., Laslop, A., Miossec, P., Thomas, T., Tuzun, S., Veronese, N., & Rizzoli, R. (2019). Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Ageing Research Reviews, 55. doi:10.1016/j.arr.2019.100946

BOUQUEGNEAU, A., Evenepoel, P., PAQUOT, F., MALAISE, O., CAVALIER, E., & DELANAYE, P. (2019). Sclerostin within the chronic kidney disease spectrum. Clinica Chimica Acta, 502, 84-90. doi:10.1016/j.cca.2019.12.008

Bukabau, J., Yayo, E., Gnionsahé, A., Monnet, D., Pottel, H., CAVALIER, E., Nkodila, A., Makula, Mokoli, V., Lepira, F., Nseka, M., KRZESINSKI, J.-M., Sumaili, E., & DELANAYE, P. (2019). Performance of creatinine- or cystatin C-based equations to estimate glomerular filtration rate in sub-Saharan African populations. Kidney International, 95 (5), 1181-1189. doi:10.1016/j.kint.2018.11.045

Cavalier, E. (2019). Professor Howard A. Morris. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 30 (8), 1711. doi:10.1007/s00198-019-05019-1

CAVALIER, E. (January 2019). Parathyroid hormone results interpretation in the background of variable analytical performance. Journal of Laboratory and Precision Medicine, 4 (1). doi:10.21037/jlpm.2018.12.03

Cavalier, E., Eastell, R., Rye Jørgensen, N., Makris, K., Tournis, S., Vasikaran, S., Kanis, J. A., Cooper, C., Pottel, H., & Morris, H. A. (2019). A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type i procollagen (PINP): A report from the IFCC-IOF Joint Committee for Bone Metabolism. Clinical Chemistry and Laboratory Medicine. doi:10.1515/cclm-2019-0174

Cavalier, E., Sagou Yayo, E., Attoungbre-Hauhouot, M.-L., Konan, J.-L., Yao-Yapo, C., Monnet, D., Gnionsahe, A., Souberbielle, J.-C., & DELANAYE, P. (2019). Vitamin D, bone alkaline phosphatase and parathyroid hormone in healthy subjects and haemodialysed patients from West Africa: impact of reference ranges and parathyroid hormone generation assays on the KDIGO guidelines. Clinical Kidney Journal, 12 (2), 288-293. doi:10.1093/ckj/sfy074

Delanaye, P., Bataille, P., Quinonez, K., Buckinx, F., Warling, X., KRZESINSKI, J.-M., Pottel, H., Burtey, S., Bruyère, O., & CAVALIER, E. (2019). Myostatin and insulin growth factor 1 are biomarkers of muscle strength, muscle mass, and mortality in hemodialysis patients. Osteoporosis International, 30 (S2), 270.

Delvin, E., Alos, N., Rauch, F., Marcil, V., Morel, S., Boisvert, M., Lecours, M.-A., Laverdière, C., Sinnett, D., Krajinovic, M., Dubois, J., Drouin, S., Lefebvre, G., Samoilenko, M., Nyalendo, C., Cavalier, E., & Levy, E. (2019). Vitamin D nutritional status and bone turnover markers in childhood acute lymphoblastic leukemia survivors: A PETALE study. Clinical Nutrition. doi:10.1016/j.clnu.2018.02.006

Dupuy, A. M., Bargnoux, A. S., Morena, M., Lauret, E., Souberbielle, J.-C., Cavalier, E., & Cristol, J. P. (2019). Moving from the second to the third generation Roche PTH assays: What are the consequences for clinical practice? Clinical Chemistry and Laboratory Medicine. doi:10.1515/cclm-2018-0300

Durazo-Arvizu, R., Ahmed, F., Berry, J., Cavalier, E., Gunter, E., Jones, G., Jones, J., Sempos, C. T., Twomey, P. J., Williams, E. L., & Carter, G. D. (2019). Estimating uncertainty of target values for DEQAS serum materials. Journal of Steroid Biochemistry and Molecular Biology. doi:10.1016/j.jsbmb.2018.12.011

Evenepoel, P., Claes, K., Cavalier, E., Meijers, B., Stenvinkel, P., Behets, G. J., Jankowska, M., D'Haese, P., & Bammens, B. (2019). A distinct bone phenotype in ADPKD patients with end-stage renal disease. Kidney International, 95 (2), 412-419. doi:10.1016/j.kint.2018.09.018

Evenepoel, P., Claes, K., Meijers, B., Laurent, M., Bammens, B., Naesens, M., Sprangers, B., Pottel, H., Cavalier, E., & Kuypers, D. (2019). Poor Vitamin K Status Is Associated With Low Bone Mineral Density and Increased Fracture Risk in End-Stage Renal Disease. Journal of Bone and Mineral Research. doi:10.1002/jbmr.3608

Evenepoel, P., Claes, K. J., Meijers, B. K. I., Laurent, M. R., Bammens, B. R. M., Naesens, M., Sprangers, B., Pottel, H., Cavalier, E., & Kuypers, D. R. J. (2019). Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients. Kidney International, 95 (6), 1461-1470. doi:10.1016/j.kint.2018.12.024

Fabregat Cabello, N., DARIMONT, P., Huyghebaert, L., Reynier, P., Annweiler, C., Milea, D., Le Goff, C., & Cavalier, E. (2019). Liquid chromatography-tandem mass spectrometry for monitoring Vitamin D hydroxymetabolites in human aqueous humor. Analytical Methods, 11 (41), 5282-5288. doi:10.1039/c9ay01896d

Fabregat Cabello, N., PEETERS, S., Yilmaz, T., Cavalier, E., & Le Goff, C. (2019). Establishment of reference intervals for serum concentrations of androstanediol glucuronide by a newly developed LC-MS/MS method. Steroids, 143, 62-66. doi:10.1016/j.steroids.2018.12.008

Ion, V., Nys, G., COBRAIVILLE, G., Cavalier, E., Crommen, J., Servais, A.-C., Muntean, D.-L., & Fillet, M. (2019). Ultra-high-performance liquid chromatography-mass spectrometry method for neutrophil gelatinase-associated lipocalin as a predictive biomarker in acute kidney injury. Talanta, 195, 668-675. doi:10.1016/j.talanta.2018.11.050

LE GOFF, C., Zelzer, S., Farre Segura, J., Fabregat Cabello, N., Hermann, M., & CAVALIER, E. (2019). METHOD COMPARISON OF THE 24,25(OH)2D3 MEASUREMENT WITH TWO DIFFERENT LC-MS/MS METHODS. Poster session presented at RBSLM.

Lorentzon, M., Branco, J. C., Brandi, M. L., Bruyère, O., Chapurlat, R. D., Cooper, C., Cortet, B., Diez-Perez, A. D., Ferrari, S. L., Gasparik, A. I., Herrmann, M., Jorgensen, N. R., Kanis, J. A., Kaufman, J.-M., Laslop, A., Locquet, M., Matijevic, R., McCloskey, E. V., Minisola, S., & Cavalier, E. (2019). Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis. Advances in Therapy, 36 (10), 2811-2824. doi:10.1007/s12325-019-01063-9

masson, G., VRANKEN, L., KRZESINSKI, J.-M., Pottel, H., CAVALIER, E., & DELANAYE, P. (2019). Impact of the creatinine-based equations used on the chronic kidney disease classification in a large laboratory database. Nephrology Dialysis Transplantation.

Nyssen, L., Fillet, M., Cavalier, E., & Servais, A.-C. (2019). Highly sensitive and selective separation of intact parathyroid hormone and variants by sheathless CE-ESI-MS/MS. Electrophoresis. doi:10.1002/elps.201800507

Pitarch-Motellón, J., Fabregat Cabello, N., Le Goff, C., Roig-Navarro, A. F., Sancho-Llopis, J. V., & Cavalier, E. (2019). Comparison of isotope pattern deconvolution and calibration curve quantification methods for the determination of estrone and 17β-estradiol in human serum. Journal of Pharmaceutical and Biomedical Analysis, 171, 164-170. doi:10.1016/j.jpba.2019.04.013

Pitarch-Motellón, J., Roig-Navarro, A. F., Le Goff, C., CAVALIER, E., & Fabregat Cabello, N. (2019). Re-certification of hydroxyvitamin D standards by isotope pattern deconvolution. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 1120, 89-94. doi:10.1016/j.jchromb.2019.04.043

Souberbielle, J.-C., Cormier, C., Cavalier, E., Breuil, V., Debiais, F., Fardellone, P., Guggenbuhl, P., Javier, R.-M., Legrand, É., Lespessailles, É., Paccou, J., Thomas, T. C., & Cortet, B. (2019). La supplémentation en vitamine D en France chez les patients ostéoporotiques ou à risque d'ostéoporose : données récentes et nouvelles pratiques. Revue du Rhumatisme (Edition Francaise), 86, 448-452. doi:10.1016/j.rhum.2019.02.014

Souberbielle, J.-C., Cormier, C., Cavalier, E., Breuil, V., Debiais, F., Fardellone, P., Guggenbuhl, P., Javier, R.-M., Legrand, É., Lespessailles, É., Paccou, J., Thomas, T., Cortet, B., & au nom du Groupe de recherche et d'information sur les osteoporoses, G. (2019). Vitamin D Supplementation in France in patients with or at risk for osteoporosis: Recent data and new practices. Joint Bone Spine. doi:10.1016/j.jbspin.2019.04.004

STOJKOVIC, V., Delanaye, P., COLLARD, G., FERRANTE, N., Le Goff, C., Lutteri, L., & Cavalier, E. (2019). Estimated glomerular filtration rate using a point of care measure of creatinine in patients with iohexol determinate GFR. Clinica Chimica Acta, 499, 123-127. doi:10.1016/j.cca.2019.08.032

Sumaili, E. K., Shemer, R., Kruzel-Davila, E., Cohen, E. P., Mutantu, P. N., Bukabau, J. B., Makulo, J. R. R., Mokoli, V. M., Luse, J. L., Pakasa, N. M., Cavalier, E., Wumba, R. D., Reiner-Benaim, A., Boner, G., Lifschitz, M., Nseka, N. M., Skorecki, K., & Wasser, W. G. (2019). G1 is the major APOL1 risk allele for hypertension-attributed nephropathy in Central Africa. Clinical Kidney Journal, 12 (2), 188-195. doi:10.1093/ckj/sfy073

Urena-Torres, P. A., Vervloet, M., Mazzaferro, S., Oury, F., Brandenburg, V., Bover, J., Cavalier, E., Cohen-Solal, M., Covic, A., Drueke, T. B., Hindie, E., Evenepoel, P., Frazao, J., Goldsmith, D., Kazama, J. J., Cozzolino, M., & Massy, Z. A. (2019). Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease. Clinical Kidney Journal, 12 (2), 269-280. doi:10.1093/ckj/sfy061

Van Egroo, M., Narbutas, J., Chylinski, D., Villar Gonzalez, P., Ghaemmaghami Tabrizi, P., Muto, V., Schmidt, C., Gaggioni, G., Besson, G., Pepin, X., Tezel, E., Marzoli, D., Le Goff, C., Cavalier, E., Luxen, A., Salmon, E., Maquet, P., Bahri, M. A., Phillips, C., & Vandewalle, G. (2019). Preserved wake-dependent cortical excitability dynamics predict cognitive fitness beyond age-related brain alterations. Communications Biology, 2, 449. doi:10.1038/s42003-019-0693-y

Xia, W., Cooper, C., Li, M., Xu, L., Rizzoli, R., Zhu, M., Lin, H., Beard, J., Ding, Y., Yu, W., CAVALIER, E., Zhang, Z., Kanis, J. A., Cheng, Q., Wang, Q., & Reginster, J.-Y. (2019). East meets West: current practices and policies in the management of musculoskeletal aging. Aging Clinical and Experimental Research, 31 (10), 1351-1373. doi:10.1007/s40520-019-01282-8

Ion, V., Nys, G., COBRAIVILLE, G., CAVALIER, E., Servais, A.-C., Muntean, D.-L., & Fillet, M. (19 December 2018). Targeted LC-MS/MS proteomics approach for the analysis of Neutrophyl Gelatinase Associated Lipocalin in AKI patients. Poster session presented at 1st CIRM Day, Liège, Belgium.

Nyssen, L., Fillet, M., CAVALIER, E., & Servais, A.-C. (19 December 2018). High sensitive and selective separation of intact parathyroid hormone and related forms by sheathless CE-ESI-MS/MS. Poster session presented at 1st CIRM Day, Liège, Belgium.

Cavalier, E. (11 December 2018). Bone and mineral symposium. Paper presented at Bone and mineral symposium, Diasorin Workshop, Amersfoort, Netherlands.

Cavalier, E. (07 December 2018). What would be the drivers to use 3rd generation PTH assays in CKD patients? Paper presented at FGF23 and PTH 3rd generation, Diasorin working group.

Courtois, J., Hamidou, T., Van der Brempt, X., GADISSEUR, R., Cavalier, E., & Tollenaere, S. (01 December 2018). Highlighting of allergens found in edible crickets (Ornithachris turbida cavroisi) from Niger using 2D Western blot – a clinical case report. Paper presented at BelSACI.

Castiglione, V., GADISSEUR, R., Bernard, M., & Cavalier, E. (16 November 2018). Urine sediment analysis: comparison of three automated analyzers to manual microscopy. Poster session presented at Joint annual meeting of the Royal belgian Society of Laboratory Medicine and the Belgian Thyroid Club.

Castiglione, V., GADISSEUR, R., Bernard, M., & Cavalier, E. (16 November 2018). Diagnostic accuracy of three automated urine analyzers compared to urine culture. Poster session presented at Joint annual meeting of the Royal belgian Society of Laboratory Medicine and the Belgian Thyroid Club.

Castiglione, V., GADISSEUR, R., Bernard, M., & Cavalier, E. (16 November 2018). Comparison of three automated strip analyzers to Cobas 800 for the analysis of glucose, proteins, albumin and creatinine. Poster session presented at Joint annual meeting of the Royal belgian Society of Laboratory Medicine and the Belgian Thyroid Club.

Castiglione, V., Sacre, P.-Y., Cavalier, E., Hubert, P., GADISSEUR, R., & Ziemons, E. (16 November 2018). Raman chemical imaging, a new tool in kidney stone structure analysis: Case-study and comparison to Fourier Transform Infrared spectroscopy. Poster session presented at Joint Annual Meeting of the Royal Belgian Society of Laboratory Medicine and the Belgian Thyroid Club.

Courtois, J., Hamidou, T., Van der Brempt, X., GADISSEUR, R., Cavalier, E., & Tollenaere, S. (16 November 2018). Highlighting of allergens found in edible crickets (Ornithachris turbida cavroisi) from Niger using 2D Western blot – a clinical case report. Poster session presented at Royal Belgian Society of Laboratory Medicine, Belgium.

Courtois, J., Quinting, B., Van der Brempt, X., GADISSEUR, R., Cavalier, E., & Tollenaere, S. (16 November 2018). Highlighting of an allergenic cross-reaction between crustaceans, house dust mites and crickets using 2D Western blot. Poster session presented at Royal Belgian Society of Laboratory Medicine, Belgium.

Cavalier, E. (11 November 2018). Thematic Approaches: the exemple of Bone metabolism. Paper presented at IFCC General Conference, Budapest, Hungary.

CASTIGLIONE, V., CAVALIER, E., & GADISSEUR, R. (2018). Clinical data on rare Sulfamethoxazole crystalluria assessed by Fourier Transform Infrared Spectrophotometry. Data in Brief. doi:10.1016/j.dib.2018.11.006

Nicolescu, C. R., Lombet, J., & Cavalier, E. (November 2018). Vitamin D-Resistant Rickets and Cinacalcet-One More Favorable Experience. Frontiers in Pediatrics, 6, 376. doi:10.3389/fped.2018.00376

Castiglione, V., DELANAYE, P., LUKAS, P., & CAVALIER, E. (19 October 2018). Matrix-Gla-Protein: un nouveau marqueur de lithiase urinaire? Paper presented at 23e Confrontations Clinico-Biologiques sur la Lithiase Urinaire, Paris, France.

CAVALIER, E. (17 October 2018). Current European practices for using biochemical markers of bone turnover in the diagnosis and management of osteoporosis. Paper presented at East meets West, Suzhou, China.

Nyssen, L., Fillet, M., CAVALIER, E., & Servais, A.-C. (October 2018). CESI-MS Workflow for Protein Quantification. Poster session presented at CESI-MS symposium 2018, Leiden, Netherlands.

Résimont, G., GADISSEUR, R., LUTTERI, L., KRZESINSKI, J.-M., CAVALIER, E., & DELANAYE, P. (October 2018). Comment j'explore...Une protéinurie. Revue Médicale de Liège, 73 (10), 519-525.

GADISSEUR, R., MUSSO, G., Cavalier, E., & VRANKEN, L. (Other coll.). (28 September 2018). Validation of 24 blood gas analyzers, GEM 5000 Premier. Poster session presented at AACC POCT, washington, United States.

Cavalier, E. (14 September 2018). Biomarkers from bone...and beyond! Paper presented at EURECA-m and CKD-MBD working group, Thessaloniki, Greece.

Farre Segura, J., Fabregat Cabello, N., Nyssen, L., PEETERS, S., Le Goff, C., & Cavalier, E. (13 September 2018). A newly developed LC-MS/MS method for the quantitation of Glucagon in plasma shows the lack of specificity of a former immunoassay method. Paper presented at 5th Annual Conference MSACL (Mass Spectrometry: Applications to the Clinical Lab) 2018 EU, Salzburg, Austria.

Arias-Carnero, B., PEETERS, S., DEVILLE, M., LE GOFF, C., Cavalier, E., & Fabregat Cabello, N. (12 September 2018). Cortisol everywhere! Poster session presented at MSACL EU 2018, Salzburg, Austria.

Pitarch-Motellón, J., Cavalier, E., LE GOFF, C., PEETERS, S., & Fabregat Cabello, N. (12 September 2018). Development and Validation of the Simultaneous Measurement of Estrone and 17β-Estradiol in Serum by LC-MS/MS for Clinical Laboratory Applications. Poster session presented at MSACL EU 2018, Salzburg, Austria.

Van Egroo, M., Narbutas, J., Besson, G., Muto, V., Chylinski, D., Villar Gonzalez, P., Gaggioni, G., Ghaemmaghami Tabrizi, P., Pepin, X., Cerasuolo, M., Blanpain, M., Tezel, E., LE GOFF, C., CAVALIER, E., Lambot, E., Laloux, S., Hagelstein, C., Luxen, A., Degueldre, C., & Vandewalle, G. (September 2018). Preserved Neuron Reactivity Dynamics during Prolonged Wakefulness is Linked to Cognitive Fitness in Aging, Independently of Tau and Amyloid Beta Burden. Paper presented at 24th Congress of the European Sleep Research Society, Basel, Switzerland.

Castiglione, V., Sacre, P.-Y., CAVALIER, E., Hubert, P., GADISSEUR, R., & Ziemons, E. (03 August 2018). Raman Chemical Imaging, a new tool in kidney stone structure analysis: Case-study and comparison to Fourier Transform Infrared spectroscopy. PLoS ONE, 13 (8), 0201460. doi:10.1371/journal.pone.0201460

Le Goff, C., VRANKEN, L., Kaux, J.-F., Lennartz, L., & Cavalier, E. (2018). CARDIAC BIOMARKERS FLUCTUATION IN RUNNERS OF MARATHONS, SEMI-MARATHONS AND UNTRAINED RUNNERS. In 23rd Annual Congress of the ECSS (pp. 150).

Yayo, E., Aye, M., Yao, C., Gnionsahe, A., Attoungbre, M.-L., Cavalier, E., Pottel, H., Monnet, D., & DELANAYE, P. (July 2018). Measured (and estimated) glomerular filtration rate: reference values in West Africa. Nephrology Dialysis Transplantation, 33 (7), 1176-1180. doi:10.1093/ndt/gfx244

Cavalier, E. (11 June 2018). Parathormone: aspects clinique et analytiques. Paper presented at Lundis de Lausanne, Switzerland.

Cavalier, E. (07 June 2018). Parathyroid hormone: analytical and clinical perspectives. Paper presented at Serbis 2018.

Schmidt, C., Xhrouet, M., Hamacher, M., Delloye, E., Le Goff, C., Cavalier, E., Collette, F., & Vandewalle, G. (June 2018). Light exposure via a head-mounted device suppresses melatonin and improves vigilant attention without affecting cortisol and comfort. PsyCh Journal, 7. doi:10.1002/pchj.215

Cavalier, E. (04 May 2018). Biomarkers of bone and muscle remoddeling in osteoporosis and sarcopenia: diagnosis and monitoring. Paper presented at ESPRM.

Coic, L., Castiglione, V., Sacre, P.-Y., Hubert, P., GADISSEUR, R., CAVALIER, E., & Ziemons, E. (May 2018). Elucidation de la structure de la lithiase urinaire par imagerie IR-TF. Poster session presented at 11èmes journées scientifiques du Réseau Français de Métabolomique et Fluxomique, Liege, Belgium.

Courtois, J., GADISSEUR, R., Quinting, B., Van der Brempt, X., CAVALIER, E., & Tollenaere, S. (May 2018). Interest of 2D Western blot in the analysis of an allergenic cross-reaction with crickets. Poster session presented at International symposium of the European Academy of Allergy and Clinical Immunology.

De Niet, S., Coffiner, M., Da Silva, S., JANDRAIN, B., Souberbielle, J.-C., & Cavalier, E. (May 2018). A Randomized Study to Compare a Monthly to a Daily Administration of Vitamin D(3) Supplementation. Nutrients, 10 (6). doi:10.3390/nu10060659

VALDES SOCIN, H. G., BETEA, D., Daly, A., DELANAYE, P., Souberbielle, J.-C., Beckers, A., & CAVALIER, E. (May 2018). hCG as a diagnostic test to differentiate between parathyroid carcinoma, primary benign hyperparathyroidism and secondary hyperparathyroidism. Poster session presented at 20th European Congress of Endocrinology.

VRANKEN, L., FONTAINE, C., SOUBERBIELLE, J.-C., & CAVALIER, E. (May 2018). 24,25-dihydroxyvitamin D: a new biomarker in non-parathyroid hypercalcemia diagnosis. Clinical Laboratory International, 42 (April/May), 23-25.

Cavalier, E. (21 April 2018). Meet- the-expert session: Sound use of bone turnover markers. Paper presented at WCO WORLD CONGRESS ON OSTEOPOROSIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASES.

Cavalier, E. (21 April 2018). Clinical application of bone markers assay standardization. Report of the IOF/IFCC Bone turnover marker working group. Paper presented at WORLD CONGRESS ON OSTEOPOROSIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASES, krakow, Poland.

Fabregat Cabello, N., Pitarch-Motellón, J., LE GOFF, C., & Cavalier, E. (20 April 2018). Recertification of 25-hydroxyvitamin D standards by Isotope Pattern Deconvolution (IPD). Paper presented at Benelux Association of Stable Isotopes, (BASIS), Liège, Belgium.

Courtois, J., GADISSEUR, R., Quinting, B., Van der Brempt, X., CAVALIER, E., & Tollenaere, S. (16 April 2018). Mise en évidence par Western blot 2D de réactions allergiques croisées entre les crustacés, acariens et grillons. Revue Française d'Allergologie, 58 (3), 232. doi:10.1016/j.reval.2018.02.024

Cavalier, E., Salse, M., Dupuy, A.-M., Bargnoux, A.-S., WATAR, F., Souberbielle, J.-C., DELANAYE, P., & Cristol, J.-P. (April 2018). Establishment of reference values in a healthy population and interpretation of serum PTH concentrations in hemodialyzed patients according to the KDIGO Guidelines using the Lumipulse(R) G whole PTH (3rd generation) assay. Clinical Biochemistry, 54, 119-122. doi:10.1016/j.clinbiochem.2018.02.019

Reginster, J.-Y., Arden, N. K., Haugen, I., Rannou, F., Cavalier, E., Bruyère, O., Branco, J., Chapurlat, R., Basset, S., Al-Daghri, N., Dennison, E., Herrero-Beaumont, G., Laslop, A., Leeb, B., Maggi, S., Mkinsi, O., Povzun, A., Prieto-Alhambra, D., Thomas, T., & Cooper, C. (April 2018). Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: consensus of a working group of the ESCEO. Osteoporosis International, 29 (Suppl1), 71-2.

Fabregat Cabello, N., LE GOFF, C., DARIMONT, P., & Cavalier, E. (16 March 2018). Dealing with small sample volumes and analyte levels: the case of vitamin D metabolites in aqueous humor. Paper presented at EBF 4th YSS : The BioA Brain : Embracing new ideas, Ghent, Belgium.

Cavalier, E., SCHLECK, M.-L., & Souberbielle, J.-C. (February 2018). Spurious intraoperative PTH results observed with 2(nd), but not with 3(rd) generation PTH assays. Clinica Chimica Acta, 477, 72-73. doi:10.1016/j.cca.2017.12.012

Cavalier, E. (24 January 2018). 24,25(OH)2 vitamin D and vitamin D metabolite ratio: new players in the exploration of non -parathyroid hypercalcemia. Paper presented at MSACL 2018 US.

Bargnoux, A.-S., Kuster, N., CAVALIER, E., Piéroni, L., Souweine, J.-S., DELANAYE, P., & Cristol, J.-P. (2018). Serum creatinine: advantages and pitfalls. Journal of Laboratory and Precision Medicine. doi:10.21037/jlpm.2018.08.01

Bataille, S., QUINONEZ, K., Buckinx, F., Warling, X., KRZESINSKI, J.-M., Pottel, H., Burtey, S., Bruyère, O., CAVALIER, E., & DELANAYE, P. (2018). La myostatine et l’IGF1 sont de bons biomarqueurs de la force musculaire chez les patients hémodialysés chroniques. Néphrologie et Thérapeutique, 14 (5), 4.

Buckinx, F., Bruyère, O., Reginster, J.-Y., Charles, A., DELANAYE, P., & CAVALIER, E. (2018). Plasma Klotho and Mortality Risk Among Nursing Home Residents: Results From the SENIOR Cohort [letter to the editor]. Journal of the American Medical Directors Association, 19 (12), 1139-1140. doi:10.1016/j.jamda.2018.08.010

Bukabau, J., Gnionsahé, A., Monnet, D., Pottel, H., CAVALIER, E., Makulo, J., Nseka, Sumaili, E., DELANAYE, P., & Yayo, E. (2018). Performance des équations basées sur la créatinine ou la cystatine C en Afrique sub-saharienne : intérêt de l’équation « Full Age Spectrum ». Néphrologie et Thérapeutique, 14 (5), 14.

Bukabau, J., Sumaili, E., CAVALIER, E., Pottel, H., Kifakiou, B., Nkodila, A., Makulo, J., Mokoli, V., Zinga, C., Longo, A., Engole, Y., Nlandu, Y., Lepira, F., Nseka, N., KRZESINSKI, J.-M., & DELANAYE, P. (2018). Performance of glomerular filtration rate estimation equations in Congolese healthy adults: the inopportunity of the ethnic correction. PLoS ONE, 13 (3), 0193384. doi:10.1371/journal.pone.0193384

Castiglione, V., CAVALIER, E., & GADISSEUR, R. (2018). Case report: Uncommon Sulfamethoxazole Crystalluria. Clinical Biochemistry. doi:10.1016/j.clinbiochem.2018.05.009

CAVALIER, E., Salsé, M., Dupuy, A.-M., Bargnoux, A.-S., Souberbielle, J.-C., DELANAYE, P., & Cristol, J.-P. (2018). Lumipulse W-PTH 3rd generation assay: reference values in healthy population and classification of secondary hyperparathyroidism in CKD. Nephrology, Dialysis and Transplantation.

Cavalier, E., SCHLECK, M.-L., & Souberbielle, J.-C. (2018). Spurious intraoperative PTH results observed with 2nd, but not with 3rd generation PTH assays. Clinica Chimica Acta, 477, 72-73. doi:10.1016/j.cca.2017.12.012

Cavalier, E., & Souberbielle, J.-C. (2018). Vitamin D and its metabolites: from now and beyond. eJIFCC: Electronic journal of the International Federation of Clinical Chemistry and Laboratory Medicine, 29 (2), 105-110.

De Niet, S., Coffiner, M., Da Silva, S., JANDRAIN, B., Souberbielle, J.-C., & Cavalier, E. (2018). A randomized study to compare a monthly to a daily administration of vitamin D3 supplementation. Nutrients, 10 (6). doi:10.3390/nu10060659

DELANAYE, P., Flamant, M., Dubourg, L., Vidal-Petiot, E., Lemoine, S., Cavalier, E., Schaeffner, E., Ebert, N., & Pottel, H. (2018). Single- versus multiple-sample method to measure glomerular filtration rate. Nephrology Dialysis Transplantation, 33 (10), 1778-1785. doi:10.1093/ndt/gfx345

DELANAYE, P., PAQUOT, F., BOUQUEGNEAU, A., Blocki, F., Krzesinski, J.-M., Evenepoel, P., Pottel, H., & Cavalier, E. (2018). Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know. Nephrology Dialysis Transplantation, 33 (8), 1404-1410. doi:10.1093/ndt/gfx282

DELANAYE, P., Pottel, H., Flamant, M., Vidal-Petiot, E., Lemoine, S., CAVALIER, E., Schaeffner, E., Ebert, N., & Dubourg, L. (2018). Measurement of glomerular filtration rate by plasma iohexol clearance with different single-sample methods. Poster session presented at LV Congress of ERA-EDTA, Copenhagen, Denmark.

DELANAYE, P., Résimont, G., Bigot-Corbel, E., & CAVALIER, E. (2018). Protéinuries et bandelettes urinaires : une technique simple d’interprétation compliquée. Annales de Biologie Clinique, 76 (6), 617-626. doi:10.1684/abc.2018.1388

Dinic, M., Maillard, N., DELANAYE, P., KRZESINSKI, J.-M., SAINT-REMY, A., CAVALIER, E., & Mariat, C. (2018). Association between matrix gla protein and aortic stiffness in kidney transplantation. Poster session presented at LV Congress of ERA-EDTA, Copenhagen, Denmark.

Flamant, M., DELANAYE, P., Pottel, H., Vidal-Petiot, E., Lemoine, S., CAVALIER, E., Schaeffner, E., Ebert, N., & Dubourg, L. (2018). Mesure du débit de filtration glomérulaire par prélèvement plasmatique unique : impact des différentes modelisations mathématiques. Poster session presented at III congrès de la Société francophone de néphrologie dialyse et transplantation, Lille, France.

Gonzalez-Aguilera, B., BETEA, D., LUTTERI, L., CAVALIER, E., GEENEN, V., Beckers, A., & VALDES SOCIN, H. G. (2018). Conversion to Graves disease from Hashimoto thyroiditis : a study of 24 patients. Archives of Endocrinology and Metabolism. doi:10.20945/2359-3997000000086

LE GOFF, C., Gonzalez-Antuña, A., PEETERS, S., Fabregat Cabello, N., Gugten, J. G. V. D., VROONEN, L., Pottel, H., Holmes, D. T., & Cavalier, E. (2018). Migration from RIA to LC-MS/MS for aldosterone determination: Implications for clinical practice and determination of plasma and urine reference range intervals in a cohort of healthy Belgian subjects. Clinical Mass Spectrometry, 9, 7 - 17. doi:10.1016/j.clinms.2018.06.002

Lutteri, L., ALDENHOFF, M.-C., & Cavalier, E. (2018). Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument. Clinica Chimica Acta, 487, 161-167. doi:10.1016/j.cca.2018.09.030

Mariat, C., DELANAYE, P., Bastard, J.-P., Résimont, G., CAVALIER, E., & Piéroni, L. (2018). Expression des résultats d’une protéinurie : le ratio protéines ou albumine sur créatinine urinaire. Annales de Biologie Clinique, 76 (6), 643-650. doi:10.1684/abc.2018.1394

PAQUOT, F., DELANAYE, P., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Maillard, N., Pottel, H., Evenepoel, P., & CAVALIER, E. (2018). Variations of sclerostin with other bone biomarkers over a one-year period in hemodialysis patients [letter to the editor]. Clinica Chimica Acta, 486, 183-184. doi:10.1016/j.cca.2018.08.003

Perić, M., Cavalier, E., Toma, S., & Lasserre, J. F. (2018). Serum vitamin D levels and chronic periodontitis in adult, Caucasian population—a systematic review. Journal of Periodontal Research, 53 (5), 645-656. doi:10.1111/jre.12560

Reginster, J.-Y., Arden, N. K., Haugen, I. K., Rannou, F., Cavalier, E., Bruyère, O., Branco, J., Chapurlat, R., Collaud Basset, S., Al-Daghri, N. M., Dennison, E. M., Herrero-Beaumont, G., Laslop, A., Leeb, B. F., Maggi, S., Mkinsi, O., Povzun, A. S., Prieto-Alhambra, D., Thomas, T., & Cooper, C. (2018). Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Seminars in Arthritis and Rheumatism, 48, 1-8. doi:10.1016/j.semarthrit.2017.12.003

Résimont, G., GADISSEUR, R., DUBOIS, B., KRZESINSKI, J.-M., CAVALIER, E., & DELANAYE, P. (2018). Bandelette urinaire positive pour une recherche de protéinurie : correspondance avec un résultat quantitatif sur échantillon. Poster session presented at III congrès de la Société francophone de néphrologie dialyse et transplantation, Lille, France.

Van Egroo, M., Narbutas, J., Chylinski, D., Villar Gonzalez, P., Besson, G., Muto, V., Gaggioni, G., Ghaemmaghami Tabrizi, P., LE GOFF, C., Cavalier, E., Bahri, M. A., MAQUET, P., Salmon, E., Schmidt, C., Phillips, C., Bastin, C., Collette, F., & Vandewalle, G. (2018). Preserved neuron reactivity dynamics during prolonged wakefulness is linked to cognitive fitness in aging, independently of amyloid-beta burden, tau burden, and cortical atrophy. Paper presented at Belgian Association for Sleep Research and Sleep Medicine - Autumn Meeting - Sleep: a truly pluridisciplinary field.

Van Egroo, M., Narbutas, J., Chylinski, D., Villar Gonzalez, P., Besson, G., Muto, V., Gaggioni, G., Ghaemmaghami Tabrizi, P., Tezel, E., LE GOFF, C., Cavalier, E., Lambot, E., Laloux, S., Hagelstein, C., Luxen, A., Degueldre, C., Bahri, M. A., Maquet, P., Salmon, E., & Vandewalle, G. (2018). Preserved Neuron Reactivity Dynamics during Prolonged Wakefulness is Linked to Cognitive Fitness in Aging, Independently of Tau Burden, Amyloid Beta Burden, and Cortical Atrophy. Paper presented at 20th EURON PhD Days.

VRANKEN, L., EMONTS, P., Bruyère, O., & CAVALIER, E. (January 2018). Prévalence de l’hypovitaminose D chez la femme enceinte : quelle est la situation en région liégeoise ? Revue Médicale de Liège, 73 (1), 10-16.

Yayo, E., Bukabau, J., Gnionsahé, A., Monnet, D., Pottel, H., CAVALIER, E., Sumaili, E., DELANAYE, P., & Nseka, N. (2018). Mesure du DFG en population africaine par la clairance plasmatique de l’iohexol : comparaison des méthodes à prélèvement unique et prélèvements multiples. Poster session presented at III congrès de la Société francophone de néphrologie dialyse et transplantation, Lille, France.

CAVALIER, E. (15 December 2017). Clinical management of the osteoporotic patient. Paper presented at BBC course - IOF/ISCD technologist bone densitometry course.

CAVALIER, E. (December 2017). Assay performance in patient populations. Paper presented at Vitamin D standardization program (VDSP), Rockville, Maryland, United States.

Courtois, J., Tollenaere, S., Quinting, B., Van der Brempt, X., Cavalier, E., & GADISSEUR, R. (01 December 2017). Intérêt du Western blot 2D dans les réactions croisées avec les insectes. Poster session presented at CICBAA, Lille, France.

Libon, F., Courtois, J., LE GOFF, C., LUKAS, P., Fabregat Cabello, N., SEIDEL, L., Cavalier, E., & NIKKELS, A. (2017). Sunscreens block cutaneous vitamin D production with only a minimal effect on circulating 25-hydroxyvitamin D. Archives of Osteoporosis. doi:10.1007/s11657-017-0361-0

VALDES SOCIN, H. G., BETEA, D., Daly, A., DELANAYE, P., souberbielle, J.-C., BECKERS, A., & CAVALIER, E. (December 2017). Paraneoplastic secretion in parathyroid carcinoma: serum hCG as a tumor marker. Acta Clinica Belgica, 72 (2), 5.

VALDES SOCIN, H. G., BETEA, D., Daly, A., DELANAYE, P., Souberbielle, J.-C., Beckers, A., & Cavalier, E. (December 2017). Paranéoplasic secretion in Parathyroid carcinoma : serum hCG as a tumor marker. Paper presented at Annual Congress of the Belgian Society of Internal Medicine, La hulpe, Belgium.

Courtois, J., Goddé, M., Tollenaere, S., Cavalier, E., & GADISSEUR, R. (25 November 2017). Should we all eat insects ? Poster session presented at BelSACI, Bruxelles, Belgium.

Castiglione, V., & CAVALIER, E. (24 November 2017). Oral calcium load test for recurrent calcium stone-formers. Paper presented at Joint National Symposium of the Belgian Lipid Club and the Royal Belgian Society of Laboratory Medicine 2017, Bruges, Belgium.

Castiglione, V., & CAVALIER, E. (24 November 2017). Oral calcium load test for recurrent calcium stone-formers. Poster session presented at Joint National Symposium of the Belgian Lipid Club and the Royal Belgian Society of Laboratory Medicine 2017, Bruges, Belgium.

Castiglione, V., Diop, C. S., CAVALIER, E., & GADISSEUR, R. (24 November 2017). Rare Sulfamethoxazole Crystalluria – case report. Poster session presented at Joint National Symposium of the Belgian Lipid Club and the Royal Belgian Society of Laboratory Medicine 2017, Bruges, Belgium.

Courtois, J., BERTHOLET, C., Cavalier, E., Gillard, N., Tollenaere, S., Quinting, B., & GADISSEUR, R. (24 November 2017). Interest of 2D Immunoblot and mass spectrometry in the diagnosis of wheat allergy. Poster session presented at Royal Belgian Society of Laboratory Medicine, Bruges, Belgium.

Courtois, J., BERTHOLET, C., Cavalier, E., Gillard, N., Tollenaere, S., Quinting, B., & GADISSEUR, R. (24 November 2017). How immunoblotting and mass spectrometry can help to diagnose mustard allergy. Poster session presented at Royal Belgian Society of Laboratory Medicine, Bruges, Belgium.

VRANKEN, L., PIELTAIN, C., & CAVALIER, E. (24 November 2017). Evaluation of neonatal bilirubin method on RapidLab 500 blood gas analyzer. Poster session presented at National Symposium of the Royal Belgian Society of Laboratory Medicine.

Castiglione, V., Sacre, P.-Y., CAVALIER, E., Hubert, P., GADISSEUR, R., & Ziemons, E. (02 November 2017). Raman Chemical Imaging in Kidney Stone Analysis. Poster session presented at American Society of Nephrology Kidney Week 2017 Annual Meeting, New Orleans, United States.

LADANG, A., VRANKEN, L., & CAVALIER, E. (November 2017). Pediatric reference intervals: Retrospective study for 8 common chemistry parameters on Cobas c6000 analyzer (Roche°). Poster session presented at meeting annuel RBSLM.

CAVALIER, E. (10 October 2017). Lumipulse wPTH: a new 3rd generation assay in the era of PTH standardization. Why sould we use it? Paper presented at Symposium Fujirebio, Utrecht-Houten, Netherlands.

Courtois, J., Goddé, M., Cavalier, E., Van der Brempt, X., Quinting, B., Tollenaere, S., & GADISSEUR, R. (10 October 2017). Entomophagy : what about allergies ? Paper presented at Insectinov 2 - Adebiotech, Paris, France.

Schmidt, C., Xhrouet, M., Hamacher, M., Delloye, E., LE GOFF, C., CAVALIER, E., Collette, F., & Vandewalle, G. (October 2017). Light exposure via head-mounted devices suppresses melatonin and improves vigilant attention without affecting cortisol and comfort. Poster session presented at World Sleep Congress, Prague, Czechia.

CAVALIER, E. (08 September 2017). PTH measurement in CKD subjects. Paper presented at Conférence PTH, Paris, France.

Fabregat Cabello, N., Farre Segura, J., Huyghebaert, L., PEETERS, S., LE GOFF, C., & Cavalier, E. (September 2017). A fast and simple method for simultaneous measurements of 25(OH)D, 24,25(OH)2D and the Vitamin D Metabolite Ratio (VMR) in serum samples by LC-MS/MS (powerpoint). Paper presented at MSACL, Salzburg, Austria.

Le Goff, C., VRANKEN, L., Kaux, J.-F., & Cavalier, E. (September 2017). Comparison of cardiac biomarkers fluctuation in runners of marathons, semi-marathons and untrained runners. European Journal of Sports Medicine, 5 (Supplement 1), 16.

Fabregat Cabello, N., Farre Segura, J., Huyghebaert, L., PEETERS, S., LE GOFF, C., Souberbielle, J.-C., & Cavalier, E. (2017). A fast and simple method for simultaneous measurements of 25(OH)D, 24,25(OH)2D and the Vitamin D Metabolite Ratio (VMR) in serum samples by LC-MS/MS. Clinica Chimica Acta. doi:10.1016/j.cca.2017.08.024

Schmidt, C., Xhrouet, M., Hamacher, M., Delloye, E., LE GOFF, C., CAVALIER, E., Collette, F., & Vandewalle, G. (30 July 2017). Light exposure via head-mounted devices suppresses melatonin and improves vigilant attention without affecting cortisol and comfort. Poster session presented at European Biological Rhythms Society (EBRL) XV Congress, Amsterdam, Netherlands.

Schmidt, C., Xhrouet, M., Hamacher, M., Delloye, E., LE GOFF, C., CAVALIER, E., Collette, F., & Vandewalle, G. (25 June 2017). Light exposure via head-mounted devices suppresses melatonin and improves vigilant attention without affecting cortisol and subjective comfort. Paper presented at Society for Light Treatment and Biological Rhythms (SLTBR) Meeting, Berlin, Germany.

Schmidt, C., Xhrouet, M., Hamacher, M., Delloye, E., LE GOFF, C., Cavalier, E., Collette, F., & Vandewalle, G. (25 June 2017). Blue light exposure via head-mounted devices suppresses melatonin and improves vigilant attention without affecting cortisol and subjective comfort. Paper presented at Society for Light Treatment and Biological Rhythms.

Courtois, J., BERTHOLET, C., Cavalier, E., Gillard, N., Quinting, B., & GADISSEUR, R. (20 June 2017). Mustard allergy: diagnostic and identification of specific allergens by immunoblotting. Poster session presented at European Academy of Allergy and Clinical Immunology, Helsinki, Finland.

Courtois, J., BERTHOLET, C., Cavalier, E., Gillard, N., Quinting, B., & GADISSEUR, R. (18 June 2017). How immunoblotting and mass spectrometry can help to diagnose kiwi fruit allergy. Poster session presented at European Academy of Allergy and Clinical Immunology, Helsinki, Finland.

CAVALIER, E. (14 June 2017). State of the art of the new automated determination of FGF23 on the DiaSorin Liaison XL. Paper presented at Euromedlab, Ahtens, Greece.

VRANKEN, L., BEKAERT, A.-C., GENDEBIEN, A.-S., & CAVALIER, E. (14 June 2017). Impact of vitamin D binding protein on calculated free 25OH vitamin D. Poster session presented at 22 nd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Athens 2017, Athènes, Greece.

VRANKEN, L., BERTHOLET, C., GEBOES, S., Huberty, V., Szabo, B., & CAVALIER, E. (14 June 2017). Comparison of six automated assays for the determination of cobalamin and holotranscobalamin in serum. Is there any better assay? Poster session presented at 22 nd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Athens 2017, Athènes, Greece.

VRANKEN, L., LE GOFF, C., BEKAERT, A.-C., GENDEBIEN, A.-S., & CAVALIER, E. (14 June 2017). Comparison of measured and calculated free 25-hydroxyvitamin D : impact of vitamin D binding protein assay and race. Poster session presented at 22 nd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Athens 2017, Athènes, Greece.

CAVALIER, E. (13 June 2017). Lumipulse wPTH: a new third generation assay in the area of PTH standardization. Why should we use it? Paper presented at Euromedlab, Athens, Greece.

CAVALIER, E. (13 June 2017). Clinical chemistry and nephrology: An essential link. Paper presented at Euromedlab, Athens, Greece.

LE GOFF, C., Fabregat Cabello, N., Huyghebaert, L., PEETERS, S., VROONEN, L., & CAVALIER, E. (13 June 2017). Validation of a 13 steroids panel with the Chromsystem kit by LC-MS/MS. Poster session presented at Euromedlab IFCC, Athenes, Greece.

LE GOFF, C., Fabregat Cabello, N., Huyghebaert, L., PEETERS, S., VROONEN, L., & CAVALIER, E. (2017). Reference interval determination for serum and urine aldosterone for healthy Belgian population. Clinical Chemistry and Laboratory Medicine.

LE GOFF, C., Fabregat Cabello, N., Huyghebaert, L., PEETERS, S., VROONEN, L., & CAVALIER, E. (2017). Establishment of reference values for 6 six steroids in serum. Clinical Chemistry and Laboratory Medicine.

LE GOFF, C., Kaux, J.-F., Gergelé, L., Millet, G., Viallon, M., Croisille, P., & CAVALIER, E. (2017). Impact of an ultra-trail of 330 km on plasma levels. Clinical Chemistry and Laboratory Medicine.

LE GOFF, C., VRANKEN, L., van Nueten, J., Lennartz, L., & CAVALIER, E. (2017). Comparison of cardiac biomarker fluctuation in runners of marathons, semi-marathons and untrained runners. Clinical Chemistry and Laboratory Medicine.

CAVALIER, E. (18 May 2017). L'insuffisance rénale aigue, aspects biologiques (cystatine C). Paper presented at Jeudi de Fleurus, Belgium.

Courtois, J., BERTHOLET, C., LUKAS, P., Cavalier, E., Gillard, N., Tollenaere, S., Quinting, B., & GADISSEUR, R. (26 April 2017). Allergie au froment : caractérisation de nouveaux allergènes par immunoblot 2D et spectrométrie de masse. Poster session presented at Congrès Francophone d'Allergologie, Paris, France. doi:10.1016/j.reval.2017.02.052

Seidowsky, A., Villain, C., Vilaine, E., Baudoin, R., Tabarin, A., Kottler, M.-L., Cavalier, E., Souberbielle, J.-C., & Massy, Z. A. (2017). Hypercalcemie par mutation inactivatrice du CYP24A1. Etude d'un cas et revue de la litterature. Néphrologie et Thérapeutique. doi:10.1016/j.nephro.2017.01.019

Sturgeon, C. M., Sprague, S., Almond, A., Cavalier, E., Fraser, W. D., Algeciras-Schimnich, A., Singh, R., Souberbielle, J.-C., & Vesper, H. W. (April 2017). Perspective and priorities for improvement of parathyroid hormone (PTH) measurement - A view from the IFCC Working Group for PTH. Clinica Chimica Acta, 467, 42-47. doi:10.1016/j.cca.2016.10.016

VRANKEN, L., PIELTAIN, C., & CAVALIER, E. (17 March 2017). Evaluation of neonatal bilirubin method on RapidLab 500 blood gas analyzer. Poster session presented at 3rd National POCT Symposium, Anvers, Belgium.

Cavalier, E., LUKAS, P., BEKAERT, A.-C., CARLISI, I., Le Goff, C., DELANAYE, P., & Souberbielle, J.-C. (March 2017). Analytical and clinical validation of the new Abbot Architect 25(OH)D assay: fit for purpose? Clinical Chemistry and Laboratory Medicine, 55 (3), 378-384. doi:10.1515/cclm-2016-0566

CAVALIER, E., & Reginster, J.-Y. (March 2017). Biomarkers of osteoarthritis : practical considerations. Osteoporosis International, 28 Suppl 1, 625-626.

CAVALIER, E., Reginster, J.-Y., & DELANAYE, P. (March 2017). Impact of the renal function on sclerostin determination: illustration with four different ELISA methods in patients undergoing GFR determination with Iohexol. Osteoporosis International, 28 Suppl 1, 629.

Libon, F., Courtois, J., LE GOFF, C., LUKAS, P., Fabregat Cabello, N., SEIDEL, L., CAVALIER, E., Reginster, J.-Y., & NIKKELS, A. (March 2017). Effect of body surface, body site and sunscreen application on production of Vitamin D and 25-hydroxyvitamin D after a single narrowband UVB exposure. Osteoporosis International, 28 Suppl 1, 143-144.

Souberbielle, J.-C., Brazier, F., Piketty, M.-L., Cormier, C., Minisola, S., & Cavalier, E. (March 2017). How the reference values for serum parathyroid hormone concentration are (or should be) established? Journal of Endocrinological Investigation, 40 (3), 241-256. doi:10.1007/s40618-016-0553-2

Le Goff, C., Kaux, J.-F., Gergelé, L., Millet, G., Giardini, G., Viallon, M., Croisille, P., & Cavalier, E. (February 2017). Impact of an ultra-marathon of 330km on plasma levels of cardiac biomarkers. British Journal of Sports Medicine, 51 (4), 347.

CAVALIER, E. (25 January 2017). Marqueurs osseux et lithiases (Marqueurs osseux chez la personne souffrant de calculs urinaires). Paper presented at 43ème séminaire universitaires de néphrologie LUNE, Paris, France.

CAVALIER, E. (25 January 2017). Marqueurs osseux chez la personne souffrant de calculs urinaires récidivants: Intérêt ? Chez qui ? Pour en faire quoi ? Analyse ? (ex : problématiques des bornes de ces marqueurs chez l'homme jeune...). Paper presented at 43ème séminaires universitaires de Néphrologie, Paris, France.

Gregoire, E., Claisse, G., GUIOT, J., MORIMONT, P., KRZESINSKI, J.-M., Mariat, C., LAMBERMONT, B., CAVALIER, E., & DELANAYE, P. (13 January 2017). The added value of plasma or urinary NGAL concentrations in clinical practice. Poster session presented at Reanimation 2017, Paris, France.

Bargnoux, A.-S., Pieroni, L., Cristol, J.-P., Kuster, N., DELANAYE, P., Carlier, M.-C., Fellahi, S., Boutten, A., Lombard, C., Gonzalez-Antuna, A., Delatour, V., & Cavalier, E. (2017). Multicenter Evaluation of Cystatin C Measurement after Assay Standardization. Clinical Chemistry, 63 (4), 833-841. doi:10.1373/clinchem.2016.264325

Bruyère, O., Bergmann, P., CAVALIER, E., Gielen, E., Goemaere, S., Kaufman, J.-M., Rozenberg, S., & Body, J.-J. (2017). Skeletal health in breast cancer survivors. Maturitas, 105, 78-82. doi:10.1016/j.maturitas.2017.08.008

Bruyère, O., Cavalier, E., Buckinx, F., & Reginster, J.-Y. (January 2017). Relevance of vitamin D in the pathogenesis and therapy of frailty. Current Opinion in Clinical Nutrition and Metabolic Care, 20 (1), 26-29. doi:10.1097/MCO.0000000000000334

Bruyère, O., CAVALIER, E., & Reginster, J.-Y. (2017). Vitamin D and osteosarcopenia: an update from epidemiological studies. Current Opinion in Clinical Nutrition and Metabolic Care, 20 (6). doi:10.1097/MCO.0000000000000411

Bukabau, J., Sumaili, E., CAVALIER, E., Kayembe, P., Makulo, J., Mokoli, V., Kifakiou, B., Nkodila, A., Engole, Y., Lepira, F., Nseka, N., & DELANAYE, P. (2017). Performance des équations d’estimation du débit de filtration glomérulaire chez l’adulte sain en Afrique centrale (Congo Kinshasa). Poster session presented at Deuxième congrès de la Société francophone de néphrologie, dialyse et transplantation (SFNDT), Nice, France.

Castiglione, V., CAVALIER, E., Diop, C. S., & GADISSEUR, R. (2017). Distinction between urine crystals by automated urine analyzer SediMAX conTRUST is specific but lacks of sensitivity [letter to the editor]. Clinical Chemistry and Laboratory Medicine, 15-17. doi:10.1515/cclm-2017-0228

Cavalier, E., Torres, P. U., DUBOIS, B., Smelten, N., Pottel, H., Krzesinski, J.-M., & DELANAYE, P. (2017). Impact of the type of dialysis membranes on the circulating concentration of markers of vitamin D metabolism. International Journal of Artificial Organs, 0. doi:10.5301/ijao.5000565

DELANAYE, P., Cavalier, E., & Pottel, H. (2017). Serum Creatinine: Not So Simple! Nephron, 136 (4), 302-308. doi:10.1159/000469669

DELANAYE, P., QUINONEZ, K., Buckinx, F., Bruyère, O., & CAVALIER, E. (2017). Intérêt de nouveaux marqueurs biologiques dans l’évaluation de la sarcopénie en dialyse. Néphrologie et Thérapeutique, 13 (5), 269.

DELANAYE, P., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Maillard, N., Pottel, H., & CAVALIER, E. (2017). Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients. Scientific Reports, 7 (1), 12623. doi:10.1038/s41598-017-12808-3

Dinic, M., Maillard, N., DELANAYE, P., KRZESINSKI, J.-M., SAINT-REMY, A., CAVALIER, E., & Mariat, C. (2017). Association entre les taux circulants de matrix-gla protein et rigidité artérielle en transplantation rénale. Néphrologie et Thérapeutique, 13 (5), 309.

Ebert, N., Schaeffner, E., Pottel, H., CAVALIER, E., Dubourg, L., Flamant, M., & DELANAYE, P. (2017). Measuring Plasma Clearance for Exact Assessment of GFR: Multi versus Single Sampling. Poster session presented at Renal Week, New Orleans, United States - Louisiana.

Evenepoel, P., Cavalier, E., & D'Haese, P. C. (2017). Biomarkers Predicting Bone Turnover in the Setting of CKD. Current Osteoporosis Reports. doi:10.1007/s11914-017-0362-3

Flamant, M., Vidal-Petiot, E., Dubourg, L., Ebert, N., Lemoine, S., Schaeffner, E., Pottel, H., Cavalier, E., & DELANAYE, P. (2017). Mesure du débit de filtration glomérulaire par clairance plasmatique : comparaison d’une procédure à prélèvements multiples et à prélèvement unique. Poster session presented at Deuxième congrès de la Société francophone de néphrologie, dialyse et transplantation (SFNDT), Nice, France.

Fusaro, M., Gallieni, M., Rizzo, M., Stucchi, A., DELANAYE, P., CAVALIER, E., Moyses, R., Jorgetti, V., Iervasi, G., Giannini, S., Fabris, F., Aghi, A., Sella, S., Galli, F., Viola, V., & Plebani, M. (2017). Vitamin K plasma levels determination in human health. Clinical Chemistry and Laboratory Medicine, 55 (6), 789-799. doi:10.1515/cclm-2016-0783

Gielen, E., Bergmann, P., Bruyère, O., Cavalier, E., DELANAYE, P., Goemaere, S., Kaufman, J.-M., Locquet, M., Reginster, J.-Y., Rozenberg, S., Vandenbroucke, A.-M., & Body, J.-J. (2017). Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone Club. Calcified Tissue International, 101 (2), 111-31. doi:10.1007/s00223-017-0266-3

Herrmann, M., Farrell, C.-J. L., Pusceddu, I., Fabregat Cabello, N., & Cavalier, E. (2017). Assessment of vitamin D status - a changing landscape. Clinical Chemistry and Laboratory Medicine. doi:10.1515/cclm-2016-0264

LADANG, A., VRANKEN, L., LUYCKX, F., LEBRETHON, M.-C., & CAVALIER, E. (2017). Etude rétrospective du bilan thyroïdien: définition de valeurs de référence pédiatriques. Revue Médicale de Liège.

Libon, F., COURTOIS, J., Le Goff, C., LUKAS, P., Fabregat Cabello, N., SEIDEL, L., Cavalier, E., & Nikkels, A. (2017). Effect of Body Site and Surface on Vitamin D and 25-Hydroxyvitamin D Production after a Single Narrowband UVB Exposure. Journal of Investigative Dermatology, 137 (6), 1391-1393. doi:10.1016/j.jid.2017.01.032

Maillard, N., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Pottel, H., CAVALIER, E., & DELANAYE, P. (2017). Les pentes d’évolution des CTX, de la phosphatase alkaline osseuse et du P1NP sont associées à celles de la PTH en hémodialyse chronique. Poster session presented at Deuxième congrès de la Société francophone de néphrologie, dialyse et transplantation (SFNDT), Nice, France.

Phinney, K. W., Sempos, C. T., Tai, S. S.-C., Camara, J. E., Wise, S. A., Eckfeldt, J. H., Hoofnagle, A. N., Carter, G. D., Jones, J., Myers, G. L., Durazo-Arvizu, R., Miller, W. G., Bachmann, L. M., Young, I. S., Pettit, J., Caldwell, G., Liu, A., Brooks, S. P. J., Sarafin, K., & Betz, J. M. (2017). Baseline Assessment of 25-Hydroxyvitamin D Reference Material and Proficiency Testing/External Quality Assurance Material Commutability: A Vitamin D Standardization Program Study. Journal of AOAC International, 100 (5), 1288-1293. doi:10.5740/jaoacint.17-0291

Piéroni, L., Bargnoux, A., Cristol, J., CAVALIER, E., & DELANAYE, P. (2017). Did creatinine standardization give benefits to the evaluation of glomerular filtration rate? eJIFCC: Electronic journal of the International Federation of Clinical Chemistry and Laboratory Medicine, 28 (4), 251-257.

ROUSSEAU, A.-F., Bawin, M., CAVALIER, E., Reginster, J.-Y., DAMAS, P., & Bruyère, O. (2017). Occurrence of bone fracture in the 2 years following a prolonged ICU stay: a retrospective study including a control group. Osteoporosis International, 28 (Suppl 1), 504.

ROUSSEAU, A.-F., CAVALIER, E., Reginster, J.-Y., DAMAS, P., & Bruyère, O. (2017). Occurrence of Clinical Bone Fracture Following a Prolonged Stay in Intensive Care Unit: A Retrospective Controlled Study. Calcified Tissue International, 101 (5), 465-472. doi:10.1007/s00223-017-0300-5

SCHLECK, M.-L., Souberbielle, J.-C., DELANAYE, P., Plebani, M., & Cavalier, E. (2017). Parathormone stability in hemodialyzed patients and healthy subjects: comparison on non-centrifuged EDTA and serum samples with second- and third-generation assays. Clinical Chemistry and Laboratory Medicine, 55 (8), 1152-1159. doi:10.1515/cclm-2016-0914

Sempos, C. T., Betz, J. M., Camara, J. E., Carter, G. D., Cavalier, E., Clarke, M. W., Dowling, K. G., Durazo-Arvizu, R., Hoofnagle, A. N., Liu, A., Phinney, K. W., Sarafin, K., Wise, S. A., & Coates, P. M. (2017). General Steps to Standardize the Laboratory Measurement of Serum Total 25-Hydroxyvitamin D. Journal of AOAC International, 100 (5), 1230-1233. doi:10.5740/jaoacint.17-0259

Souberbielle, J.-C., Prie, D., Piketty, M.-L., Rothenbuhler, A., DELANAYE, P., Chanson, P., & Cavalier, E. (2017). Evaluation of a New Fully Automated Assay for Plasma Intact FGF23. Calcified Tissue International, 101 (5), 510-518. doi:10.1007/s00223-017-0307-y

Tournier, H., Tran, N., Dray, N., Brusset, M., Rander, B., Millot, X., Bourcier, C., Cavalier, E., & Souberbielle, J.-C. (2017). Supplementation with 80,000 IU vitamin D3/month between November and April corrects vitamin D insufficiency without overdosing: Effect on serum 25-hydroxyvitamin D serum concentrations. Presse Médicale. doi:10.1016/j.lpm.2016.05.027

Winckert, A., VRANKEN, L., BOEMER, F., Courtois, J., & Cavalier, E. (2017). L'hypophosphatasie. Revue Médicale de Liège, 72 (12), 547-551.

Wise, S. A., Phinney, K. W., Tai, S. S.-C., Camara, J. E., Myers, G. L., Durazo-Arvizu, R., Tian, L., Hoofnagle, A. N., Bachmann, L. M., Young, I. S., Pettit, J., Caldwell, G., Liu, A., Brooks, S. P. J., Sarafin, K., Thamm, M., Mensink, G. B. M., Busch, M., Rabenberg, M., & Sempos, C. T. (2017). Baseline Assessment of 25-Hydroxyvitamin D Assay Performance: A Vitamin D Standardization Program (VDSP) Interlaboratory Comparison Study. Journal of AOAC International, 100 (5), 1244-1252. doi:10.5740/jaoacint.17-0258

yayo, E., Yao-Papo, E., Gnionsahé, A., Monnet, D., Pottel, H., CAVALIER, E., & DELANAYE, P. (2017). DFG en population saine africaine : comparaison des performances de 11 équations d’estimation à marquer unique ou combinés, avec et sans facteur ethnique. Néphrologie et Thérapeutique, 13 (5), 277.

CAVALIER, E. (01 December 2016). Vitamin D - Biochemistry and Physiology. Paper presented at 4th International south Tyrolean Diagnostic Forum - Frontiers in osteoporosis and malignant bon disease, Bolzano, Italy.

Dinic, M., Maillard, N., DELANAYE, P., KRZESINSKI, J.-M., SAINT-REMY, A., CAVALIER, E., & Mariat, C. (December 2016). Association entre taux circulants de matrix-gla protéine et rigidité artérielle en transplantation rénale. Paper presented at XVI réunion annuelle de la Société Francophone de Transplantation, Liège, Belgium.

Wolff, F., Gervy, C., Cavalier, E., Bergmann, P., Cotton, F., Heureux, M., Corvilain, B., & Badot, V. (2016). When obtaining a blood sample from the right arm was not the right thing to do: a case of elevated parathyroid hormone levels 27 years after thyroidectomy. Clinical Chemistry and Laboratory Medicine. doi:10.1515/cclm-2016-0345

CAVALIER, E., & DELANAYE, P. (November 2016). Large variations between four methods for sclerotin determination in patients undergoing GFR measurement and in hemodialyzed patients before and after a single dialysis session. Poster session presented at ASN Kidney Week, Chicago, United States - Illinois.

DELANAYE, P., & CAVALIER, E. (November 2016). Measurement of glomerular filtration rate by plasma iohexol clearance: single versus multiple samples method. Poster session presented at ASN Kidney Week, Chicago, United States - Illinois.

Nejjar, B., Bour, A., Beaudart, C., Bruyère, O., & CAVALIER, E. (November 2016). Prevalence of the hypovitaminosis D among Moroccan woman consulting in ambulatory medicine. Journal of Innovative Research and Applied Sciences, 3 (2), 476-483.

Blomme, A., Costanza, B., De Tullio, P., Thiry, M., Van Simaeys, G., Boutry, S., Doumont, G., Di Valentin, E., Hirano, T., Yokobori, T., GOFFLOT, S., Peulen, O., Bellahcene, A., Sherer, F., Le Goff, C., Cavalier, E., Mouithys-Mickalad, A., Jouret, F., CUSUMANO, G., & Turtoi, A. (2016). Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer. Oncogene. doi:10.1038/onc.2016.369

CAVALIER, E. (15 October 2016). Biomarkers of BTR: methodological aspects. Paper presented at Annual meeting of the Royal Beligian Society of Laboratory Medicine and joint meeting with the Belgian Bone Club on bone turn-over and bone resorption markers, Seraing, Belgium.

Courtois, J., GADISSEUR, R., BERTHOLET, C., LUKAS, P., Cavalier, E., Gillard, N., & Quinting, B. (15 October 2016). Hunting for new wheat allergens : a 2D Immunoblot and mass spectrometry approach. Poster session presented at 4th Food Allergy and Anaphylaxis meeting, Rome, Italy.

VRANKEN, L., BEKAERT, A.-C., GENDEBIEN, A.-S., & CAVALIER, E. (14 October 2016). Impact of vitamin D binding protein on calculated free 25OH vitamin D. Paper presented at Annual Congress of the Royal Belgian Society of Laboratory Medecin, Seraing, Belgium.

VRANKEN, L., BEKAERT, A.-C., GENDEBIEN, A.-S., & CAVALIER, E. (14 October 2016). Impact of vitamin D binding protein on calculated free 25OH vitamin D. Poster session presented at Annual Congress of the Royal Belgian Society of Laboratory Medecin.

VRANKEN, L., BERTHOLET, C., GEBOES, S., HUBERTY, V., SZABO, B., & CAVALIER, E. (14 October 2016). Comparison of six automated assays for the the determination of cobalamin and holotranscobalamin in serum. Is there any better assay? Poster session presented at Annual RBSLM meeting October 14th and 15th, 2016, Seraing, Belgium.

Beaudart, C., McCloskey, E., Bruyère, O., Cesari, M., Rolland, Y., Rizzoli, R., Araujo de Carvalho, I., Amuthavalli Thiyagarajan, J., Bautmans, I., Bertière, M.-C., Brandi, M. L., Al-Daghri, N. M., Burlet, N., CAVALIER, E., Cerreta, F., Cherubini, A., Fielding, R., Gielen, E., Landi, F., & Cooper, C. (October 2016). Sarcopenia in daily practice: assessment and management. BMC Geriatrics, 16 (170). doi:10.1186/s12877-016-0349-4

DELANAYE, P., Ebert, N., Melsom, T., Gaspari, F., Mariat, C., CAVALIER, E., Björk, J., Christensson, A., Nyman, U., Porrini, E., Remuzzi, G., Ruggenenti, P., Schaeffner, E., Soveri, I., Sterner, G., Odvar Eriksen, B., & Bäck, S.-E. (2016). Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1 : How to measure glomerular filtration rate with iohexol? NDT Plus. doi:10.1093/ckj/sfw070

DELANAYE, P., Melson, T., Ebert, N., Bäck, S.-E., Mariat, C., CAVALIER, E., Björk, J., Christensson, A., Nyman, U., Porrini, Remuzzi, G., Ruggenenti, P., Schaeffner, E., Soveri, I., Sterner, G., Odvar Eriksen, B., & Gaspari, F. (2016). Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 2: Why to measure glomerular filtration rate with iohexol? NDT Plus. doi:10.1093/ckj/sfw071

LADANG, A., VRANKEN, L., & CAVALIER, E. (October 2016). Unexpected high levels of Cobalamin (Vitamin B12): Numerous interferences are decreased by PEG treatment. Poster session presented at Congrès de la société belge de médecine de laboratoire.

LE GOFF, C., Fabregat Cabello, N., & Cavalier, E. (14 September 2016). Quantification of serum androstanediol glucuronide. Paper presented at MSACL.

DELANAYE, P., & CAVALIER, E. (September 2016). Mesure du débit de filtration glomérulaire par la clearance plasmatique de l'iohexol: comparaison d'une procédure à prélèvements multiples et à un prélèvement unique. Poster session presented at Premier congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT), Strasbourg, France.

DELANAYE, P., & CAVALIER, E. (September 2016). Mesure du débit de filtration glomérulaire par la clearance plasmatique de l'iohexol: comparaison d'une procédure à prélèvements multiples & à un prélèvement unique. Poster session presented at Premier congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT), Strasbourg, France.

Fabregat Cabello, N., Huyghebaert, L., Gonzalez Antuña, A., LE GOFF, C., & Cavalier, E. (September 2016). Development of a new methodology for the simultaneous determination of cholecalciferol and 24,25(OH)2D3 by LC-MS/MS. Paper presented at MSACL, Salzbourg, Austria.

LE GOFF, C., Kaux, J.-F., LAURENT, T., Vannuscorps, J., SEIDEL, L., Rodriguez de la Cruz, C., Forthomme, B., Bury, T., CHAPELLE, J.-P., Cavalier, E., & Croisier, J.-L. (September 2016). The cardiovascular impact of intense eccentric isokinetic exercise versus aerobic treadmill running. Isokinetics and Exercise Science, 24 (3), 201-208. doi:10.3233/IES-160618

Pieroni, L., Bargnoux, A. S., DELANAYE, P., Kuster, N., Carlier, M. C., Fellahi, S., Boutten, A., Lombard, C., Delatour, V., Cristol, P., & CAVALIER, E. (September 2016). La standardisation des dosages de cystatine C améliore l'estimation du DFG au stade 3: une étude multicentrique conduite par la société française de biologie clinique (SFBC). Poster session presented at Premier congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT), Strabsourg, France.

STOJKOVIC, V., SCHLECK, M.-L., CAVALIER, E., & DELANAYE, P. (September 2016). Evaluation du débit de filtration glomérulaire estimé à l'aide d'un dosage de créatinine par analyseur de biologie délocalisé (Point of Care). Poster session presented at Premier congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT), Strasbourg, France.

Van Houcke, S. K., Seaux, L., Cavalier, E., Speeckaert, M. M., Dumoulin, E., Lecocq, E., & Delanghe, J. R. (2016). Determination of iohexol and iothalamate in serum and urine by capillary electrophoresis. Electrophoresis. doi:10.1002/elps.201600084

Yayo, E., Monnet, D., Attoungbré, M.-L., Gnionsahé, A., CAVALIER, E., Pottel, H., & DELANAYE, P. (September 2016). Valeurs de référence de débit de filtration glomérulaire en population noire-africaine. Néphrologie et Thérapeutique, 12 (5), 273.

LE GOFF, C., Kaux, J.-F., D'OTREPPE DE BOUVETTE, S., Goffaux, S., Fillet, M., Chapelle, J.-P., & Cavalier, E. (August 2016). Release of cardiac biomarkers during a cycling race. World Journal of Cardiovascular Diseases, 6 (8), 285-294.

Cavalier, E., Bergmann, P., Bruyère, O., DELANAYE, P., Durnez, A., Devogelaer, J.-P., Ferrari, S. L., Gielen, E., Goemaere, S., Kaufman, J.-M., Nzeusseu Toukap, A., Reginster, J.-Y., ROUSSEAU, A.-F., Rozenberg, S., Scheen, A., & Body, J.-J. (July 2016). The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club. Osteoporosis International, 27, 2181-2195. doi:10.1007/s00198-016-3561-3

Le Goff, C., Gergelé, L., Kaux, J.-F., Cavalier, E., & Millet, G. (2016). Impact of a mountain ultra-marathon (UTMB) on cardiac biomarkers. In European journal of sport sciences (pp. 509).

CAVALIER, E. (28 May 2016). Vitamine D: de l'origine de l'humanité aux grandes études interventionnelles. Paper presented at Cours donné à l'Académique de médecine, Belgium.

Cavalier, E., Jandrain, B., Coffiner, M., Da Silva, S., De Niet, S., Vanderbist, F., & Souberbielle, J.-C. (May 2016). A Randomised, Cross-Over Study to Estimate the Influence of Food on the 25-Hydroxyvitamin D(3) Serum Level after Vitamin D(3) Supplementation. Nutrients, 8 (5). doi:10.3390/nu8050309

Ebert, N., DELANAYE, P., Shlipak, M., Jakob, O., Martus, P., Bartel, J., Gaedeke, J., van der Giet, M., Schuchardt, M., CAVALIER, E., & Schaeffner, E. (May 2016). Cystatin C standardization decreases assay variation and improves assessment of glomerular filtration rate. Clinica Chimica Acta, 456, 115-121. doi:10.1016/j.cca.2016.03.002

CAVALIER, E., WATAR, F., KOVACS, S., Beaudart, C., Buckinx, F., Bruyère, O., LE GOFF, C., & Reginster, J.-Y. (16 April 2016). Evaluation of the intra-individual variability of Myostatin and Activin A (and PIIINP): impact on the least significant change and follow-up of the patients. Paper presented at World Congresse on Osteoporosis Osteoarthritis and musculoskeletal diseases, Malaga, Spain.

CAVALIER, E., CARLISI, I., KOVACS, S., WATAR, F., Beaudart, C., Buckinx, F., Bruyère, O., & Reginster, J.-Y. (April 2016). Brain-derived neurotrophic factor (BDNF) in normal healthy and hemodialyzed populations. Osteoporosis International, 27 (Supplement 1), 512.

CAVALIER, E., Piron, C., WATAR, F., KOVACS, S., Beaudart, C., Buckinx, F., Bruyère, O., LE GOFF, C., & Reginster, J.-Y. (April 2016). Evaluation of the intra-individual variability of myostatin and activin A, two biomarkers of sarcopenia: impact on the least significant change and followup of the patients. Osteoporosis International, 27 (supplement 1), 56.

Le Goff, C., Kaux, J.-F., Cavalier, E., & Croisier, J.-L. (April 2016). Is isokinetic exercise dangerous for the heart? European Journal of Physical and Rehabilitation Medicine, 52 (suppl. 1 No. 2), 457.

Souberbielle, J.-C., Massart, C., Brailly-Tabard, S., CAVALIER, E., & Chanson, P. (2016). Prevalence and determinants of vitamin D deficiency in healthy French adults: the VARIETE study. Endocrine. doi:10.1007/s12020-016-0960-3

DELANAYE, P., LE GOFF, C., JOURET, F., & CAVALIER, E. (February 2016). Concordance between Iothalamate and Iohexol Plasma Clearance [letter to the editor]. American Journal of Kidney Diseases, 68 (2), 329-330. doi:10.1053/j.ajkd.2016.01.007

Bargnoux, A.-S., Kuster, N., Delatour, V., DELANAYE, P., Gonzalez-Antuna, A., Cristol, J.-P., Piéroni, L., & CAVALIER, E. (2016). Reference Method and Reference Material Are Necessary Tools to Reveal the Variability of Cystatin C Assays [letter to the editor]. Archives of Pathology and Laboratory Medicine, 140 (2), 117-118. doi:10.5858/arpa.2015-0198-LE

Buckinx, F., Reginster, J.-Y., Cavalier, E., PETERMANS, J., RICOUR, C., Dardenne, C., & Bruyère, O. (January 2016). Determinants of vitamin D supplementation prescription in nursing homes: a survey among general practitioners. Osteoporosis International, 27, 881-6. doi:10.1007/s00198-015-3469-3

Cavalier, E., Beaudart, C., Buckinx, F., Bruyère, O., & Reginster, J.-Y. (2016). Critical analytical evaluation of promising markers for sarcopenia. European Geriatric Medicine, 7 (3), 239-242. doi:10.1016/j.eurger.2015.11.002

CAVALIER, E., Carlisi, A. S., WATAR, F., KOVACS, S., Beaudart, C., Buckinx, F., Bruyère, O., & Reginster, J.-Y. (2016). Brain-derived neurotrophic factor (BDNF) in normal healthy and hemodialyzed populations. Journal of Frailty and Aging, 5 (Supplement 1), 116.

CAVALIER, E., LUKAS, P., BEKAERT, A.-C., PEETERS, S., LE GOFF, C., Yayo, E., DELANAYE, P., & Souberbielle, J.-C. (2016). Analytical and clinical evaluation of the new Fujirebio Lumipulse G non-competitive assay for 25(OH)-vitamin D and three immunoassays for 25(OH)D in healthy subjects, osteoporotic patients, third trimester pregnant women, healthy African subjects, hemodialyzed and intensive care patients. Clinical Chemistry and Laboratory Medicine. doi:10.1515/cclm-2015-0923

CAVALIER, E., Piron, C., WATAR, F., KOVACS, S., Beaudart, C., Buckinx, F., Bruyère, O., LE GOFF, C., & Reginster, J.-Y. (2016). Evaluation of the intra-individual variability of myostatin and activin A, two biomarkers of sarcopenia. Impact of the least significant change and follow-up of the patients. Journal of Frailty and Aging, 5 (Supplement 1), 82.

DELANAYE, P., CAVALIER, E., Fafin, C., DUBOIS, B., KRZESINSKI, J.-M., & Moranne, O. (2016). Efficiency of delivery observed treatment in hemodialysis patients: the example of the native vitamin D therapy. Journal of Nephrology, 29 (1), 99-103. doi:10.1007/s40620-015-0196-y

DELANAYE, P., Flamant, M., CAVALIER, E., Guerber, F., Valloton, T., Moranne, O., Pottel, H., Boffa, J., & Mariat, C. (2016). Adaptation posologique des médicaments et fonction rénale : Quel(s) estimateur(s) faut-il choisir? Néphrologie et Thérapeutique, 12 (1), 18-31. doi:10.1016/j.nephro.2015.07.472

DELANAYE, P., JOURET, F., LE GOFF, C., & CAVALIER, E. (2016). Concordance between iohexol and iothalamate plasma clearance. American Journal of Kidney Diseases. doi:10.1053/j.ajkd.2016.01.007

Ebert, N., DELANAYE, P., Shlipak, M., Jakob, O., Martus, P., Gaedek, J., Schurchardt, M., van der Giet, M., Bartel, J., CAVALIER, E., & Schaeffner, E. (2016). Cystatin C standardization decreases assay variation and improves assessment of GFR. Poster session presented at LIII Congress of ERA-EDTA, Vienna, Austria.

Gonzalez Aguilera, B., Syrios, P., GADISSEUR, R., LUYCKX, F., Cavalier, E., Beckers, A., & VALDES SOCIN, H. G. (2016). Persistent low levels of serum hCG due to heterophilic mouse antibodies: an unrecognized pitfall in the diagnosis of trophoblastic disease. Gynecological Endocrinology, 1-3. doi:10.3109/09513590.2015.1132303

Jean, G., Chazot, C., Bresson, E., Zaoui, E., & CAVALIER, E. (2016). High serum sclerostin levels are associated with a better outcome in haemodialysis patients. Nephron. Clinical Practice. doi:10.1159/000443845

JOURET, F., CAVALIER, E., & DELANAYE, P. (2016). Concordance between iothalamate and iohexol plasma clearances. Poster session presented at LIII Congress of ERA-EDTA, Vienna, Austria.

LUTTERI, L., Dierge, L., PESSER, M., WATRIN, P., & Cavalier, E. (2016). A paperless autoimmunity laboratory: myth or reality? Annales de Biologie Clinique, 74 (4), 477-89. doi:10.1684/abc.2016.1164

Moreau, E., Bächer, S., Mery, S., Goff, C., Piga, N., Vogeser, M., Hausmann, M., & CAVALIER, E. (2016). Performance characteristics of the VIDAS 25-OH Vitamin D total assay - comparison with four immunoassays and two liquid chromatography-tandem mass spectrometry methods in a multicentric study. Clinical Chemistry and Laboratory Medicine. doi:10.1515/cclm-2014-1249

Morris, H. A., Eastell, R., Jorgesen, N. R., Cavalier, E., Vasikaran, S., Chubb, S. A. P., Kanis, J. A., Cooper, C., & Makris, K. (2016). Clinical usefulness of bone turnover marker concentrations in osteoporosis. Clinica Chimica Acta, 467, 34-41. doi:10.1016/j.cca.2016.06.036

Nyssen, L., DELANAYE, P., Le Goff, C., PEETERS, S., & Cavalier, E. (2016). A simple LC-MS method for the determination of iohexol and iothalamate in serum, using ioversol as an internal standard. Clinica Chimica Acta, 463, 96-102. doi:10.1016/j.cca.2016.10.021

PAQUOT, F., BOUQUEGNEAU, A., CAVALIER, E., & DELANAYE, P. (2016). Sclérostine & insuffisance rénale: que nous apprennent les différents méthodes de dosage? Néphrologie et Thérapeutique, 12 (5), 374.

ROUSSEAU, A.-F., Damas, P., DELANAYE, P., & Cavalier, E. (2016). Bone markers during acute burn care: Relevance to clinical practice? Burns: Journal of the International Society for Burn Injuries. doi:10.1016/j.burns.2016.07.020

ROUSSEAU, A.-F., Michel, L., Bawin, M., CAVALIER, E., Reginster, J.-Y., DAMAS, P., & Bruyère, O. (2016). Incidence of bone fractures after critical illness. Intensive Care Medicine Experimental, 4 (Suppl 1), 1131.

ROUSSEAU, A.-F., SOUBERBIELLE, J.-C., DELANAYE, P., Damas, P., & Cavalier, E. (2016). Fibroblast growth factor 23 in acute burn patients: Novel insights from an intact-form assay. Burns: Journal of the International Society for Burn Injuries. doi:10.1016/j.burns.2016.01.024

Sagou Yayo, E., Aye, E., Konan, J., Emième, A., Attoungbré, M., Gnionsahé, A., CAVALIER, E., Monnet, D., & DELANAYE, P. (2016). Inadéquation du facteur ethnique pour l’estimation du débit de filtration glomérulaire en population générale noire-africaine : résultats en Côte d’Ivoire. Néphrologie et Thérapeutique, 12 (6), 454-459. doi:10.1016/j.nephro.2016.03.006

Souberbielle, J.-C., Massart, C., Brailly-Tabard, S., Cormier, C., CAVALIER, E., DELANAYE, P., & Chanson, P. (2016). Serum PTH reference values established by an automated third-generation assay in Vitamin D-replete subjects with normal renal function: Consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients. European Journal of Endocrinology, 174 (3), 315-323. doi:10.1530/EJE-15-0595

Souberbielle, J.-C., CAVALIER, E., DELANAYE, P., Massart, C., Brailly-Tabard, S., Cormier, C., Borderie, D., Benachi, A., & Chanson, P. (07 December 2015). Serum calcitriol concentrations measured with a new direct automated assay in a large population of adult healthy subjects and in various clinical situations. Clinica Chimica Acta, 451 (Pt B), 149-53. doi:10.1016/j.cca.2015.09.021

Bruyère, O., DEROISY, R., Dardenne, N., Cavalier, E., COFFINER, M., da silva, S., De Niet, S., & Reginster, J.-Y. (December 2015). A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods. Osteoporosis International, 26 (12), 2863-8. doi:10.1007/s00198-015-3205-z

DELANAYE, P., CAVALIER, E., BOUQUEGNEAU, A., & Khwaja, A. (December 2015). Sclerostin levels in CKD patients : an important, but not definitive, step on the way to clinical use. Kidney International, 88 (6), 1221-1223. doi:10.1038/ki.2015.258

Hoge, A., Donneau, A.-F., Streel, S., Kolh, P., CHAPELLE, J.-P., Albert, A., CAVALIER, E., & Guillaume, M. (December 2015). La déficience en vitamine D est fréquente chez les adultes wallons: résultats de l'étude "Nutrition, Environnement et Santé CardioVasculaire". Ortho-Rhumato, 13 (6), 31-36.

CAVALIER, E. (20 November 2015). KDIGO a guidelines for bone turnover management in dialysis patients. Paper presented at WASPaLM 28th World Congress of Pathology and Laboratory Medicine, Cancun, Mexico.

CAVALIER, E. (20 November 2015). 3rd Generation PTH: Clinical utility. Paper presented at WASPaLM 28th World Congress of Pathology and Laboratory Medicine, Cancun, Mexico.

LUTTERI, L., CAVALIER, E., & ALDENHOFF, M.-C. (14 November 2015). CALPROTECTIN IN STOOL: COMPARISON BETWEEN ELISA AND CHEMILUMINESCENT IMMUNOASSAY. Poster session presented at Congrès annuel SRBML, Bruxelles, Belgium.

Cavalier, E., Plebani, M., DELANAYE, P., & Souberbielle, J.-C. (November 2015). Considerations in parathyroid hormone testing. Clinical Chemistry and Laboratory Medicine, 53 (12), 1913-9. doi:10.1515/cclm-2015-0314

VRANKEN, L., DELCOUR, S., & CAVALIER, E. (24 October 2015). Using S-Monovette° lower the rate of hemolysed specimen from a belgian academic emergency department. Poster session presented at 15th EFLM Continuing Postgraduate Course in Clinical Chemistry and Laboratory Medicine, Zagreb, Croatia.

Castiglione, V., Pieroni, L., Conort, P., Dousseaux, M.-P., Bonnal, C., Renard-Penna, R., Isnard-Bagnis, C., Deray, G., CAVALIER, E., & Tostivint, I. (01 October 2015). La prise en charge interdisciplinaire des patients lithiasiques réduit-elle à long terme le taux de geste urologique pour récidive ? Poster session presented at 17ème réunion commune des Sociétés Francophone de Dialyse et de Néphrologie, Lyon, France.

Libon, F., Courtois, J., LUKAS, P., LE GOFF, C., SEIDEL, L., CAVALIER, E., & NIKKELS, A. (October 2015). Effect of body surface, body site and sunscreen application on production of vitamin D and 25-hydroxyvitamin D after a single narrowband-UVB exposure. Paper presented at EADV Congress, Cophenhague, Denmark.

VRANKEN, L., DELCOUR, S., & CAVALIER, E. (2015). Using S-Monovette° lower the rate of hemolysed specimen from a belgian academic emergency department. Clinical Chemistry and Laboratory Medicine.

CAVALIER, E. (23 September 2015). Performances analytiques d’un biomarqueur : dialogue. Paper presented at Corata Belgique - 3ème Congrès de Biologie clinique, Beaune, France.

CAVALIER, E. (17 September 2015). Analytical performance of a biomarker: what the clinician should know. Paper presented at Biomarkers in Nephrology: ready for prime time?, Lyon, France.

CAVALIER, E. (11 September 2015). Role of biochemical markers in the diagnosis and management of sarcopenia in daily practice. Paper presented at Biological and imaging (MRI,DXA,...) markers in the assessment and management of sarcopenia in daily practice, Geneva, Switzerland.

Buckinx, F., Reginster, J.-Y., Cavalier, E., Petermans, J., Dardenne, C., & Bruyère, O. (September 2015). Derteminants of prescription of vitamin D supplementations in nursing homes: an online survey among general practitioners. European Geriatric Medicine, 6S1, 139.

LE GOFF, C., Kaux, J.-F., Couffignal, V., Coubard, R., Mélon, P., Cavalier, E., & Croisier, J.-L. (September 2015). Identification of cardiac repercussions after intense and prolonged concentric isokinetic exercise in young sedentary people. Clinical Physiology and Functional Imaging, 35 (5), 368-375. doi:10.1111/cpf.12172

LE GOFF, C., Kaux, J.-F., Gergelé, L., Millet, G., Viallon, M., Croisille, P., & Cavalier, E. (September 2015). Impact of an ultra-trail of 330 km on plasma levels of cardiac biomarkers. European Journal of Sports Medicine, 3 (Suppl 1), 77.

Delvin, E., LE GOFF, C., CAVALIER, E., & Souberbielle, J.-C. (2015). Measurement of circulating 25-hydroxyvitamin D: A historical review. Practical Laboratory Medicine. doi:10.1016/j.plabm.2015.04.001

Hoge, A., Donneau, A.-F., Streel, S., Kolh, P., CHAPELLE, J.-P., Albert, A., CAVALIER, E., & Guillaume, M. (August 2015). Vitamin D deficiency is common among adults in Wallonia (Belgium, 51°30′ North): findings from the Nutrition, Environment and Cardio-Vascular Health study. Nutrition Research, 35 (8), 716-25. doi:10.1016/j.nutres.2015.06.005

ROUSSEAU, A.-F., DAMAS, P., LEDOUX, D., LUKAS, P., CARLISI, I., LE GOFF, C., GADISSEUR, R., & CAVALIER, E. (August 2015). Vitamin D status after a high dose of cholecalciferol in healthy and burn subjects. Burns: Journal of the International Society for Burn Injuries, 41 (5), 1028-1034. doi:10.1016/j.burns.2014.11.011

DELANAYE, P., Liabeuf, S., BOUQUEGNEAU, A., CAVALIER, E., & Massy, Z. (July 2015). L'éveil de la matrix-gla-protéine sonnera le glas des calcifications vasculaires. Néphrologie et Thérapeutique, 11 (4), 191-200. doi:10.1016/j.nephro.2014.12.003

CAVALIER, E. (12 June 2015). Problèmes liés aux dosages de PTH. Paper presented at 58èmes Journées Internationales d'Endocrinologie Clinique, HP Klotz, Paris, France.

CAVALIER, E. (05 June 2015). Place de la vitamine D dans l'exploration des troubles minéraux: problèmes liés aux dosages. Paper presented at 15èmes Journées marocaines de Biologie clinique, Casablanca, Morocco.

LE GOFF, C., Kaux, J.-F., Gergelé, L., Millet, G., Viallon, M., Croisille, P., & Cavalier, E. (2015). Galectin-3 and Suppression of Tumorigenicity 2 measurement in participants at the “Tor des Géants”. In A. Radmann, S. Hedenborg, & E. Tsolakidis, 20th annual Congress of the EUROPEAN COLLEGE OF SPORT SCIENCE - BOOK OF ABSTRACTS0th annual Congress of the EUROPEAN COLLEGE OF SPORT SCIENCE - BOOK OF ABSTRACTS (pp. 435-436).

Liabeuf, S., DELANAYE, P., Cavalier, E., Guerin, A., Kamel, S., & Massy, Z. A. (June 2015). Inhibiteurs des calcifications cardiovasculaires. Annales de Biologie Clinique, 73 (3), 315-22. doi:10.1684/abc.2015.1047

CAVALIER, E., DELANAYE, P., Nyssen, L., & Souberbielle, J.-C. (May 2015). Problems with the PTH assays. Annales d'Endocrinologie, 76 (2), 128-133. doi:10.1016/j.ando.2015.03.018

CAVALIER, E., GADISSEUR, R., & Castiglione, V. (2015). Vitamine D et lithiases rénales : la pierre d'achoppement. In C.-L. Benhamou & J.-C. Souberbielle (Eds.), La vitamine D chez l'adulte. Montpellier, France: Sauramps Medical.

LE GOFF, C., Kaux, J.-F., Goffaux, S., & Cavalier, E. (May 2015). Cardiac Biomarkers and Cycling Race. Journal of Sports Science and Medicine, 14 (2 (eCollection 2015 Jun)), 475-476.

Pelletier, S., Jean, G., Fouque, D., CAVALIER, E., DELANAYE, P., Souberbielle, J.-C., Zaoui, P., Cristol, J. P., Urena-Torres, P., Boutten, A., Hannedouche, T., Brunet, P., Jean, G., Pieroni, L., Mercadal, L., Lafage-Proust, M.-H., Guérin, A., Prié, D., Kamel, S., & Arnaud, J. (May 2015). La sclérostine: un nouveau biomarqueur d'intérêt en néprhologie. Annales de Biologie Clinique, 73 (3), 305-13. doi:10.1684/abc.2015.1049

Souberbielle, J.-C., CAVALIER, E., & Cormier, C. (May 2015). How to manage an isolated elevated PTH? Annales d'Endocrinologie, 76 (2), 134-141. doi:10.1016/j.ando.2015.03.005

LUTTERI, L., CAVALIER, E., & Frenay, S. (16 April 2015). IS IT POSSIBLE TO MONITOR MONOCLONAL GAMMOPATHY WITH N LATEX FLC (SIEMENS) AS WELL AS FREELITE? Poster session presented at 7ème congrès international : Clinical applications of free light chain and heavy chain analysis, Edinburgh, United Kingdom.

Rehan, M., Raizman, J., CAVALIER, E., Don-Wauchope, A., & Holmes, D. (April 2015). Laboratory challenges in primary aldosteronism screening and diagnosis. Clinical Biochemistry, 48 (6), 377-387. doi:10.1016/j.clinbiochem.2015.01.003

BOUQUEGNEAU, A., KRZESINSKI, J.-M., DELANAYE, P., & CAVALIER, E. (30 March 2015). Biomarkers and physiolpathology in the cardiorenal syndrome. Clinica Chimica Acta, 443, 100-107.

CAVALIER, E. (05 March 2015). La détermination du débit de filtration glomérulaire. Aspects biologiques. Paper presented at Les jeudis de Fleurus, Fleurus, Belgium.

Castiglione, V., GADISSEUR, R., & CAVALIER, E. (March 2015). Les pierres aux reins. sofiadis mag, 19, p. 14-16.

ROUSSEAU, A.-F., FOIDART-DESSALLE, M., LEDOUX, D., REMY, C., CROISIER, J.-L., DAMAS, P., & CAVALIER, E. (March 2015). Effects of cholecalciferol supplementation and optimized calcium intakes on vitamin D status, muscle strength and bone health: A one-year pilot randomized controlled trial in adults with severe burns. Burns: Journal of the International Society for Burn Injuries, 41 (2), 317-325. doi:10.1016/j.burns.2014.07.005

CAVALIER, E. (02 February 2015). MBD du laboratoire à la clinique. Paper presented at Global Kidney Academy, Alger, Algeria.

Castiglione, V., JOURET, F., Bruyère, O., DUBOIS, B., THOMAS, A., WALTREGNY, D., BEKAERT, A.-C., CAVALIER, E., & GADISSEUR, R. (February 2015). Epidémiologie de la lithiase urinaire sur base d'une analyse morpho-constitutionnelle. Néphrologie et Thérapeutique, 11, 42-49. doi:10.1016/j.nephro.2014.08.003

DELANAYE, P., BOUQUEGNEAU, A., KRZESINSKI, J.-M., CAVALIER, E., Jean, G., Urena-Torres, P., & Souberbielle, J.-C. (February 2015). Place de la vitamine D native en dialyse. Néphrologie et Thérapeutique, 11 (1), 5-15. doi:10.1016/j.nephro.2014.10.004

LE GOFF, C., Souberbielle, J.-C., Delvin, E., & CAVALIER, E. (February 2015). Le dosage de la vitamine D: considérations pré-analytiques et analytiques. Annales de Biologie Clinique, 73 (1), 79-92. doi:10.1684/abc.2014.1002

Buckinx, F., Reginster, J.-Y., CAVALIER, E., PETERMANS, J., RICOUR, C., Dardenne, C., & Bruyère, O. (2015). Determinants of prescription of vitamin D supplementation in nursing homes: a survey among general practitioners. The Journal of Nursing Home Research Sciences, 1, 43.

Cavalier, E. (2015). APPROCHE GLOBALE ET PERSONNALISEE DES BIOMARQUEURS. Revue Médicale de Liège, 70 (5-6), 257-61.

CAVALIER, E., GADISSEUR, R., GEBOES, S., BEKAERT, A.-C., CARLISI, I., Bruyère, O., & Reginster, J.-Y. (2015). Critical evaluation of promising markers for sarcopenia. Osteoporosis International, 26 (S1), 49-S50.

DELANAYE, P., & CAVALIER, E. (2015). Vitamine D et maladie rénale chronique. In C. Benhamou & J. Souberbielle, La vitamine D chez l’adulte. Sauramps Medical.

DELANAYE, P., DUBOIS, B., LUKAS, P., PETERS, P., KRZESINSKI, J.-M., Pottel, H., & CAVALIER, E. (2015). impact of stopping vitamin K antagonist therapy on concentrations of dephospho-uncarboxylated Matrix Gla protein [letter to the editor]. Clinical Chemistry and Laboratory Medicine, 53 (8), 191-193. doi:10.1515/cclm-2015-0073

DELANAYE, P., LAMBERMONT, B., MORIMONT, P., KRZESINSKI, J.-M., Maillard, N., Claisse, G., Mariat, C., & CAVALIER, E. (2015). Discrepancies between urinary and plasma NGAL concentrations in patients adlmitted to the medical intensive care. Poster session presented at LII Congress of ERA-EDTA, London, United Kingdom.

DELANAYE, P., Warling, Moonen, M., Smelten, N., KRZESINSKI, J.-M., Moranne, O., Pottel, H., & CAVALIER, E. (2015). Variation de la parathormone et de différents biomarqueurs osseux chez le patient hémodialysé. Poster session presented at XVII réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lyon, France.

DELANAYE, P., Warling, X., Moonen, M., Smelten, N., KRZESINSKI, J.-M., Pottel, H., & CAVALIER, E. (2015). Variation of PTH and bone biomarkers in hemodialysis patients. Poster session presented at ASN Kidney Week, San Diego, United States - California.

Deroyer, C., Magne, J., Moonen, M., Le Goff, C., Dupont, L., Hulin, A., Radermecker, M., Colige, A., Cavalier, E., Kolh, P., Pierard, L., LANCELLOTTI, P., Merville, M.-P., & Fillet, M. (2015). New biomarkers for primary mitral regurgitation. Clinical Proteomics, 12, 25. doi:10.1186/s12014-015-9097-2

EVRARD, S., DELANAYE, P., Kamel, S., Cristol, J., & CAVALIER, E. (January 2015). Vascular calcification: from pathophysiology to biomarkers. Clinica Chimica Acta, 438, 401-14. doi:10.1016/j.cca.2014.08.034

Libon, F., SEIDEL, L., CAVALIER, E., & NIKKELS, A. (2015). Vitamin D supplementation does not improve the severity or the resolution of ultraviolet B-induced acute erythema. Dermatology, 231, 280-285. doi:10.1159/000430983

Masson, I., Maillard, N., CAVALIER, E., Alamartine, E., Mariat, C., & DELANAYE, P. (2015). KDIGO Guidelines and Kidney Transplantation: Is the cystatin-C Based Recommendation relevant? American Journal of Transplantation, 15 (8), 2211-4. doi:10.1111/ajt.13258

Rabenda, V., Bruyère, O., Cavalier, E., DEROISY, R., LECART, M.-P., COLLETTE, J., & Reginster, J.-Y. (2015). Serum concentrations of osteoprotegerin (OPG) and dickkope-1 (DKK1) poorly predict bone mineral density changes and fracture incidence in postmenopausal osteoporotic women. Osteoporosis International, 26 (S1), 240.

Raizman, J., Diamantis, E., Holmes, D., Stowasser, M., Auchus, R., & Cavalier, E. (2015). A Renin-ssance in primary aldosteronism testing: obstacles and opportunities for screening, diagnosis, and management. Clinical Chemistry, 61 (8), 1022-1027.

SCHLECK, M.-L., Souberbielle, J.-C., JANDRAIN, B., Da Silva, S., De Niet, S., Vanderbist, F., SCHEEN, A., & CAVALIER, E. (2015). A Randomized, Double-Blind, Parallel Study to Evaluate the Dose-Response of Three Different Vitamin D Treatment Schemes on the 25-Hydroxyvitamin D Serum Concentration in Patients with Vitamin D Deficiency. Nutrients, 7, 5413-22. doi:10.3390/nu7075227

Yayo, E., Konan, J., Aye, M., Amième, A., Gnionsahé, A., Gbago, G., Monnet, D., CAVALIER, E., & DELANAYE, P. (2015). Evaluation du débit de filtration glomérulaire en population générale : résultats en Côte d’Ivoire E. Poster session presented at XVII réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lyon, France.

CAVALIER, E. (02 December 2014). «25 OH Vitamin D Total: Une aide dans l’evalution de l’auto-suffisance en vitamine D. Paper presented at Conférence clinico-biologique, Tanger, Morocco.

ROUSSEAU, A.-F., & CAVALIER, E. (11 November 2014). Vitamin D status in critically ill patients: back to basics! [letter to the editor]. Critical Care, 18 (6), 611. doi:10.1186/s13054-014-0611-0

CAVALIER, E., DUBOIS, B., Urena, P., Smelten, N., & DELANAYE, P. (November 2014). Impact of the dialysis membrane on the Vitamin D metabolims markers. Poster session presented at Kidney week, Philadelphia, United States.

Ebert, N., DELANAYE, P., Martus, P., Jakob, O., Bartel, J., Schuchardt, M., CAVALIER, E., & Schaeffner, E. (November 2014). Systematic Analysis of two cystatin C assays using samples of 2057 older adults - The Berlin initiative study. Poster session presented at Kidney Week, Philadelphia, United States.

ROUSSEAU, A.-F., DAMAS, P., JANSSENS, M., KALIN, S., LEDOUX, D., LE GOFF, C., GADISSEUR, R., DELANAYE, P., & CAVALIER, E. (November 2014). Critical care and vitamin D status assessment: What about immunoassays and calculated free 25OH-D? Clinica Chimica Acta, 437, 43-47. doi:10.1016/j.cca.2014.07.007

Castiglione, V., Jouret, F., Bruyère, O., BEKAERT, A.-C., DUBOIS, B., THOMAS, A., CAVALIER, E., & GADISSEUR, R. (18 October 2014). Epidemiology of urolithiasis in Liège on the basis of a morpho-constitutional classification. Poster session presented at BVKB, Leuven, Belgium.

HALENG, J., & CAVALIER, E. (18 October 2014). Case report : Rhabdomyolysis following acute alcohol intoxication. Poster session presented at congrès de la société belge de biologie clinique.

Castiglione, V., JOURET, F., Bruyère, O., BEKAERT, A.-C., THOMAS, A., DUBOIS, B., WALTREGNY, D., CAVALIER, E., & GADISSEUR, R. (17 October 2014). Épidémiologie de la lithiase urinaire en Province de Liège. Paper presented at Confrontations clinico-biologiques autour de la lithiase urinaire, Paris, France.

CAVALIER, E. (16 October 2014). Vitamine D: métabolisme, sources, modes d'action. Paper presented at 8ème symposium bioclinique : Actualités Vitamine D, Paris, France.

CAVALIER, E. (02 October 2014). Les biomarqueurs du remodelage osseux. Paper presented at 16ème réunion commune Société de néphrologie et Société francophone de Dialyse, Saint-Etienne, France.

Castiglione, V., Jouret, F., Bruyère, O., BEKAERT, A.-C., DUBOIS, B., THOMAS, A., WALTREGNY, D., CAVALIER, E., & GADISSEUR, R. (01 October 2014). Épidémiologie de la lithiase urinaire en Province de Liège. Néphrologie et Thérapeutique, 10 (5), 270.

CAVALIER, E., BEKAERT, A.-C., LUKAS, P., PEETERS, S., GADISSEUR, R., LE GOFF, C., & DELANAYE, P. (October 2014). Les résultats des formules de calcul de la 25(OH)-vitamine D libre varient en fonction des méthodes de dosage de la 25(OH)D. Poster session presented at 16ème Réunion commune - Société de néphrologie - Société de dialyse, Saint-Etienne, France.

CAVALIER, E., DUBOIS, B., BEKAERT, A.-C., LUKAS, P., PEETERS, S., GADISSEUR, R., LE GOFF, C., KRZESINSKI, J.-M., & DELANAYE, P. (October 2014). La membrane de dialyse peut-elle avoir une influence sur le statut en vitamine D du patient? Poster session presented at 16ème réunion commune - Société de néphrologie - Société de dialyse, Saint Etienne, France.

CAVALIER, E., PONCIN, J., MUSSO, G., & HALENG, J. (October 2014). Evaluation de la mesure rapide de la creatinine par le StaSensor (Nova Biomedical). Poster session presented at 16ème réunion commune - Société de néphrologie - Société de dialyse, Saint Etienne, France.

DELANAYE, P., CAVALIER, E., Cristol, J.-P., & Delanghe, J. (October 2014). Calibration and precision of serum creatinine and plasma cystatin C measurement: impact on the estimation of glomerular filtration rate. Journal of Nephrology, 27 (5), 467-75. doi:10.1007/s40620-014-0087-7

LUYCKX, F., Texeira, J., VALDES SOCIN, H. G., Beckers, A., & Cavalier, E. (2014). Hypervitaminémie B12 : un piège diagnostique pour le biologiste et pour le clinicien ? In Abstract book - Annales d'Endocrinologie : 31ème Congrès de la Société Française d'Endocrinologie, Lyon 5-8 novembre 2014.

CAVALIER, E. (27 September 2014). Dosage de la vitamine D: Point de vue du Biologiste. Paper presented at Rencontre clinico-biologique : "Dosage de la vitamine D: Aspects clinico-biologiques", Fès, Morocco.

CAVALIER, E., Souberbielle, J.-C., GADISSEUR, R., DUBOIS, B., KRZESINSKI, J.-M., & DELANAYE, P. (September 2014). Inter-method variability in bone alkaline phosphatase measurement : clinical impact on the management of dialysis patients. Clinical Biochemistry, 47 (13-14), 1227-30. doi:10.1016/j.clinbiochem.2014.04.007

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Moonen, M., Smelten, N., Médart, Pottel, H., & CAVALIER, E. (September 2014). Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrology, 15, 145. doi:10.1186/1471-2369-15-145

GADISSEUR, R., Castiglione, V., JOURET, F., Bruyère, O., BEKAERT, A.-C., THOMAS, A., DUBOIS, B., WALTREGNY, D., & CAVALIER, E. (September 2014). Epidémiologie de la lithiase urinaire en Province de Liège. Néphrologie et Thérapeutique, 10 (5), 270.

CAVALIER, E., DELANAYE, P., LUKAS, P., CARLISI, I., GADISSEUR, R., & Souberbielle, J.-C. (01 August 2014). Standardization of DiaSorin and Roche automated third generation PTH assays with an international standard: impact on clinical populations. Clinical Chemistry and Laboratory Medicine, 52 (8), 1137-41. doi:10.1515/cclm-2013-1027

CAVALIER, E., Mismetti, V., & Souberbielle, J.-C. (July 2014). Evaluation of circulating irisin levels in healthy young individuals after a single 100,000 IU vitamin D dose. Annales d'Endocrinologie, 73 (3), 162-164. doi:10.1016/j.ando.2014.05.005

De Bock, M., BEGUIN, Y., Leprince, P., WILLEMS, E., BARON, F., Deroyer, C., Seidel, L., CAVALIER, E., DE SENY, D., MALAISE, M., GOTHOT, A., MERVILLE, M.-P., & Fillet, M. (July 2014). Comprehensive plasma profiling for the characterization of graft-versus-host disease biomarkers. Talanta, 125, 265-275. doi:10.1016/j.talanta.2014.03.017

LE GOFF, C., Devaux, S., BREVERS, E., PEETERS, S., Kaux, J.-F., Fillet, M., Mélon, P., & Cavalier, E. (July 2014). Galectin-3: a new promising cardiac biomarker in sports endurance? Cardiovascular Research, 103 (Supplement 1), 255.

CAVALIER, E. (26 June 2014). Bone markers in patients with CKD. Paper presented at IFCC Worldlab Istanbul 2014: 22nd international Congress of Clinical Chemistry and Laboratory Medicine, Istanbul, Turkey.

CAVALIER, E. (24 June 2014). Standardisation of 25(OH)-vitamin D assays: beware of limitations. Paper presented at IFCC Wordlab Istanbul 2014 22nd International Congress of Clinical Chemistry, Istanbul, Turkey.

LE GOFF, C., DELCOUR, S., PEETERS, S., CRINE, Y., NETCHACOVITCH, M., & Cavalier, E. (June 2014). URINARY AND SALIVARY CORTISOL IN LIQUID CHROMATOGRAPHY–TANDEM MASS SPECTROMETRY: METHOD VALIDATION AND EXPECTED VALUES DETERMINATION. Clinical Chemistry and Laboratory Medicine, 52 (Special Suppl), 1241.

LE GOFF, C., EVRARD, S., BREVERS, E., Kaux, J.-F., & Cavalier, E. (June 2014). Evaluation of troponin T on AQT90 Flex and COBAS 8000 as a rule in/out tool in an emergency ward. Clinical Chemistry and Laboratory Medicine, 52 (Special Suppl), 510.

SCHLECK, M.-L., NETCHACOVITCH, M., CRINE, Y., PEETERS, S., Lucas, P., Cavalier, E., & LE GOFF, C. (June 2014). SUITABILITY OF 24,25(OH)2 VITAMIN D3 DETERMINATION WITH AN ADAPTED VERSION OF THE CHROMSYSTEMS® MASSCHROM® 25-OH-VITAMIN D3/D2– LC-MS/MS KIT. Clinical Chemistry and Laboratory Medicine, 52 (Special Suppl), 1235.

CAVALIER, E. (22 May 2014). L'exploration de la fonction thyroïdienne: interférences et erreurs analytiques en immuno-analyse. Aspects biologiques. Paper presented at Les jeudis de Fleurus, Fleurus, Belgium.

CAVALIER, E. (14 May 2014). Supplémentation, statut optimal et détermination analytique de la vitamine D. Paper presented at Symposium Vitamine D - 10ème Congrès international francophone de gérontologie et gériatrie, Liège, Belgium.

DELANAYE, P., Souberbielle, J.-C., Lafage-Proust, M.-H., Jean, G., & CAVALIER, E. (May 2014). Can we use circulating biomarkers to monitor bone turnover in CKD haemodialysis patients? Hypotheses and facts. Nephrology Dialysis Transplantation, 29 (5), 997-1004. doi:10.1093/ndt/gft275

Djennane, M., Lebbah, S., Roux, C., Djoudi, H., CAVALIER, E., & Souberbielle, J.-C. (May 2014). Vitamin D status of schoolchildren in Northern Algeria, seasonal variations and determinants of vitamin D deficiency. Osteoporosis International, 25 (5), 1493-502. doi:10.1007/s00198-014-2623-7

LE GOFF, C., Kaux, J.-F., LAURENT, T., Vannuscorps, J., PINCEMAIL, J., Chapelle, J.-P., Cavalier, E., & Croisier, J.-L. (May 2014). Is isokinetic eccentric exercise dangerous for the heart? Isokinetics and Exercise Science, 22 (2), 131-136. doi:10.3233/IES-130529

CAVALIER, E., LUKAS, P., CRINE, Y., PEETERS, S., CARLISI, I., LE GOFF, C., GADISSEUR, R., DELANAYE, P., & Souberbielle, J.-C. (20 April 2014). Evaluation of automated immunoassays for 25 (OH)-vitamin D determination in different critical populations before and after standardization of the assays. Clinica Chimica Acta, 431, 60-5. doi:10.1016/j.cca.2014.01.026

CAVALIER, E., JANDRAIN, B., Da Silva, S., De Niet, S., Vanderbist, F., & SCHEEN, A. (April 2014). A randomized, double-blinded, parallel study to evaluate the dose-response of a monthly supplementation of 25000, 50000 or 100000 IU of vitamin D3 in subjects with deficiency in vitamin D. Poster session presented at Vitamin D and human health: from the gamete to the grave, Londres, United Kingdom.

CAVALIER, E., LUKAS, P., CRINE, Y., PEETERS, S., CARLISI, I., LE GOFF, C., GADISSEUR, R., DELANAYE, P., & Souberbielle, J.-C. (April 2014). Standardization of 25-hydroxyvitamin D assays: impact of vitamin-D binding protein concentrations and uremic media on the re-standardization of six different 25(OH) vitamin D immunoassays. Poster session presented at WCO-IOF-ESCEO Seville 2014 : World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases, Séville, Spain.

LE GOFF, C., Kaux, J.-F., Fillet, M., MELON, P., & Cavalier, E. (April 2014). Two biomarkers for the screening of cardiac risk among runners ? British Journal of Sports Medicine, 48 (7), 174.

LE GOFF, C., Kaux, J.-F., Fillet, M., MELON, P., & Cavalier, E. (April 2014). Cardiac troponins and natriuretic peptides in runners: useful for cardiac risk screening ? British Journal of Sports Medicine, 48 (7), 173. doi:10.1136/bjsports-2014-093494.173

ROUSSEAU, A.-F., BARGUES, L., LE BEVER, H., VEST, P., CAVALIER, E., LEDOUX, D., PIERARD, G., & DAMAS, P. (April 2014). Effect of gamma-hydroxybutyrate on keratinocytes proliferation: a preliminary prospective controlled study in severe burn patients. International Journal of Critical Illness and Injury Science, 4 (2), 108-113. doi:10.4103/2229-5151.134150

CAVALIER, E., BETEA, D., SCHLECK, M.-L., GADISSEUR, R., VROONEN, L., DELANAYE, P., Daly, A., & BECKERS, A. (March 2014). The Third/Second Generation PTH Assay Ratio as a Marker for Parathyroid Carcinoma: Evaluation Using an Automated Platform. Journal of Clinical Endocrinology and Metabolism, 99 (3), 453-7. doi:10.1210/jc.2013-3730

LUTTERI, L., PESSER, M., WATRIN, P., & CAVALIER, E. (March 2014). ANTI-NUCLEAR ANTIBODIES : PREVALENCE OF DIFFERENT PATTERNS AND ANTIBODIES IN A BELGIAN UNIVERSITY LABORATORY. Poster session presented at 9ème congrès international d’auto-immunité, Nice, France.

LUTTERI, L., PESSER, M., WATRIN, P., & CAVALIER, E. (March 2014). A PAPERLESS AUTOIMMUNITY LABORATORY : IS IT POSSIBLE ? Poster session presented at 9ème congrès international d’auto-immunité.

CAVALIER, E. (18 January 2014). At which level of vitamin D should we aim? Paper presented at Belgian Bone Club - Clinical Update Symposium - Hot topics in osteoporosis management, Bruxelles, Belgium.

DELANAYE, P., CAVALIER, E., Morel, J., Mehdi, M., Maillard, N., Claisse, G., LAMBERMONT, B., DUBOIS, B., DAMAS, P., KRZESINSKI, J.-M., Lautrette, A., & Mariat, C. (13 January 2014). Detection of decreased glomerular filtration rate in intensive care units: serum cystatin C versus serum creatinine. BMC Nephrology, 15 (9), 1471-2369. doi:10.1186/1471-2369-15-9

Beaudart, C., Buckinx, F., Rabenda, V., CAVALIER, E., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2014). The effects of vitamin D on skeletal muscle strength, muscle mass and muscle power: a meta-analysis of randomized controlled trials. Journal of Frailty and Aging, 3 (1), 27.

Beaudart, C., Buckinx, F., Rabenda, V., GILLAIN, S., Cavalier, E., Slomian, J., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2014). The effects of vitamin D on skeletal muscle strength, muscle mass and muscle power: a systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Endocrinology and Metabolism, 99 (11), 4336-4345. doi:10.1210/jc.2014-1742

Beaudart, C., Buckinx, F., Rabenda, V., GILLAIN, S., CAVALIER, E., Slomian, J., PETERMANS, J., Reginster, J.-Y., & Bruyère, O. (2014). The effects of vitamin D on skeletal muscle strength, muscle mass and muscle power: a meta-analysis of randomized controlled trials. Osteoporosis International, 25 (2), 46.

Beaudart, C., Buckinx, F., Rabenda, V., GILLAIN, S., CAVALIER, E., Slomian, J., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2014). Les effets d'une supplémentation en vitamine D sur la force, la masse et la puissance musculaire : une méta-analyse d'essais randomisés contrôlés. Gériatrie et Psychologie Neuropsychiatrie du Vieillissement, 12 (1), 73.

Beaudart, C., Reginster, J.-Y., Cavalier, E., & Bruyère, O. (2014). Les effets d'une supplémentation en vitamine D sur la fonction musculaire. Ortho-Rhumato, 12 (5), 33-37.

BOUQUEGNEAU, A., Vidal-Petiot, E., Vrtovsnik, F., CAVALIER, E., KRZESINSKI, J.-M., Flamant, M., & DELANAYE, P. (2014). Accuracy of Cockcroft&Gault and CKD-EPI equations to estimate glomerular filtration rate in obese population. Poster session presented at LI Congress of ERA-EDTA, Amsterdam, Netherlands.

BOUQUEGNEAU, A., Vidal-Petito, E., Vrtovsnik, F., CAVALIER, E., KRZESINSKI, J.-M., Flamant, M., & DELANAYE, P. (2014). Cockcroft&Gault and CKD-EPI equations: are these equations concordant to adjust drug dosage? Poster session presented at LI Congress of ERA-EDTA, Amsterdam, Netherlands.

Bruyère, O., Cavalier, E., & Reginster, J.-Y. (2014). La prévalence du déficit en vitamine D en Belgique et en Europe chez les femmes âgées. Ortho-Rhumato, 12 (4), 3.

Bruyère, O., CAVALIER, E., Souberbielle, J.-C., Bischoff-Ferrari, H., Beaudart, C., Buckinx, F., Reginster, J.-Y., & Rizzoli, R. (2014). Effects of vitamin D in the elderly population : current status and perspectives. Archives of Public Health, 72, 32-42. doi:10.1186/2049-3258-72-32

Bruyère, O., Slomian, J., Beaudart, C., Buckinx, F., Cavalier, E., GILLAIN, S., Petermans, J., & Reginster, J.-Y. (2014). Prevalence of vitamin D inadequacy in European women aged over 80 years. Archives of Gerontology and Geriatrics, 59, 78-82. doi:10.1016/j.archger.2014.03.010

Bruyère, O., Slomian, J., Beaudart, C., Buckinx, F., CAVALIER, E., GILLAIN, S., PETERMANS, J., & Reginster, J.-Y. (2014). Prevalence of vitamin D inadequacy in European women aged over 80 years. Osteoporosis International, 25 (2), 196. doi:10.1016/j.archger.2014.03.010

Buckinx, F., Reginster, J.-Y., Cavalier, E., Slomian, J., Beaudart, C., & Bruyère, O. (2014). Evaluation du nombre de résidents en maison de retraite médicalisée bénéficiant d'une supplémentation en vitamine D. Cahiers de l'Année Gérontologique, 6 (Suppl. 1), 68.

DELANAYE, P., DUBOIS, B., LUKAS, P., PETERS, P., KRZESINSKI, J.-M., & CAVALIER, E. (2014). Impact of the stopping of vitamin K antagonist treatment on concentrations of Dephosphorylated and uncarboxylated Matrix Gla protein. Poster session presented at ASN Kidney Week, Philadelphia, United States - Pennsylvania.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Moonen, M., Smelten, N., Médart, L., Pottel, H., & CAVALIER, E. (2014). Sclerostin concentration is not predictive of mortality in hemodialysis patients. Poster session presented at LI Congress of ERA-EDTA, Amsterdam, Netherlands.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Moonen, M., Smelten, N., Médart, M., Bruyère, O., REGINSTER, J.-Y., Pottel, H., & CAVALIER, E. (2014). Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients. Nephron. Clinical Practice, 128, 127-134. doi:10.1159/000366449

DELANAYE, P., LAMBERMONT, B., MORIMONT, P., KRZESINSKI, J.-M., Maillard, N., Claisse, M., Mariat, C., & CAVALIER, E. (2014). Mesure du NGAL dans le sang et les urines : comparaison des méthodes de mesure et éventuel impact sur la décision clinique. Poster session presented at XVI réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Saint-Etienne, France.

DELANAYE, P., Souberbielle, J.-C., GADISSEUR, R., DUBOIS, B., Krzesinski, J.-M., & CAVALIER, E. (2014). Inter-method variability in bone alkaline phosphatase measurement: clinical impact on the management of dialysis patients. Poster session presented at LI Congress of ERA-EDTA, Amsterdam, Netherlands.

DELANAYE, P., WEEKERS, L., Warling, X., Moonen, M., Smelten, N., KRZESINSKI, J.-M., & CAVALIER, E. (2014). Effet de la vitamine D native sur la concentration de parathormone chez le patient hémodialysé : y a-t-il un intérêt au dosage de la parathormone non oxydée ? Poster session presented at XVI réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Saint-Etienne, France.

Kuster, N., Cristol, J.-P., CAVALIER, E., Bargnoux, A.-S., Halimi, J.-M., Froissart, M., Piéroni, L., & DELANAYE, P. (January 2014). Enzymatic creatinine assays allowestimation of glomerular filtration rate in stages 1 and 2 chronic kidney disease using CKD-EPI equation. Clinica Chimica Acta, 428, 89-95. doi:10.1016/j.cca.2013.11.002

ROUSSEAU, A.-F., DAMAS, P., LEDOUX, D., CARLISI, I., LUKAS, P., GADISSEUR, R., & CAVALIER, E. (2014). Vitamin D status during acute phase of burn injury : is 25(OH)D measurement an accurate marker ? Nutrients, 6, 2770.

ROUSSEAU, A.-F., DAMAS, P., LEDOUX, D., & CAVALIER, E. (2014). Effect of cholecalciferol recommended daily allowances on vitamin D status and fibroblast growth factor-23: an observational study in acute burn patients. Burns: Journal of the International Society for Burn Injuries, 40 (5), 865-70. doi:10.1016/j.burns.2013.11.015

ROUSSEAU, A.-F., FOIDART-DESSALLE, M., REMY, C., LEDOUX, D., DAMAS, P., & CAVALIER, E. (2014). Effect of optimized cholecalciferol and calcium intakes on bone mineral density: a randomized controlled trial in adult burns during sequelae stage. Nutrients, 6, 2771.

Sepulchre, E., LUTTERI, L., CAVALIER, E., Guerci, B., & RADERMECKER, R. (2014). A propos de l'hémoglobine glyquée: Les limites de son interprétation. Revue Médicale de Liège, 69 (9), 497-503.

VALDES SOCIN, H. G., LUTTERI, L., Cavalier, E., POLUS, M., Geenen, V., Louis, E., & Beckers, A. (2014). El sindrome tirogastrico autoinmune : sus efectos sobre los micronutrientes y la tumorigenesis gastrica. Revista Argentina de Endocrinologia y Metabolismo, 51, 37-43.

Beaudart, C., Buckinx, F., Rabenda, V., GILLAIN, S., CAVALIER, E., Slomian, J., PETERMANS, J., Reginster, J.-Y., & Bruyère, O. (28 November 2013). Les effets d’une supplémentation en vitamine D sur la force musculaire : une méta-analyse d’essais randomisés contrôlés. Paper presented at Journée des Doctorants de l'Ecole Doctorale "SPSS", Bruxelles, Belgium.

CAVALIER, E. (16 November 2013). La vitamine D, état des lieux et recommandations. Paper presented at 67ème journée d'enseignement post-universitaire du Cercle Gilkinet, Liège, Belgium.

CAVALIER, E., & DELANAYE, P. (08 November 2013). PINP in renal impaired patients: the assay matters. Poster session presented at ASN Kidney week, Atlanta, United States.

CAVALIER, E., & DELANAYE, P. (08 November 2013). Performance of a novel fully automated method for the detection of dephospho-uncarboxylated matrix gla ptrotein (dp-ucMGP). Poster session presented at ASN Kidney week, Atlanta, United States.

CAVALIER, E., & DELANAYE, P. (08 November 2013). Inter-method variability for the measurement of bone alkaline phosphatase: Implication for the monitoring of CKD-MBD. Poster session presented at ASN Kidney week, Atlanta, United States.

CAVALIER, E., & DELANAYE, P. (08 November 2013). Analytical performance of a new bone specific ALP automated immunoassay. Poster session presented at ASN Kidney week, Atlanta, United States.

BOUQUEGNEAU, A., Vidal-Petiot, E., Vrtovsnik, F., CAVALIER, E., RORIVE, M., KRZESINSKI, J.-M., DELANAYE, P., & Flamant, M. (November 2013). Modification of diet in renal disease versus chronic kidney disease epidemiology collaboration equation to estimate glomerular filtration rate in obese patients. Nephrology Dialysis Transplantation, 28 (4), 122-130. doi:10.1093/ndt/gft329

Brunel, E., SCHNITZLER, M., Foidart-Dessalle, M., Souberbielle, J.-C., & CAVALIER, E. (2013). A Double-Blind, Placebo Controlled, Randomized Trial to Assess the Impact of a Monthly Administration of 50,000 IU of Vitamin D3 for 6 Months on Serum Levels of 25-Hydroxyvitamin D in Healthy Young Adults. International Journal of Endocrinology. doi:10.1155/2013/652648

Hoge, A., Donneau, A.-F., Streel, S., Albert, A., Guillaume, M., & CAVALIER, E. (November 2013). Vitamin D coverage among adults in Wallonia (Belgium): findings from the NESCaV study. European Journal of Public Health, 23.

ROUSSEAU, A.-F., LEDOUX, D., DAMAS, P., & CAVALIER, E. (November 2013). Hypovitaminose D du patient brûlé : une équation à plusieurs inconnues. Revue Médicale de Liège, 68 (11), 574-578.

VALDES SOCIN, H. G., SYRIOS, P., GADISSEUR, R., TEIXEIRA, J., LUYCKX, F., BECKERS, A., & CAVALIER, E. (November 2013). Persistent low levels of serum hCG: please do not miss phantom hCG! (pseudohypergonadotropinemia syndrome). Acta Clinica Belgica, 68 (6), 465.

CAVALIER, E. (24 October 2013). Standardization of bone markers assays. Paper presented at 10. Jahrestagung Deutsche Vereinte Gesellschaft fur Klinische Chemie und Laboratoriumsmedizin e.V, Dresden, Germany.

CAVALIER, E., LUKAS, P., CARLISI, I., GADISSEUR, R., & DELANAYE, P. (October 2013). Aminoterminal propeptide of type I procollagen (P1NP) in chronic kidney disease patients: the assay matters [letter to the editor]. Clinica Chimica Acta, 425, 117-118.

CAVALIER, E., ROUSSELLE, O., FERRANTE, N., CARLISI, I., LE GOFF, C., & Souberbielle, J.-C. (October 2013). Technical and clinical evaluation of the VITROS Immunodiagnostic Products 25-OH Vitamin D Total Assay - comparison with marketed automated immunoassays and a liquid chromatography - tandem mass spectrometry method. Clinical Chemistry and Laboratory Medicine, 51 (10), 1983-1989. doi:10.1515/cclm-2013-0138

DELANAYE, P., & CAVALIER, E. (October 2013). Staging chronic kidney disease and estimating glomerular filtration rate: an opinion paper about the new international recommendations. Clinical Chemistry and Laboratory Medicine, 51 (10), 1911-1917. doi:10.1515/cclm-2013-0223

Morovat, A., Catchpole, A., MEURISSE, A., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., paddon, M., James, T., & CAVALIER, E. (October 2013). IDS iSYS automated intact procollagen-1-Nterminus pro-peptide assay: method evaluation and reference intervals in adults and children. Clinical Chemistry and Laboratory Medicine, 51 (10), 2009-2018. doi:10.1515/cclm-2012-0531

Beaudart, C., Buckinx, F., Rabenda, V., GILLAIN, S., CAVALIER, E., Petermans, J., Reginster, J.-Y., & Bruyère, O. (September 2013). Les effets d'une supplémentation en vitamine D sur la force musculaire : une méta-analyse d'essais randomisés contrôlés. Cahiers de l'Année Gérontologique, 5 (1-2), 38.

Bruyère, O., Slomian, J., Beaudart, C., Buckinx, F., Cavalier, E., GILLAIN, S., Petermans, J., & Reginster, J.-Y. (September 2013). Importance du déficit en vitamine D chez les femmes françaises ostéoporotiques et ostéopéniques âgées de plus de 80 ans. Cahiers de l'Année Gérontologique, 5 (1-2), 75.

LE GOFF, C., Kaux, J.-F., Leroy, L., PINCEMAIL, J., Chapelle, J.-P., & Cavalier, E. (September 2013). Fatty acids and associated cardiovascular risk. Food and Nutrition Sciences, 4 (9A), 188-194.

LE GOFF, C., Kaux, J.-F., MELON, P., Fillet, M., CHAPELLE, J.-P., & Cavalier, E. (September 2013). Running races: study of the stress and cardiac biomarkers. European Journal of Sports Medicine, 1 (Supplement 1), 212.

DELANAYE, P., WEEKERS, L., WARLING, X., MOONEN, M., Smelten, N., MEDART, L., KRZESINSKI, J.-M., & CAVALIER, E. (07 July 2013). Cholecalciferol in haemodialysis patients : a randomized, double-blind, proof-of-concept and safety study. Nephrology Dialysis Transplantation, 28 (7), 1779-1786. doi:10.1093/ndt/gft001

CAVALIER, E., LUKAS, P., CARLISI, I., & Souberbielle, J.-C. (July 2013). Standardization of 25-hydroxyvitamin D assays: impact of vitamin-D binding protein concentrations and uremic media on the restandarization of six different 25 (OH) vitamin D immunoassays. Poster session presented at AACC Annual meeting 2013, Houston, United States.

DELANAYE, P., Krzesinski, J.-M., & CAVALIER, E. (July 2013). EVOLVE: entre déception et optimisme. Néphrologie et Thérapeutique, 9 (4), 241-245. doi:10.1016/j.nephro.2013.04.001

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Smelten, N., & CAVALIER, E. (July 2013). VITAMIN K ANTAGONISTS IN HEMODIALYSIS PATIENTS: IMPACT ON THE PLASMA LEVELS OF DEPHOSPHO-UNCARBOXYLATED MATRIX GLA-PROTEIN. Poster session presented at AACC Annual meeting 2013, Houston, United States.

GADISSEUR, R., LUKAS, P., CARLISI, I., & CAVALIER, E. (July 2013). Performance of the IDS-iSYS 1,25-dihydroxy vitamin D assay. Poster session presented at AACC Annual meeting, Houston, United States.

GADISSEUR, R., LUKAS, P., CARLISI, I., & CAVALIER, E. (July 2013). Analytical performance of the IDS-iSYS N-Mid osteocalcin immunoassay. Poster session presented at AACC Annual meeting 2013, Houston, United States.

LE GOFF, C., MELON, P., BREVERS, E., Fillet, M., Kaux, J.-F., Chapelle, J.-P., & Cavalier, E. (2013). Comparison of the Heart-type fatty acid-binding protein (H-FABP) with the high sensitive cardiac troponin T in healthy runners. In Book of abstracts of 18th Annual Congress of the ECSS (pp. 465).

LE GOFF, C., MELON, P., Thébault, J., Kaux, J.-F., Cavalier, E., & Chapelle, J.-P. (2013). Impact of different endurance races on the heart: the point of view of the biologist. In Book of abstracts of 18th Annual Congress of the ECSS (pp. 93-94).

ROUSSEAU, A.-F., LEDOUX, D., DAMAS, P., & CAVALIER, E. (June 2013). Are we doing enough for burn related hypovitaminosis D ? Poster session presented at Vitamin D 16th Workshop, San Francisco, United States - California.

CAVALIER, E., DELANAYE, P., & MORANNE, O. (May 2013). Variability of new bone mineral metabolism markers in patients treated with maintenance hemodialysis: implications for clinical decision making. American Journal of Kidney Diseases, 61 (5), 847-8. doi:10.1053/j.ajkd.2012.12.013

CAVALIER, E., GADISSEUR, R., LUKAS, P., CARLISI, I., & DELANAYE, P. (May 2013). Association of the circulating inactive form of matrix GLA protein (DP-UCMGP) levels and abdominal aortic calcification score (AACS) in haemodialysis patients. Biochimica Clinica, 37 (SS), 215.

CAVALIER, E., LE GOFF, C., CARLISI, I., BEKAERT, A.-C., FERRANTE, N., ROUSSELLE, O., DELANAYE, P., & Souberbielle, J.-C. (May 2013). Comparison of the total error obtained with six immuno-assays for 25-hydroxy vitamin D with the minimal, desirable and optimal total allowable errors calculated according to the biological variation. Biochimica Clinica, 37 (SS), 259.

CAVALIER, E., LUKAS, P., FERRANTE, N., ROUSSELLE, O., CARLISI, I., & DELANAYE, P. (May 2013). Difference between total and intact assays for N-Terminal propeptide of type I procollagen (P1NP) determination in renal impaired patients. Biochimica Clinica, 37 (SS), 498.

DELANAYE, P., Bruyère, O., Moranne, O., LUTTERI, L., KRZESINSKI, J.-M., & CAVALIER, E. (May 2013). Creatinine-or cystatin C-based equations to estimate glomerular filtration: impact on the epidemiology of chronic kidney disease. Poster session presented at 20th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab), Milan, Italy.

DELANAYE, P., Cavalier, E., Moranne, O., Bruyère, O., LUTTERI, L., & Krzesinski, J.-M. (May 2013). Creatinine- or cystatin C-based equations to estimate glomerular filtration rate in the general population: impact on the epidemiology of chronic kidney disease. Poster session presented at 50th ERA-EDTA Congress, Istanbul, Turkey.

Dierge, L., LUTTERI, L., Chauvet, D., Hastir, D., CHAPELLE, J.-P., & CAVALIER, E. (May 2013). Heavy/light chain (HLC) and free light chain (FLC) analysis allow sensitive monitoring of multiple myeloma patients and AID detection of clonal changes. Biochimica Clinica, 37 (SS), 618.

GADISSEUR, R., LUKAS, P., CARLISI, I., & CAVALIER, E. (May 2013). Evaluation of the performance of the new automated IDS-ISYS 1,25-dihydroxy vitamin D assay. Biochimica Clinica, 37 (SS), 498.

LE GOFF, C., Kaux, J.-F., BREVERS, E., Fillet, M., MELON, P., CHAPELLE, J.-P., & Cavalier, E. (May 2013). Comparison of the Heart-type fatty acid-binding protein (H-FABP) with the high sensitive cardiac troponin T in healthy runners. Biochimica Clinica, 37 (SS), 544.

LE GOFF, C., Kaux, J.-F., MELON, P., Fillet, M., CHAPELLE, J.-P., & Cavalier, E. (May 2013). Race Cycling: biological evolution. Biochimica Clinica, 37 (SS), 544.

LE GOFF, C., MELON, P., Kaux, J.-F., Fillet, M., CHAPELLE, J.-P., & Cavalier, E. (May 2013). Impact of strenuous exercise on the release of cardiac biomarkers. Biochimica Clinica, 37 (SS), 545.

LE GOFF, C., PEETERS, S., CRINE, Y., NETCHACOVITCH, M., Kaux, J.-F., & Cavalier, E. (May 2013). Comparison between Perkin-Elmer and Chromsytem Vitamin D kit on TQ 5500 from AB SCIEX. Biochimica Clinica, 37 (SS), 471.

LE GOFF, C., PEETERS, S., NETCHACOVITCH, M., Kaux, J.-F., CRINE, Y., & Cavalier, E. (May 2013). Determination of urinary metanephrine, normetanephrine and methoxymetanephrine by liquid chromatography-electrospray tandem mass spectrometry. Biochimica Clinica, 37 (SS), 316.

Masson, I., Flamant, M., Maillard, N., Rule, A., Vrtovsnik, F., Peraldi, M.-N., Thibaudin, L., CAVALIER, E., Vidal-Petiot, E., Bonneau, C., Moranne, O., Alamartine, E., Mariat, C., & DELANAYE, P. (May 2013). MDRD versus CKD-EPI equation to estimate glomerular filtration rate in kidney transplant recipients. Transplantation, 95 (10), 1211-1217. doi:10.1097/TP.0b013e318288caa6

Schleck, M.-L., LAURENT, T., GADISSEUR, R., CARLISI, I., ROUSSELLE, O., & CAVALIER, E. (May 2013). Evaluation of the third-generation to second-generation PTH ratio on the Liaison XL (DIASORIN) as a marker for parathyroïd carcinoma. Biochimica Clinica, 37 (SS), 161.

VRANKEN, L., CAVALIER, E. (Other coll.), & VALDES SOCIN, H. G. (Other coll.). (May 2013). Holotranscobalamin as an earlier indicator of vitamin B12 deficiency in thyrogastric syndrome. Poster session presented at 20th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, Milano, Italy.

VRANKEN, L., CAVALIER, E., & VALDES SOCIN, H. G. (May 2013). Holotranscobalamin as an earlier indicator of vitamin B12 deficiency in thyrogastric syndrome. Biochimica Clinica, 37 (SS), 324.

BOUQUEGNEAU, A., CAVALIER, E., Krzesinski, J.-M., & DELANAYE, P. (18 April 2013). MDRD VERSUS CKD-EPI EQUATIONS TO ESTIMATE GLOMERULAR FILTRATION RATE IN OBESE PATIENTS. Poster session presented at 50th ERA-EDTA Congress, Istanbul, Turkey.

Boutten, A., Bargnoux, A.-S., Carlier, M.-C., DELANAYE, P., Rozet, E., Delatour, V., CAVALIER, E., Hanser, A.-M., Froissart, M., Cristol, J.-P., Piéroni, L., & Société Française de Biologie clinique. (April 2013). Enzymatic but not compensated Jaffe methods reach the desirable specifications of NKDEP at normal levels of creatinine. results of the French multicentric evaluation. Clinica Chimica Acta, 419, 132-135. doi:10.1016/j.cca.2013.01.021

LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations in healthy subjects. Osteoporosis International, 24 (S1), 279.

LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on phosphocalcic metabolism biomarkers in healthy adults subjects. Osteoporosis International, 24 (S1), 282.

LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on bone biomarkers in healthy dults subjects. Osteoporosis International, 24 (S1), 329.

CAVALIER, E. (27 March 2013). Measuring 25-hydroxyvitamin D: where are we standing in 2013? Paper presented at Vitamine D, van de wieg tot de oude dag?, Ameersfoort, Netherlands.

DELANAYE, P., CAVALIER, E., Moranne, O., LUTTERI, L., KRZESINSKI, J.-M., & Bruyère, O. (12 March 2013). Creatinine - or cystatin C - based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease. BMC Nephrology, 14, 57. doi:10.1186/1471-2369-14-57

VRANKEN, L., CAVALIER, E. (Other coll.), & VALDES SOCIN, H. G. (Other coll.). (01 March 2013). Holotranscobalamin versus Total Vitamin B12 as Indicators of Vitamin B12 deficiency in Thyrogastric Syndrome. Poster session presented at Belgian week of gastroenterology, Anvers, Belgium.

DELANAYE, P., DUBOIS, B., JOURET, F., KRZESINSKI, J.-M., MORANNE, O., & CAVALIER, E. (February 2013). Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients : Is it so simple? Clinica Chimica Acta, 417, 35-38. doi:10.1016/j.cca.2012.12.009

CAVALIER, E. (31 January 2013). Vitamin D testing and clinical practice. Paper presented at Arab Health 2013, Dubaï, United Arab Emirates.

Beaudart, C., Buckinx, F., Rabenda, V., GILLAIN, S., Cavalier, E., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2013). The effects of vitamin D on skeletal muscle strenght : a meta-analysis of randomized controlled trials. European Geriatric Medicine, 4 (S1), 72.

Beaudart, C., Buckinx, F., Rabenda, V., GILLAIN, S., Cavalier, E., Slomian, J., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2013). Les effets d'une supplémentation en vitamine D sur la force, la masse et la puissance musculaire : une méta-analyse d'essais randomisés contrôlés. Revue du Rhumatisme, 80 (S1), 180-A181.

BOUQUEGNEAU, A., DELANAYE, P., CAVALIER, E., & Krzesinski, J.-M. (2013). Annual meeting of the SBN/BVN. Paper presented at Annual meeting of the SBN/BVN, Bruxelles, Belgium.

Bruyère, O., Slomian, J., Beaudart, C., Buckinx, F., CAVALIER, E., GILLAIN, S., Petermans, J., & REGINSTER, J.-Y. (2013). Prevalence of vitamin D inadequacy in European postmenopausal women aged over 80 years. European Geriatric Medicine, 4 (S1), 13-S14.

CAVALIER, E., Faché, W., & Souberbielle, J.-C. (2013). A randomised, double-blinded, placebo-controlled, parallel study of vitamin D3 supplementation with different schemes based on multiples of 25,000 IU doses. International Journal of Endocrinology. doi:10.1155/2013/327265

CAVALIER, E., Thervet, E., & Courbebaisse, M. (2013). Vitamine D et rein. Presse Médicale, 42, 1391-1397. doi:10.1016/j.lpm.2013.07.011

DELANAYE, P., CAVALIER, E., Maillard, N., Mehdi, M., LAMBERMONT, B., DUBOIS, B., DAMAS, P., KRZESINSKI, J.-M., Morel, J., Lautrette, A., & Mariat, C. (2013). Intérêt de la cystatine C aux soins intensifs : validation par rappoert à une mesure de référence du débit de filtration glomérulaire. Paper presented at XLI congrès de la Société de Réanimation de Langue Française, Paris, France.

DELANAYE, P., Claisse, G., Mehdi, M., Maillard, N., LAMBERMONT, B., DUBOIS, B., DAMAS, P., KRZESINSKI, J.-M., Morel, J., Lautrette, A., CAVALIER, E., & Mariat, C. (2013). Déterminant physiologique du NGAL sanguin et discordance entre NGAL sanguin et urinaire. Poster session presented at XLI congrès de la Société de Réanimation de Langue Française, Paris, France.

DELANAYE, P., Claisse, G., Mehdi, M., Maillard, N., LAMBERMONT, B., DUBOIS, B., DAMAS, P., KRZESINSKI, J.-M., Morel, J., Lautrette, A., CAVALIER, E., & Mariat, C. (2013). Déterminant physiologique du NGAL sanguin et discordance entre NGAL sanguin et urinaire. Poster session presented at XLI congrès de la Société de Réanimation de Langue Française, Paris, France.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Smelten, N., & CAVALIER, E. (2013). Vitamin K antagonists in hemodialysis patients: impact on the levels of dephospho- uncarboxylated matrix gla-protein. Paper presented at L Congress of ERA-EDTA, Istanbul, Turkey.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Smelten, N., & CAVALIER, E. (2013). La concentration de la Matrix Gla protéine décarboxylée déphosphorylée est prédictive du statut en vitamine K, mais pas des calcifications vasculaires, chez les patients hémodialysés chroniques. Paper presented at XV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Nantes, France.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Smelten, N., & CAVALIER, E. (2013). Determinants of sclerostin concentration in hemodialysis patients. Poster session presented at ASN Kidney Week, Atlanta, United States - Georgia.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Smelten, N., & CAVALIER, E. (2013). Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and correlated with vascular calcification in hemodialysis patients. Poster session presented at ASN Kidney Week, Atlanta, United States - Georgia.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Smelten, N., Pottel, H., & CAVALIER, E. (2013). Variables cliniques et biologiques associées à la mortalité du patient hémodialysé. Poster session presented at XV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Nantes, France.

DELANAYE, P., LAMBERMONT, B., CLAISSE, G., MEHDI, M., MAILLARD, N., DUBOIS, B., DAMAS, P., KRZESINSKI, J.-M., MOREL, J., LAUTRETTE, A., CAVALIER, E., & MARIAT, C. (January 2013). Le débit de filtration glomérulaire est-il un déterminant de la concentration plasmatique du NGAL aux soins intensifs ? Paper presented at Congrès de la société de réanimation de langue française.

DELANAYE, P., Vidal-Patiot, E., BOUQUEGNEAU, A., Vrtovsnik, F., CAVALIER, E., KRZESINSKI, J.-M., & Flamant, M. (2013). MDRD versus CKD-EPI equations to estimate glomerular filtration rate in obese patients. Poster session presented at ASN Kidney Week, Atlanta, United States - Georgia.

Fillet, M., Deroyer, C., COBRAIVILLE, G., LE GOFF, C., Cavalier, E., Chapelle, J.-P., Marée, R., Legrand, V., Pierard, L., Kolh, P., & Merville, M.-P. (2013). Identification of protein biomarkers associated with cardiac ischemia by a proteomic approach. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 18 (7), 614-24. doi:10.3109/1354750X.2013.838306

LIBON, F., CAVALIER, E., & NIKKELS, A. (2013). Skin color is relevant to vitamin D synthesis. Dermatology, 227 (3), 250-4. doi:10.1159/000354750

LIBON, F., CAVALIER, E., & NIKKELS, A. (2013). La vitamine D et la peau. Revue Médicale de Liège, 68 (9), 458-464.

Masson, I., Flamant, M., Maillard, N., CAVALIER, E., Moranne, O., Alamartine, E., Mariat, C., & DELANAYE, P. (2013). MDRD versus CKD-EPI equation to estimate glomerular filtration rate in kidney transplant recipients. Poster session presented at L Congress of ERA-EDTA, Istanbul, Turkey.

Masson, I., Maillard, N., Tack, I., Thibaudin, L., Dubourg, L., DELANAYE, P., CAVALIER, E., Bonneau, C., Kamar, N., Morelon, E., Moranne, O., Alamartine, E., & Mariat, C. (2013). GFR Estimation Using Standardized Cystatin C in Kidney Transplant Recipients. American Journal of Kidney Diseases, 61 (2), 279-284. doi:10.1053/j.ajkd.2012.09.010

Pirotte, B., Rassenfosse, M., Collin, R., De Voeght, A., MOUTSCHEN, M., & CAVALIER, E. (2013). Rôle de la vitamine D dans l'infection par le VIH: revue des connaissances actuelles. Revue Médicale de Liège, 68 (1), 25-31.

ROUSSEAU, A.-F., LEDOUX, D., DAMAS, P., & CAVALIER, E. (2013). Hypovitaminosis D and osteoporosis in burn patients: are the current practices enough ? Osteoporosis International, 24 (Suppl 1), 377.

Souberbielle, J.-C., & CAVALIER, E. (2013). Supplementation, optimal status, and analytical determination of vitamin D: Where are we standing in 2012? Anti-Cancer Agents in Medicinal Chemistry, 1, 36-44. doi:10.2174/187152013804487317

VALDES SOCIN, H. G., LUTTERI, L., CAVALIER, E., POLUS, M., LOUIS, E., & BECKERS, A. (2013). le syndrome auto-immun thyrogastrique: ses effets sur les micronutriments et la tumorigénèse gastrique. Revue Médicale de Liège.

Vidal-Petiot, E., DELANAYE, P., BOUQUEGNEAU, A., Vrtovsnik, F., CAVALIER, E., & Flamant, M. (2013). Estimation du débit de filtration glomérulaire chez l’obèse : MDRD ou CKD-EPI ? Poster session presented at XV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Nantes, France.

VRANKEN, L., CAVALIER, E. (Other coll.), & VALDES SOCIN, H. G. (Other coll.). (2013). Holotranscobalamin versus Total Vit B12 as Indicators of Vit B12 deficiency in Thyrogastric Syndrome. Acta Gastro-Enterologica Belgica, 1.

COLSON, L., Vander Rest, C., Reginster, J.-Y., DELANAYE, P., CAVALIER, E., LE GOFF, C., Crielaard, J.-M., & Kaux, J.-F. (December 2012). Ostéomalacie hypophosphatémique hyperphosphaturique avec hypersécrétion de FGF-23. Lettre du Rhumatologue, 387, 26-29.

Gagneux-Brunon, A., DELANAYE, P., LEGRAND, D., CAVALIER, E., & Mariat, C. (December 2012). NGAL biomarqueur de lésion rénale. Néphrologie et Thérapeutique, 8 (7), 508-515. doi:10.1016/j.nephro.2012.03.006

CAVALIER, E. (07 November 2012). Liaison 1-84 PTH and KDIGO guidelines. Paper presented at 4 th Annual Meeting of the Austrian Society for Laboratory Medicine and Clinical Chemistry ( ÖGLMKC), Salzburg, Austria.

DETRY, O., JANSSEN, N., CHERAMY-BIEN, J.-P., Cavalier, E., Defraigne, J.-O., DELANAYE, P., & LAMBERMONT, B. (November 2012). Effects of Large-Pore Hemofiltration in a Swine Model of Fulminant Hepatic Failure. Artificial Organs, 36 (11), 981-987. doi:10.1111/j.1525-1594.2012.01506.x

LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., Souberbielle, J.-C., & CAVALIER, E. (November 2012). Evaluation of the cross-reactivity of 25-hydroxyvitamin D2 on seven commercial immunoassays on native samples. Clinical Chemistry and Laboratory Medicine, 50 (11), 2031-2. doi:10.1515/cclm-2012-0164

Ricci, R., Krafft, E., Roels, E., Contiero, B., Clercx, C., Diez, M., & Cavalier, E. (19 October 2012). Vitamin D Status, calcium and protein metabolism in dogs fed bone and raw food (BARF) or commercial pet food. Poster session presented at 2nd Edition, Scientific Day, Liège, Belgium.

LE GOFF, C., Kaux, J.-F., Leroy, L., Cavalier, E., & Chapelle, J.-P. (October 2012). Le dosage des acides gras érythrocytaires : comparaison entre une population de référence et des sujets ayant présenté un infarctus aigu du myocarde. Immuno-Analyse and Biologie Spécialisée, 27 (5), 237-243. doi:10.1016/j.immbio.2012.04.003

Pottel, H., Hoste, L., DELANAYE, P., CAVALIER, E., & Martens, F. (October 2012). Demystifying ethnic/sex differences in kidney function: is the difference in (estimating) glomerular filtration rate or in serum creatinine concentration? Clinica Chimica Acta, 413 (19-20), 1612-17. doi:10.1016/j.cca.2012.04.034

Souberbielle, J.-C., Cheriet, S., & CAVALIER, E. (October 2012). Distinctive aspects of laboratory testing to evaluate mineral and bone metabolism in patients with chronic kidney disease. Joint Bone Spine, 79 (suppl 2), 99-S103. doi:10.1016/S1297-319X(12)70016-7

CAVALIER, E. (29 September 2012). When should we measure Vitamin D in Clinical Practice. Paper presented at 4th Slovenian Congress of Clinical Chemistry, Portoroz, Slovenia.

CAVALIER, E. (08 September 2012). Diagnosis of parathyroid carcinoma: potential role of PTH laboratory assays. Paper presented at 13th International Workshop on Multiple Endocrine Neoplasia (IWMEN), Liège, Belgium.

CAVALIER, E. (2012). Vitamin D and Diabetes. In R. R. Watson (Ed.), Bioactive Foods in Chronic Disease States. Elsevier.

VALDES SOCIN, H. G., LOLY, J., GAST, P., LUTTERI, L., VRANKEN, L., Cavalier, E., & Beckers, A. (2012). The thyrogastric syndrome : an under diagnosed etiology for acquired gastric neuroendocrine tumors. A case report. In Abstract Book - 13th International Workshop on Multiple Endocrine Neoplasia.

CAVALIER, E. (18 July 2012). Analytical performance of two Thyroglobulin assays in the low range: impact on clinical decisions. Poster session presented at AACC 2012, Los Angeles, United States.

HAMDI, E., DELANAYE, P., LUTTERI, L., CHAPELLE, J.-P., & CAVALIER, E. (18 July 2012). analytical and Clinical Validation of Beta-Trace Protein, a New Marker of Glomerular Filtration Rate. Poster session presented at AACC 2012, Los Angeles, United States.

CAVALIER, E. (17 July 2012). Evaluation of the Liaison 25-OH Vitamin D Total assay on the new Liaison XL analyser. Paper presented at AACC - booth presentation, Los Angeles, United States.

CAVALIER, E., CARLISI, I., FERRANTE, N., BEKAERT, A.-C., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Analytical Performance of the IDS-iSYS CROSSLAPS (CTX-I) Automated Immunoassay. Poster session presented at AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., FERRANTE, N., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Evaluation of the Liaison 25-OH Vitamin D TOTAL Assay on the new DiaSorin Liaison XL. Poster session presented at AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., FERRANTE, N., ROUSSELLE, O., CHAPELLE, J.-P., & DELANAYE, P. (17 July 2012). Evaluation of Sclerostin levels in patients suffering from Chronic Kidney Diseases. Poster session presented at AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., MEURISSE, A., FERRANTE, N., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Analytical Verification of the IDS-iSYS Intact Amino-terminal Propeptide of Type 1 Procollagen (P1NP). Poster session presented at AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., ROUSSELLE, O., & DELANAYE, P. (17 July 2012). Comparison of two automated 3rd generation PTH assays in different clinical populations. Poster session presented at AACC 2012, Los Angeles, United States.

CAVALIER, E., DELANAYE, P., CARLISI, I., BEKAERT, A.-C., FERRANTE, N., ROUSSELLE, O., & MORANNE, O. (17 July 2012). Variability of Different Markers of Bone mineral Metabolism in Hemodialysis PAtients: Implication on the Evaluation of the Critical Difference between two Measurements. Poster session presented at AACC 2012, Los Angeles, United States.

LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., CHAPELLE, J.-P., & CAVALIER, E. (17 July 2012). Evaluation of the Cross-reactivity of 25-Hydroxy-vitamin D2 on Six Commercial Immunoassays on Native Samples. Poster session presented at AACC 2012, Los Angeles, United States.

LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., CHAPELLE, J.-P., & CAVALIER, E. (17 July 2012). Analytical validation of the Perkin-Elmer MSMS Vit D for 25-Hydroxy-vitamin D determination on AB SCIEX TQ5500. Poster session presented at AACC 2012, Los Angeles, United States.

DELANAYE, P., Schaeffner, E., Ebert, N., CAVALIER, E., Mariat, C., KRZESINSKI, J.-M., & Moranne, O. (July 2012). Normal reference values for glomerular filtration rate: what do we really know? Nephrology Dialysis Transplantation, 27 (7), 2664-72. doi:10.1093/ndt/gfs265

CAVALIER, E. (14 June 2012). PTH in Chronic Kidney Disease - What do the KDIGO Guidelines Change. Paper presented at Swiss Medlab 2012, Bern, Switzerland.

CAVALIER, E. (09 June 2012). Mise au point sur les méthodes de dosage de la Vitamine D et de la Parathormone. Paper presented at Journée de Biologie Clinique, Beyrouth, Lebanon.

Souberbielle, J.-C., Bienaimé, F., CAVALIER, E., & Cormier, C. (June 2012). Vitamin D and primary hyperparathyroidism (PHPT). Annales d'Endocrinologie, 73 (3), 165-169. doi:10.1016/j.ando.2012.04.008

CAVALIER, E. (12 May 2012). Métabolisme phosphocalcique: prescription et impact économique. Paper presented at GJ Biologie clinique, Namur, Belgium.

CAVALIER, E., & DELANAYE, P. (03 May 2012). KDIGO Guidelines on « renal osteodystrophy»: A Critical review. Focus on the hemodialysis patient and on the lab. Paper presented at Annual Symposium of the Royal Belgian Society for Clinical Chemistry, Brussels, Belgium.

CAVALIER, E., CARLISI, I., ROUSSELLE, O., FERRANTE, N., Koivula, M.-K., & Risteli, J. (May 2012). Observed Ranges for the Healthy Paediatrics in the Serum IDS-ISYS CrossLaps® (SCTX-I). Poster session presented at European Calcified Tissue Society 39th Annual Congress, Stockholm, Sweden.

FAILLA, V., CAVALIER, E., EL HAYDERI, L., PAUROBALLY, D., Chapelle, J.-P., DEZFOULIAN, B., & NIKKELS, A. (May 2012). Seasonal variations in vitamin D levels in melanoma patients: a single-centre prospective pilot comparative study. Journal of the European Academy of Dermatology and Venereology, 26 (5), 651-3. doi:10.1111/j.1468-3083.2011.04087.x

FORTUNATO, A., LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., ROUSSELLE, O., FERRANTE, N., & CAVALIER, E. (May 2012). Cross-reactivity of 25-hydroxyvitamin D2 in ADVIA Centaur Total Vitamin D. Poster session presented at The joint 15th International Congress of Endocrinology and 14th European Congress of Endocrinoly, Florence, Italy.

CAVALIER, E. (28 April 2012). Nutritional vitamin D in CKD patients. Paper presented at 4th International Monte-Carlo Workshop: New perspectives in prevention and treatment of CKD-MBD, Monte-Carlo, Monaco.

CAVALIER, E. (18 April 2012). 1-84 PTH and KDIGO Guidelines. Paper presented at Die Triade: Knochen-Niere-Herz aktuelle biochemische und klinische Aspekte, Frankfurt, Germany.

Souberbielle, J.-C., Courbebaisse, M., Cormier, C., Pierrot-Deseilligny, C., Viard, J.-P., Jean, G., & CAVALIER, E. (April 2012). When should we measure vitamin D concentration in clinical pratice? Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum, 72 (suppl 243), 129-135.

CAVALIER, E. (30 March 2012). Suivi biologique du métabolisme phosphocalcique du patient dialysé: que nous apportent les guidelines du KDIGO en pratique? Paper presented at 4ème Journées Nationales de Biologie Praticienne, Agadir, Morocco.

CAVALIER, E. (23 March 2012). Meet-The-Expert Sessions : Clinical utility of bone turnover markers. Paper presented at IOF-ECCEO12 European Congress on Osteoporosis and Osteoarthritis, Bordeaux, France.

CAVALIER, E., & MATHIEU, C. (22 March 2012). Vitamine D et diabète. Paper presented at Congrès de la Société francophone du diabète 2012, Nice, France.

DELANAYE, P., Thibaudin, L., Souvignet, M., Maillard, N., Alamartine, E., Rozet, E., CAVALIER, E., & Mariat, C. (22 March 2012). Comparison of acid and enzymatic methods for insulin dosage: Analytical performances and impact on glomerular filtration rate evaluation. Clinica Chimica Acta, 413 (5-6), 556-560.

CAVALIER, E. (15 March 2012). Biomarkers of renal disease. Paper presented at Master-Na-Master En Navormingsprogramma Klinische Biologie 2011-2012, Brussels, Belgium.

CAVALIER, E. (March 2012). Aberrant results observed with four immuno-assays for total and free prostate-specific antigen (PSA) determination: a case-report. Clinical Chemistry and Laboratory Medicine, 50 (3), 583-584. doi:10.1515/cclm.2011.807

CAVALIER, E., CARLISI, I., ROUSSELLE, O., FERRANTE, N., & DELANAYE, P. (March 2012). Difference between total and intact assays for N-terminal propeptide of type I procollagen in renal impaired patients. Osteoporosis International, 23 (Supplement 2), 339.

CAVALIER, E., & SOUBERBIELLE, J.-C. (March 2012). Establishment of parathyroid hormone (PTH) reference on 10 different assay kits: impact of the recruitment of the population. Osteoporosis International, 23 (Supplement 2), 360.

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., & Chapelle, J.-P. (18 February 2012). Human anti-animal interference in DiaSorin Liaison total 25(OH)-vitamin D assay: Towards the end of a strange story? Clinica Chimica Acta, 413 (3-4), 527-528. doi:10.1016/j.cca.2011.11.014

Greiner, C, Remy, B., CAVALIER, E., Gabriel, A., & Carstanjen, B. (2012). Bone markers in pregnant Haflinger mares _ A trimestral evaluation. In Procedings of the Hippos-Congress 2012.

LE GOFF, C., Leroy, L., Kaux, J.-F., CAVALIER, E., & Chapelle, J.-P. (February 2012). Le dosage des acides gras érythrocytaires : comparaison entre une population de référence et des sujets ayant présenté un infarctus aigu du myocarde. Poster session presented at 28e Colloque IBS CORATA, Namur, Belgium.

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., Chapelle, J.-P., & DELANAYE, P. (18 January 2012). New insights on the stability of the Parathyroid hormone as assayed by an automated 3rd generation PTH assay. Clinica Chimica Acta, 413 (1-2), 353-4. doi:10.1016/j.cca.2011.09.034

GADISSEUR, R., & CAVALIER, E. (2012). Lait et métabolisme phosphocalcique. In CIAB ALLER-J Club d'Immuno-Allergologie Biologique.

Bargnoux, A.-S., Morena, M., Dupuy, A.-M., CAVALIER, E., Mourad, G., DELANAYE, P., Canaud, B., & Cristol, J.-P. (2012). Vascular calcifications in chronic kidney disease: can the Biologist be of some help? In P. DELANAYE (Ed.), Clinical Chemistry and Nephrology: the essential link. Bentham Science Publishers. doi:10.2174/978160805333911201010122

CAVALIER, E. (2012). Vigilance et dialogue entre biologiste et clinicien s'imposent au quotidien. Cas vécus au laboratoire. Journal de Biologie Médicale, 1 (2), 104-6.

CAVALIER, E. (2012). Good interpretation of a biological result: generality and specificity to Nephrology. In P. DELANAYE (Ed.), Clinical Chemistry and Nephrology: the essential link. Bentham Science Publishers. doi:10.2174/978160805333911201010003

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., Chapelle, J.-P., & Souberbielle, J.-C. (2012). Analytical evaluation of the new Abbott Architect 25-OH vitamin D assay. Clinical Biochemistry, 45, 505-508. doi:10.1016/j.clinbiochem.2012.01.021

CAVALIER, E., DELANAYE, P., VRANKEN, L., BEKAERT, A.-C., CARLISI, I., Chapelle, J.-P., & SOUBERBIELLE, J.-C. (2012). Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values. Nephrology Dialysis Transplantation, 27, 1950-56. doi:10.1093/ndt/gfr535

DELANAYE, P., CARLISI, I., ROUSSELLE, O., FERRANTE, N., KRZESINSKI, J.-M., & CAVALIER, E. (2012). Utilisation du propeptide N-terminal du procollagène de type 1 (P1NP) comme marqueur de formation osseuse chez le patient insuffisant rénal : différence entre le dosage total et le dosage « intact ». Poster session presented at XIV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Genève, Switzerland.

DELANAYE, P., CAVALIER, E., DUBOIS, B., & KRZESINSKI, J.-M. (2012). Adhésion thérapeutique du patient hémodialysé. Poster session presented at XIV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Genève, Switzerland.

DELANAYE, P., CAVALIER, E., Masson, I., Mehdi, Maillard, N., LAMBERMONT, B., DAMAS, P., KRZESINSKI, J.-M., Morel, J., Lautrette, A., & Mariat, C. (2012). Detection of decreased glomerular filtration rate in intensive care units: interest of cystatin C. Poster session presented at XLIX congress of ERA-EDTA, Paris, France.

DELANAYE, P., CAVALIER, E., Mehdi, M., Maillard, N., LAMBERMONT, B., DUBOIS, B., DAMAS, P., KRZESINSKI, J.-M., Morel, L., Lautrette, A., & Mariat, C. (2012). Intérêt de la cystatine C aux soins intensifs : validation par rapport à une mesure de référence du débit de filtration glomérulaire. Paper presented at XIV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Genève, Switzerland.

DELANAYE, P., DUBOIS, B., KRZESINSKI, J.-M., & CAVALIER, E. (2012). Compliance of the hemodialysis patient to the native vitamin D therapy. Poster session presented at XLIX Congress of ERA-EDTA, Paris, France.

DELANAYE, P., Mariat, C., Moranne, O., CAVALIER, E., & Flamant, M. (2012). L'estimation du débit de filtration glomérulaire en 2012: quelle valeur ajoutée pour la nouvelle équation CKD-EPI. Néphrologie et Thérapeutique, 8, 199-205. doi:10.1016/j.nephro.2012.03.002

DELANAYE, P., WEEKERS, L., DUBOIS, B., CAVALIER, E., DETRY, O., SQUIFFLET, J.-P., & KRZESINSKI, J.-M. (January 2012). Outcome of the living kidney donor. Nephrology Dialysis Transplantation, 27 (1), 41-50. doi:10.1093/ndt/gfr669

DELANAYE, P., WEEKERS, L., Warling, X., Moonen, M., Smelten, N., Médart, L., KRZESINSKI, J.-M., & CAVALIER, E. (2012). Vitamine D native chez le patient hémodialysé: efficacité et profil de sécurité. Une étude multicentrique, prospective et randomisée contre placebo sur un an. Poster session presented at XIV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Genève, Switzerland.

Masson, I., Maillard, N., Tack, I., Jaafar, A., Thibaudin, L., Hadj-Aissa, A., Dubourg, L., DELANAYE, P., CAVALIER, E., Rostaing, L., Kamar, N., Morelon, E., Alamartine, E., & Mariat, C. (2012). Performance, limitations and utility of cystatin C as an endogenous GFR marker in renal transplantation. Poster session presented at XLIX Congress of ERA-EDTA, Paris, France.

NIKKELS, A., RORIVE, A., & CAVALIER, E. (2012). Vitamine D et mélanome. Skin, 15 (3), 35.

CAVALIER, E. (2011). Séminaire de Chimie médicale - Les Immunoassays. (ULiège - Université de Liège, Bioc0341-1 - Biochimie pathologique y compris Chimie médicale: partim 1).

CAVALIER, E. (02 December 2011). Vitamin D measurement: Laboratory issues. Paper presented at 3rd Annual Meeting of the Lebanese Society for Osteoporosis and Metabolic Bone Disorders, Beyruth, Lebanon.

CAVALIER, E., MOUTSCHEN, M., & Brunel, E. (24 November 2011). Vitamine D et maladies infectieuses. Paper presented at Formations Continues en Biologie Clinique, Liège, Belgium.

CAVALIER, E. (17 November 2011). Recommendations on Vitamin D testing and analytical validation of the Architect 25 OH Vitamin D assay. Paper presented at 1° CONGRESSO NAZIONALE DELLA MEDICINA DI LABORATORIO, Parma, Italy.

CAVALIER, E. (16 November 2011). Vitamin D, 1-84 PTH and KDIGO Guidelines. Paper presented at 1° CONGRESSO NAZIONALE DELLA MEDICINA DI LABORATORIO, Parma, Italy.

Pilz, S., Tomaschitz, A., März, W., Drechsler, C., Ritz, E., Zittermann, A., CAVALIER, E., Pieber, T., Lappe, J., Grant, W., Holick, M., & Dekker, J. (November 2011). Vitamin D, cardiovascular disease and mortality. Clinical Endocrinology, 75 (5), 575-84. doi:10.1111/j.1365-2265.2011.04147.x

DE BACKER, B., Poncin, J., HALENG, J., CHAPELLE, J.-P., & CAVALIER, E. (15 October 2011). Comparison between the new AccuChek Inform II glucose meter and the Rapidlab 865 blood gas analyzer: implications for use of the Inform II in tight glycemic control. Poster session presented at BVKB - SBBC (Belgian Society for Clinical Biology) Annual Symposium 2011, Liège, Belgium.

CAVALIER, E. (03 October 2011). Les biomarqueurs de la lésion rénale: limites actuelles et perspectives. Paper presented at Dépistage de l'insuffisance rénale en réanimation, Saint-Etienne, France.

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., GUADAGNI, A., ROUSSELLE, O., Chapelle, J.-P., & DELANAYE, P. (October 2011). New insights on the stability of the (1-84) PTH as determined with an automated 3rd generation PTH assay. Clinical Chemistry, 57 (S10), 190.

CAVALIER, E., DELANAYE, P., & Souberbielle, J.-C. (October 2011). Maintenir la PTH entre 2 et 9 fois la valeur de référence supérieure du Laboratoire: d'accord, mais quelle valeur??? Néphrologie et Thérapeutique, 7 (5), 411-447 (Pub 27.

CAVALIER, E., DELANAYE, P., VRANKEN, L., CARLISI, I., BEKAERT, A.-C., Chapelle, J.-P., & Souberbielle, J.-C. (October 2011). Impact of the use of the Manufacture's published reference range for PTH vs. the reference range established in the Laboratory for the classification of the haemodialyzed patients with the KDIGO Guidelines. Clinical Chemistry, 57 (S10), 191.

CAVALIER, E., PONCIN, J., MUSSO, G., HALENG, J., & Chapelle, J.-P. (October 2011). Analytical validation of Accu-check Inform II meters and strips before their use in the wards: pratical experience of the CHU de Liège. Clinical Chemistry, 27 (S10), 143.

VAN DER REST, C., CAVALIER, E., KAUX, J.-F., KRZESINSKI, J.-M., HUSTINX, R., REGINSTER, J.-Y., & DELANAYE, P. (October 2011). Tumor-induced osteomalacia: The tumor may stay hidden! Clinical Biochemistry, 44 (14-15), 1264-6. doi:10.1016/j.clinbiochem.2011.07.013

CAVALIER, E. (30 September 2011). Dosages de la PTH et de la vitamine D: en est-on enfin au bout du tunnel? Paper presented at La Dialyse de Tassin: un patrimoine pour tous, Lyon, France.

CAVALIER, E., & Souberbielle, J.-C. (18 September 2011). Establishment of Parathyroid hormone reference range on 10 different assay kits: impact of the recruitment of the population. Poster session presented at ASBMR 2011 Annual Meeting, San-Diego, United States.

CAVALIER, E., BEKAERT, A.-C., CARLISI, I., & CHAPELLE, J.-P. (17 September 2011). Automated Measurement of Total 25OH Vitamin D in the IDS iSYS System. Poster session presented at ASBMR 2011 Annual Meeting, San-Diego, United States.

CAVALIER, E., & DELANAYE, P. (September 2011). Nouveautés sur la stabilité de la parathormone telle que mesurée à l'aide d'un kit de troisième génération: impact sur la pratique quotidienne. Néphrologie et Thérapeutique, 7 (5), 284-85.

CAVALIER, E., DELANAYE, P., Souberbielle, J.-C., & RADERMECKER, R. (September 2011). Vitamin D and type 2 diabetes mellitus: Where do we stand? Diabetes and Metabolism, 37 (4), 265-72. doi:10.1016/j.diabet.2011.01.001

DELANAYE, P., CAVALIER, E., & KRZESINSKI, J.-M. (September 2011). Détection de la maladie rénale chronique dans la population générale: créatinine ou cystatine C? Poster session presented at 13e Réunion commune de la Société Francophone de Dialyse (SFD) et de la Société de Néphrologie (SN), Bordeaux, France.

DELANAYE, P., CAVALIER, E., & KRZESINSKI, J.-M. (September 2011). Définition d'un débit de filtration "normal" fixe ou adapté à l'âge et au genre: impact sur l'épidémiologie de la maladie rénale chronique. Poster session presented at 13e Réunion commune de la Société Francophone de Dialyse (SFD) et de la Société de Néphrologie (SN), Bordeaux, France.

DELANAYE, P., CAVALIER, E., Mariat, C., KRZESINSKI, J.-M., & Rule, A. (September 2011). Estimating glomerular filtration rate in Asian subjects: where do we stand? Kidney International, 80 (5), 439-440. doi:10.1038/ki.2011.197

DELANAYE, P., CAVALIER, E., Mariat, C., Maillard, N., KRZESINSKI, J.-M., & White, C. (September 2011). Trimethoprim, creatinine and creatinine-based equations. Kidney International, 80 (5), 439-40. doi:10.1159/000328911

DELANAYE, P., KRZESINSKI, J.-M., & CAVALIER, E. (September 2011). Suivi longitudinal des concentrations de PTH et de phosphatase alcaline osseuse chez le sujet hémodialysé: mesure-t-on la même chose? Poster session presented at 13e Réunion commune de la Société Francophone de Dialyse (SFD) et de la Société de Néphrologie (SN), Bordeaux, France.

DELANAYE, P., KRZESINSKI, J.-M., & CAVALIER, E. (September 2011). Suivi à court et à long terme de la concentration de parathormone chez le patient hémodialysé: dosage de seconde et troisième génération. Poster session presented at 13e Réunion commune de la Société Francophone de Dialyse (SFD) et de la Société de Néphrologie (SN), Bordeaux, France.

Masson, I., Maillard, N., Jaafar, A., Thibaudin, L., Dubourg, L., DELANAYE, P., CAVALIER, E., Bonneau, F., Kamar, N., Morelon, E., Alarmatine, E., & Mariat, C. (September 2011). Estimation du débit de filtration glomérulaire en transplantation rénale: étude multicentrique d'évaluation de la performance de la cystatine C. Poster session presented at 13e Réunion commune de la Société Francophone de Dialyse (SFD) et de la Société de Néphrologie (SN), Bordeaux, France.

VAN DER REST, C., CAVALIER, E., COLSON, L., KAUX, J.-F., KRZESINSKI, J.-M., REGINSTER, J.-Y., HUSTINX, R., & DELANAYE, P. (August 2011). Hypophosphatémie et ostéomalacie oncogénique. Revue Médicale Suisse, 7, 1630-3.

CAVALIER, E. (29 July 2011). Recommendations on vitamin D testing and analytical validation of the Architect 25-OH vitamin D assay. Paper presented at Abbott Workshop at the AACC, Atlanta, United States.

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., GUADAGNI, A., ROUSSELLE, O., CHAPELLE, J.-P., & DELANAYE, P. (28 July 2011). New insights on the stability of the (1-84) PTH as determined with an automated 3rd generation PTH assay. Poster session presented at AACC, Atlanta, United States.

CAVALIER, E., DELANAYE, P., Vranken, L., CARLISI, I., BEKAERT, A.-C., CHAPELLE, J.-P., & Souberbielle, J.-C. (28 July 2011). Impact of the use of the Manufacturer's published reference range for PTH vs. the reference range established in the Laboratory for the classification of the haemodialyzed patients with the KDIGO Guidelines. Poster session presented at AACC, Atlanta, United States.

CAVALIER, E., PONCIN, J., MUSSO, G., HALENG, J., & CHAPELLE, J.-P. (27 July 2011). Analytical validation of Accu-check Inform II meters and strips before their use in the wards: practical experience of the CHU de Liège. Poster session presented at AACC 2011, Atlanta, United States.

WEEKERS, L., Warling, X., Moonen, M., Smelten, N., Medart, L., Krzesinski, J.-M., CAVALIER, E., & DELANAYE, P. (25 June 2011). Native vitamin D in dialysis patients : safety and biological effects. Paper presented at XLVIII ERA-EDTA, Prague, Czechia.

CAVALIER, E. (09 June 2011). Sommes-nous tous déficitaires en vitamine D? Correspondances en MHDN, 15 (6), 191-195.

CAVALIER, E. (08 June 2011). Les Guidelines du KDIGO pour le suivi des patients dialysés: impact au Laboratoire. Paper presented at CORATA, Namur, Belgium.

CAVALIER, E. (June 2011). Are we all vitamin-D deficient? Correspondances en MHDN, 15 (6), 191-195.

CAVALIER, E. (18 May 2011). Practical Experience with a Validation and QC Management Program for PoC Testing. Paper presented at Roche Hospital Point-of-Care Symposium, Berlin, Germany.

CAVALIER, E. (May 2011). Vitamine D et aspects pratiques: quels dosages? pour qui? quelle supplémentation? Paper presented at 2ème congrès du Groupe d'Etude de la Ménopause et du Vieillissement Hormonal (GEMVI), Paris, France.

CAVALIER, E. (May 2011). Vitamin D: clinical relevance, analytical issues. Clinical Chemistry and Laboratory Medicine, 49 (s1), 66.

CAVALIER, E., CARLISI, I., & DELANAYE, P. (May 2011). Human anti-animal antibodies: even today, it is still a problem in routine practice: illustration with 4 clinical cases. Clinical Chemistry and Laboratory Medicine, 49 (s1), 409.

LE GOFF, C., Leroy, L., Kaux, J.-F., CAVALIER, E., & Chapelle, J.-P. (May 2011). Fatty acids and cardiovascular risk. Clinical Chemistry and Laboratory Medicine, 49 (Special Suppl), 313. doi:10.1515/CCLM.2011.508

LE GOFF, C., Leroy, L., Pincemail, J., Kaux, J.-F., CAVALIER, E., & Chapelle, J.-P. (2011). Fatty acids determinations: an cardiovascular risk? Preliminary results. In Biomedica - Life Science Summit (pp. 153).

CAVALIER, E. (April 2011). FGF23 and Klotho: an emerging role in phosphate metabolism. Paper presented at Annual Symposium of the Royal Belgian Society, Brussels, Belgium.

DELANAYE, P., MARIAT, C., MAILLARD, N., KRZESINSKI, J.-M., & CAVALIER, E. (April 2011). Are the creatinine-based equations accurate to estimate glomerular filtration rate in african american populations ? Clinical Journal of the American Society of Nephrology, 6, 906-912. doi:10.2215/CJN.10931210

Cavalier, E., Huberty, V., Carlisi, I., Chapelle, J.-P., Vroonen, L., & Beckers, A. (18 March 2011). Human anti-animal antibodies interference in the Siemens Immulite chemiluminescent insulin immuno-assay: about one case. Clinica Chimica Acta, 412 (7-8), 668-669. doi:10.1016/j.cca.2010.12.035

DELANAYE, P., MARIAT, C., KRZESINSKI, J.-M., & CAVALIER, E. (19 February 2011). Paricalcitol for reduction of albuminuria in diabetes [letter to the editor]. Journal-Lancet, 377, 635. doi:10.1016/S0140-6736(11)60223-7

CAVALIER, E. (10 February 2011). FGF-23 et Klotho: une avancée dans le métabolisme du phosphore. Paper presented at Séminaires post-gradués de Biologie Clinique.

Bargnoux, A. S., Cavalier, E., Cristol, J. P., Simon, N., Dupuy, A. M., Garrigue, V., Delanaye, P., & Mourad, G. (February 2011). Cystatin C is a reliable marker for estimation of glomerular filtration rate in renal transplantation: validation of a new turbidimetric assay using monospecific sheep antibodies. Clinical Chemistry and Laboratory Medicine, 49 (2), 265-70. doi:10.1515/CCLM.2011.043

CAVALIER, E. (2011). Vitamine D et grossesse. (HELMO).

Cavalier, E., Huberty, V., Cormier, C., & Souberbielle, J.-C. (February 2011). Overestimation of the 25OHD serum concentration with the automated IDS EIA kit. Journal of Bone and Mineral Research, 26 (2), 434-6. doi:10.1002/jbmr.190

CAVALIER, E. (28 January 2011). Le dosage de la vitamine D. Paper presented at Séminaire clinico-biologique, Casablanca, Morocco.

Bargnoux, A.-S., Boutten, A., Cambillau, M., Carlier, M.-C., CAVALIER, E., Cristol, J.-P., Hanser, A.-M., Piéroni, L., DELANAYE, P., Frimat, L., & Froissart, M. (January 2011). Recommandations pour le choix et l'harmonisation des techniques de dosage de la créatinine. Annales de Biologie Clinique, 69 (1), 9-16.

CAVALIER, E. (2011). 2ème BBM - ostéoporose.

Cavalier, E., Bekaert, A.-C., Carlisi, I., Legrand, D., Krzesinski, J.-M., & Delanaye, P. (2011). Neutrophil gelatinase-associated lipocalin (NGAL) determined in urine with the Abbott Architect or in plasma with the Biosite Triage? The laboratory's point of view. Clinical Chemistry and Laboratory Medicine, 49 (2), 339-341. doi:10.1515/CCLM.2011.044

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., CHAPELLE, J.-P., & SOUBERBIELLE, J.-C. (2011). Validation of the Abbott Architect 25(OH)-vitamin D assay. Clinical Chemistry and Laboratory Medicine, 49 (s1), 418.

Cavalier, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Chapelle, J.-P., & Delanaye, P. (2011). Analytical validation of the Liaison Calcitonin_II-Gen (DiaSorin). Clinical Chemistry and Laboratory Medicine, 49 (2), 271-275. doi:10.1515/CCLM.2011.036

CAVALIER, E., WALLACE, A. M., CARLISI, I., CHAPELLE, J.-P., DELANAYE, P., & SOUBERBIELLE, J.-C. (2011). Cross-reactivity of 25-hydroxy vitamin D2 from different commercial immunoassays for 25-hydroxy vitamin D: an evaluation without spiked samples. Clinical Chemistry and Laboratory Medicine, 49 (3), 555-8. doi:10.1515/CCLM.2011.072

Delanaye, P., Rozet, E., Krzesinski, J.-M., & Cavalier, E. (2011). Urinary NGAL measurement : Biological variation and ratio to creatinine. Clinica Chimica Acta, 412 (3-4), 390. doi:10.1016/j.cca.2010.10.011

DELANAYE, P., Souvignet, M., Dubourg, L., Thibaudin, L., Maillard, N., KRZESINSKI, J.-M., CAVALIER, E., & Mariat, C. (2011). Le dosage de l'inuline: mise au point. Annales de Biologie Clinique, 69 (3), 273-84. doi:10.1684/abc.2011.0580

FAILLA, V., CAVALIER, E., EL HAYDERI, L., PAUROBALLY, D., CHAPELLE, J.-P., DEZFOULIAN, B., & NIKKELS, A. (2011). Seasonal variations in vitamin D levels in melanoma patients : a single-centre prospective pilot comparative study. Journal of the European Academy of Dermatology and Venereology. doi:10.1111/j.1468-3083.2011.04087.x

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (2011). A new tool in the field of in-vitro diagnosis of allergy: preliminary results in the comparison of ImmunoCAP (c) 250 with the ImmunoCAP (c) ISAC. Clinical Chemistry and Laboratory Medicine, 49 (2), 277-80. doi:10.1515/CCLM.2011.052

Pieroni, L., DELANAYE, P., Boutten, A., Bargnoux, A.-S., Rozet, E., Delatour, V., Carlier, M.-C., Hanser, A.-M., CAVALIER, E., Froissart, M., & Cristol, J.-P. (2011). A multicentric evaluation of IDMS-traceable creatinine enzymatic assays. Clinica Chimica Acta, 412, 2070-2075. doi:10.1016/j.cca.2011.07.012

VALDES SOCIN, H. G., Cavalier, E., beckaert, A. C., Carlisi, A., Chavez, M., & Beckers, A. (2011). Elévation des kisspeptines plasmatiques chez les hommes obèses avec hypogonadisme acquis et chez les hommes avec hypogonadisme congénital : Etude pilote des modifications plasmatiques des kisspeptines avant et après administration de hCG et testostérone. In Annales d'Endocrinologie - 28ème congrès de la société Française d'Endocrinologie.

VROONEN, L., Cavalier, E., Vranken, L., VALDES SOCIN, H. G., PETROSSIANS, P., & Beckers, A. (2011). Influence of drospirenone on renin-angiotensin-aldosterone system evaluation. In Endocrine Abstracts - 13th European Congress of Endocrinology.

VROONEN, L., Cavalier, E., Vranken, L., VALDES SOCIN, H. G., PETROSSIANS, P., & Beckers, A. (2011). Drospirenone and interference with renin-antiotensin system. In Annales d'Endocrinologie - 28ème congrès de la société Française d'Endocrinologie.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (18 November 2010). Analyse morphoconstitutionnelle des lithiases. Paper presented at GLEM de Biologie Clinique, Fléron, Belgium.

Cavalier, E. (04 November 2010). Which career perspectives for young scientists? Paper presented at Journées Internationales de Biologie, Paris, France.

Cavalier, E. (2010). Vitamine D: Besoins, Fonctions et Carence. Paper presented at Réunions scientifiques de l'AMSAV, Arlon, Belgium.

Cavalier, E. (07 October 2010). Current analytical aspects of vitamin D. Paper presented at Tuning Science into Caring, Vilvoorde, Belgium.

Delanaye, P., & Cavalier, E. (2010). Vascular calcifications in dialysis patients.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (October 2010). New technologies in allergology, Workshop. Paper presented at Symposium BVKB/SBBC, Anvers, Belgium.

Pilz, S., Tomaschitz, A., März, W., Cavalier, E., & Ritz, E. (October 2010). Aldosterone and parathyroid hormone: a complex and clinically relevant relationship. Calcified Tissue International, 87 (4), 373-4. doi:10.1007/s00223-010-9409-5

Cavalier, E. (17 September 2010). La vitamine D: le point en 2010. Paper presented at 27ème Colloque IBS-CORATA, Marseille, France.

Cavalier, E. (September 2010). Vitamin D and cardiovascular diseases: Where do we stand in 2010? Lipid Club Letter, 22 (3), 2-3.

Cavalier, E., Barguil, Y., Bourgeois, A. M., Boutten, A., Delanaye, P., Desch, G., Duvillard, L., Fellahi, S., Froissart, M., Piéroni, L., Rozet, E., & Cristol, J. P. (September 2010). Evaluation analytique de la cystatine C: résultats de l'étude multicentrique SN/SFBC. Néphrologie et Thérapeutique, 6 (5), 314.

Cavalier, E., Carlisi, A., Delanaye, P., & Beckers, A. (September 2010). Les anticorps hétérophiles : une cause souvent méconnue d'erreurs de diagnostic. Annales d'Endocrinologie, 71 (5), 367-68.

Cavalier, E., Carlisi, A., Delanaye, P., Beckers, A., & Souberbielle, J.-C. (September 2010). Dosage de la vitamine D : attention aux erreurs analytiques! Annales d'Endocrinologie, 71 (5), 368.

Cavalier, E., Carlisi, I., Delanaye, P., Beckers, A., & Souberbielle, J.-C. (2010). Dosage de la 25-OH vitamine D: attention aux erreurs analytiques! Congrès de la Société Française d'Endocrinologie.

Cavalier, E., Daly, A., Betea, D., Stubbs, P., DELANAYE, P., Bradwell, A., Chapelle, J., & Beckers, A. (September 2010). Un nouveau marqueur tumoral pour le carcinome parathyroïdien? Résultats observés chez 24 patients. Annales d'Endocrinologie, 71 (5), 350-351.

Cavalier, E., Delanaye, P., & Beckers, A. (2010). Les anticorps hétérophiles : une cause souvent méconnue d'erreurs de diagnostic. In 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010.

Cavalier, E., Delanaye, P., & Beckers, A. (2010). Détection précoce de l'hyperparathyroïdie secondaire : impact de l'établissement des valeurs de références de la parathormone. In 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010.

Cavalier, E., Delanaye, P., & Beckers, A. (September 2010). Détection précoce de l'hyperparathyroïdie secondaire : impact de l'établissement des valeurs de référence de la parathormone. Annales d'Endocrinologie, 71 (5), 364.

Cavalier, E., Jean, G., Delanaye, P., & Souberbielle, J.-C. (September 2010). Les cibles thérapeutiques pour la PTH dans les nouvelles recommandations du KDIGO: la fin d'un cauchemar? Néphrologie et Thérapeutique, 6 (5), 424.

Cavalier, E., Krzesinski, J.-M., & Delanaye, P. (September 2010). Mesure de la PTH chez le patient hémodialysé avec une trousse de 2è ou de 3è génération: impact pour le clinicien. Néphrologie et Thérapeutique, 6 (5), 397.

Cavalier, E., Rozet, E., Bekaert, A.-C., Legrand, D., Krzesinski, J.-M., & Delanaye, P. (September 2010). Le dosage urinaire et plasmatique du NGAL: étude analytique et implications pratiques pour le clinicien. Néphrologie et Thérapeutique, 6 (5), 350.

Delanaye, P., Cavalier, E., Mariat, C., Lambermont, B., Wiesen, P., Damas, P., & Krzesinski, J.-M. (September 2010). Intérêt de la cystatine C plasmatique pour la détection d'une insuffisance rénale chez le patient hospitalisé aux soins intensifs : résultats préliminaires. Poster session presented at 12è Réunion commune de la Société de Néphrologie (SN) et de la Société Francophone de Dialyse (SFD), Bruxelles, Belgium.

Delanaye, P., Warling, X., Moonen, M., Smelten, N., Rozet, E., Médart, L., Weekers, L., Krzesinski, J.-M., & Cavalier, E. (September 2010). Quels paramètres cliniques et biologiques peuvent être considérés comme prédictifs des calcifications vasculaires chez le patient hémodialysé? Poster session presented at 12è Réunion commune de la Société de Néphrologie (SN) et de la Société Francophone de Dialyse (SFD), Bruxelles, Belgium.

Keutgens, A., Ho, T. T. G., & Cavalier, E. (2010). Analytical validation of the Liaison hGH assay (DiaSorin). In European NeuroEndocrine Association.

Souberbielle, J.-C., Body, J. J., Lappe, J. M., Plebani, M., Shoenfeld, Y., Wang, T. J., Bischoff-Ferrari, H. A., Cavalier, E., Ebeling, P. R., Fardellone, P., Gandini, S., Gruson, D., Guerin, A. P., Heickendorff, L., Hollis, B. W., Ish-Shalom, S., Jean, G., von Landenberg, P., Largura, A., & Zittermann, A. (September 2010). Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmunity Reviews, 9 (11), 709-15. doi:10.1016/j.autrev.2010.06.009

Thibaudin, L., Delanaye, P., Maillard, N., Cavalier, E., Rozet, E., Alamartine, E., & Mariat, C. (September 2010). Comparaison d'une méthode "acide" et enzymatique pour le dosage de l'inuline. Poster session presented at 12è Réunion commune de la Société de Néphrologie (SN) et de la Société Francophone de Dialyse (SFD), Bruxelles, Belgium.

Valdes Socin, H. G., Cavalier, E., Beckaert, A., Carlisi, A., & Beckers, A. (September 2010). Kisspeptin-10 élevée chez les hommes obèses hypogonadiques - un nouveau signal périphérique entre le métabolisme et la reproduction. Annales d'Endocrinologie, 71 (5), 355.

Valdes Socin, H. G., Cavalier, E., Beckaert, A. C., Carlisi, A., & Beckers, A. (2010). High Kisspeptine-10 levels in obese hypogonadic patients : is kisspeptine-10 a periheral signal between metabolism and reproduction. In European Neuroendocrine Association - Liège, 22-25 septembre 2010.

Cavalier, E., Daly, A., Betea, D., Pruteanu-Apetrii, P. N., Delanaye, P., Stubbs, P., Bradwell, A. R., Chapelle, J.-P., & Beckers, A. (August 2010). The Ratio of Parathyroid Hormone as Measured by Third- and Second-Generation Assays as a Marker for Parathyroid Carcinoma. Journal of Clinical Endocrinology and Metabolism, 95, 3745-9. doi:10.1210/jc.2009-2791

CAVALIER, E. (04 June 2010). Vitamin D symposium. Paper presented at Vitamin D symposium, Tilburg, Netherlands.

Cavalier, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Delanaye, P., & Chapelle, J.-P. (June 2010). Evaluation of Liaison Calcitonin II Gen, a new kit for Calcitonin determination. Clinical Chemistry, 56 (S6), 188.

Cavalier, E., Daly, A., Betea, D., Pruteanu Apetrii, P., Delanaye, P., Stubbs, P., Bradwell, A. R., Chapelle, J.-P., & Beckers, A. (June 2010). The ratio of PTH as measured by third and second generation assays as a marker for parathyroid carcinoma. Clinical Chemistry, 56 (S6), 188.

Cavalier, E., Rousselle, O., Bekaert, A.-C., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (June 2010). Evaluation of the DiaSorin Liaison 1-84 PTH Assay, a new automated immunoassay for the determination of the 3rd Generation PTH. Clinical Chemistry, 56 (S6), 56.

Cavalier, E., Saarbach, D., Bekaert, A.-C., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (June 2010). Analytical validation of the Abbott Architect urine NGAL. Clinical Chemistry, 56 (S6), 96.

Gadisseur, R., Blanco Catafal, A., Chapelle, J.-P., & Cavalier, E. (June 2010). Validation of the ImmunoCAP ISAC. Clinical Chemistry, 56 (S6), 97.

Cavalier, E. (08 May 2010). Détermination de la Vitamine D : quand et à qui prescrire ? Qui supplémenter et comment corriger une carence ? Paper presented at 14ème Journée de Biologie Clinque, Bruxelles, Belgium.

Cavalier, E. (03 April 2010). Place du dosage de la vitamine D. Paper presented at 3èmes Journées Nationales de Biologie Praticienne, Tanger, Morocco.

Delanaye, P., Maillard, N., Rozet, E., Cavalier, E., Krzesinski, J.-M., Alamartine, E., & Mariat, C. (April 2010). Donor-Estimated Glomerular Filtration Rate as a Criterion for Allocation of Expended Criteria Donors Kidney into Single or Dual Transplantation : The Choice of the Estimating Equation Matters. Poster session presented at American Society of Transplantation, San Diego, United States - California.

Detry, O., Janssen, N., Cheramy-Bien, J.-P., Cavalier, E., Defraigne, J.-O., Delanaye, P., & Lambermont, B. (April 2010). Effects of large pore hemofiltration in a swine model of fulminant hepatic failure. Acta Chirurgica Belgica, 110, 86. FP45.

Nsadi, B., Pire, E., Gilson, N., Cheramy-Bien, J.-P., Pincemail, J., Cavalier, E., Le Goff, C., Scagnol, I., Meurisse, M., Defraigne, J.-O., & Detry, O. (April 2010). Consequences of laparoscopy on liver ischemia during portal triad clamping in a swine model. Acta Chirurgica Belgica, 110, 83. FP40.

Cavalier, E., & Delanaye, P. (25 March 2010). First experience with Architect urine NGAL. Paper presented at 5th Annual Abbott European Laboratory Symposium, Wiesbaden, Germany.

Cavalier, E. (09 March 2010). Vitamin D and atherosclerosis. Paper presented at Nutrition and atherosclerosis, Brussels, Belgium.

Cavalier, E. (05 March 2010). Methods for Vitamin D measurement - analytical problems and clinical relevance. Paper presented at 53 Symposion der Deutscehn Gesellschaft für Endokrinologie und Jahrestagung der Slowakischen Gesellschaft für Endokrinologie, Leipzig, Germany.

Gadisseur, R., & Cavalier, E. (02 March 2010). Laboratoire et allergologie : nouvelles applications. Paper presented at Colloque Hôpital André Renard, Herstal, Belgium.

Gadisseur, R., & Cavalier, E. (04 February 2010). Laboratoire et allergologie : nouvelles applications. Paper presented at Colloque CHPLT, Verviers, Belgium.

Cavalier, E. (2010). PARATHORMONE DETERMINATION IN THE CLINICAL LABORATORY: BIOCHEMICAL, CLINICAL AND ANALYTICAL ASPECTS. Unpublished doctoral thesis, ULiège - Université de Liège.
Jury: Chapelle, J.-P. (Promotor), Krzesinski, J.-M., Reginster, J.-Y., Collette, J., Albert, A., Bergman, P., & Souberbielle, J.-C.

Gadisseur, R., & Cavalier, E. (07 January 2010). Laboratoire et allergologie : nouvelles applications. Paper presented at Colloque de Pneumologie, Liège, Belgium.

Bruyère, O., Cavalier, E., Collette, J., & Reginster, J.-Y. (2010). La vitamine D en association avec le calcium dans le traitement de l’ostéoporose. Ortho-Rhumato, 8, 53-55.

Cavalier, E. (2010). La fonction rénale. (Biochimie pathologique y compris Chimie médicale, partim I).

Cavalier, E., Bekaert, A.-C., Legrand, D., Rozet, E., Krzesinski, J.-M., & Delanaye, P. (2010). Urinary NGAL: Use of absolute value or ratio to creatinine? Acta Clinica Belgica, 65-3, 13.

Cavalier, E., Daly, A., Chapelle, J.-P., Betea, D., Bradwell, A., Stubbs, P., Delanaye, P., & Beckers, A. (2010). The ratio of PTH as measured by third and second generation assays as a marker for parathyroid carcinoma. In 12th European Congress of Endocrinology - ICE 2010.

Cavalier, E., & Delanaye, P. (2010). Evaluation meets Precision. Sciencebook Europe, 1, 5.

Cavalier, E., Delanaye, P., Cormier, C., & Souberbielle, J.-C. (2010). Measurement uncertainty for the analysis of serum 25-hydroxyvitamin D: response to Stepman and Thienpont [letter to the editor]. Osteoporosis International, 21, 1055-1056. doi:10.1007/s00198-009-1098-4

Cavalier, E., Delanaye, P., & Krzesinski, J.-M. (2010). PTH reference target for the follow-up of hemodialyzed patients and new KDIGO guidelines: the end of a nightmare? Acta Clinica Belgica.

Cavalier, E., Jean, G., Delanaye, P., & Souberbielle, J.-C. (2010). Les cibles thérapeutiques pour la PTH dans les nouvelles recommandations du KDIGO: la fin d'un cauchemar? Néphrologie et Thérapeutique.

Cavalier, E., Krzesinski, J.-M., & Delanaye, P. (2010). Mesure de la PTH chez le patient hémodialysé avec une trousse de 2ème ou de 3ème génération: impact pour le clinicien. Néphrologie et Thérapeutique.

Cavalier, E., Rozet, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Hubert, P., Chapelle, J.-P., & Delanaye, P. (January 2010). Analytical validation of the BAP OSTASE on Liaison (DiaSorin). Clinical Chemistry and Laboratory Medicine, 48 (1), 67-72. doi:10.1515/CCLM.2010.019

Cavalier, E., Rozet, E., Gadisseur, R., Carlisi, I., Monge, M., Chapelle, J.-P., Hubert, P., Souberbielle, J.-C., & Delanaye, P. (2010). Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs. Osteoporosis International, 21, 1047-1051. doi:10.1007/s00198-009-1052-5

Cavalier, E., Saarbach, D., Bekaert, A.-C., Legrand, D., Krzesinski, J.-M., & Delanaye, P. (2010). Urinary or plasma NGAL?: Analytical point of view. Acta Clinica Belgica.

Delanaye, P., Cavalier, E., Krzesinski, J.-M., & Mariat. (2010). Can creatinine clearance in children clear the indexing GFR with BSA from the charge of errors? [letter to the editor]. Nephrology Dialysis Transplantation, 25, 2381-2386. doi:10.1093/ndt/gfq235

Delanaye, P., Cavalier, E., Maillard, N., Krzesinski, J.-M., Mariat, C., Cristol, J.-P., & Pieroni, L. (2010). La creatinine : d'hier a aujourd'hui. Annales de Biologie Clinique, 68 (5), 531-43. doi:10.1684/abc.2010.0479

Delanaye, P., Cavalier, E., Mariat, C., Maillard, N., & Krzesinski, J.-M. (2010). MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant? BMC Nephrology, 11 (8). doi:10.1186/1471-2369-11-8

Detry, O., Janssen, N., Cavalier, E., Delanaye, P., Cheramy-Bien, J.-P., Honore, P., Defraigne, J.-O., & Lambermont, B. (2010). Effects of large pore hemofiltration in a swine model of fulminant hepatic failure. Acta Gastro-Enterologica Belgica, 73 (1), 35.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (2010). Component-resolved-diagnosis and validation of an allergen-microarray technology. Allergy, 65 (suppl. 92), 93.

Gadisseur, R., Chapelle, J.-P., Cavalier, E., & Blanco-Catafal Anna, U. O. B. (Other coll.). (2010). Component-resolved diagnosis in peanut and hazelnut allergy. Allergy, 65 (Suppl.92), 106.

Gilson, N., Nsadi, B., Pire, E., Cheramy-Bien, J.-P., Pincemail, J., Cavalier, E., Le Goff, C., Defraigne, J.-O., Meurisse, M., & Detry, O. (2010). Consequences of laparoscopy on liver ischemia during portal triad clamping in a swine model. Acta Gastro-Enterologica Belgica, 73 (1), 13.

Greiner, C., Cavalier, E., Remy, B., Gabriel, A., Farnir, F., Gajewski, S., & Carstanjen, B. (2010). Bone Turnover During Pregnancy in Horses. Journal of Bone and Mineral Research, 25, 233.

Ho, T. T. G., Keutgens, A., Chapelle, J.-P., & Cavalier, E. (2010). Corrélation aldostérone et parathormone en cas d'hyperparathyroïdie primaire vs secondaire? Annales de Biologie Clinique, 68 (6), 703-4.

Souberbielle, J.-C., Cavalier, E., & Jean, G. (2010). Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory? Clinical Chemistry and Laboratory Medicine, 48 (6), 769-774. doi:10.1515/CCLM.2010.157

Gadisseur, R., & Cavalier, E. (17 December 2009). Laboratoire et allergologie : nouvelles applications. Paper presented at Symposium Société Liégeoise de Dermatologie, Liège, Belgium.

Gadisseur, R., & Cavalier, E. (11 December 2009). Laboratoire et allergologie : nouvelles applications. Paper presented at Colloque de pédiatrie, Liège, Belgium.

Cavalier, E., Delanaye, P., Hubert, P., Krzesinski, J.-M., Chapelle, J.-P., & Rozet, E. (December 2009). Estimation of the Stability of Parathyroid Hormone when Stored at -80°C for a Long Period. Clinical Journal of the American Society of Nephrology, 4 (12), 1988-92. doi:10.2215/CJN.03970609

Nsadi, B., Gilson, N., Pire, E., Cheramy-Bien, J.-P., Pincemail, J., Cavalier, E., Defraigne, J.-O., Meurisse, M., & Detry, O. (December 2009). Le pneumopéritoine aggrave l'ischémie hépatique lors du clampage hilaire dans un modèle porcin. Journal de Chirurgie, 146.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (19 November 2009). IMMUNOCAP© ISAC: INTEREST IN ALLERGY DIAGNOSIS. Poster session presented at Symposium BVKB/SBBC, Mont-Godinne, Belgium.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (19 November 2009). CRD and technical validation of ImmunoCAPISAC. Paper presented at ImmunoCAP ISAC : First International Users Meeting, Diegem, Belgium.

CAVALIER, E. (02 October 2009). Vitamin D, Status and perspectives. Paper presented at Vitami D: hype or treat?, Amersfoort, Netherlands.

Cavalier, E. (2009). Vitamin D: status and perspectives. Paper presented at Vitamine D tekort: hype of bedreiging?, Amersfoort, Netherlands.

Mariat, C., Cavalier, E., Maillard, N., Krzesinski, J.-M., & Delanaye, P. (October 2009). Prevalence of Chronic Kidney Disease in an Elderly Population: Impact of the Choice of the Equation Used for Estimating GFR. Poster session presented at American Society of Nephrology, San Diego, United States.

Cavalier, E. (2009). Pièges et difficultés d’interprétation du dosage de la PTH. Paper presented at Actualités sur le phosphocalcique, Montpellier, France.

Cavalier, E., & Delanaye, P. (September 2009). Defining a "reference population": no easy task [letter to the editor]. Journal of Bone and Mineral Research, 24 (9), 1638. doi:10.1359/jbmr.090322

Cavalier, E. (2009). Gestion à distance de la biologie délocalisée: expérience du CHU de Liège. Paper presented at 4th International Symposium Blood Gases and Critical Care Testing, Belle-Ile en Mer, France.

Cavalier, E., Carlisi, I., Chapelle, J.-P., & Rozet, E. (June 2009). VALIDATION AND ACCURACY PROFILES OF THE LIAISON BAP_OSTASE (DIASORIN), A NEW METHOD FOR THE DETERMINATION OF BONE ALKALINE PHOSPHATASE. Clinical Chemistry and Laboratory Medicine, 47 (51).

Cavalier, E., Delanaye, P., Bekaert, A.-C., Carlisi, I., & Chapelle, J.-P. (June 2009). Establishment of a reference range for the Bone Alkaline Phosphatase (BAP) with Diasorin Liaison in a biologically well-designed population. Clinical Chemistry, 55 (S6), 178.

Cavalier, E., Rozet, E., Carlisi, I., Bekaert, A.-C., Chapelle, J.-P., & Delanaye, P. (June 2009). ANALYTICAL PERFORMANCE OF THE C-TERMINAL FGF-23 (IMMUTOPICS). Clinical Chemistry and Laboratory Medicine, 47 (M-A032).

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (June 2009). A new diagnostic tool for in vitro allergy. Allergy, 64, 30-31.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (29 May 2009). Nouveaux outils de diagnostic in-vitro des allergies. Paper presented at Symposium CPALF, Mont-Godinne, Belgium.

Bouüaert, C., & Cavalier, E. (2009). La vitamine D dans tous ses états: épidémiologie de la déficience. Paper presented at 7èmes Journées de l'Enseignement post-universitaire de la Faculté de Médecine de Liège, Liège, Belgium.

Lecart, M.-P., & Cavalier, E. (2009). La vitamine D dans tous ses états: effets pleiotropes de la vitamine D. Paper presented at 7èmes Journées de l'Enseignement post-universitaire de la Faculté de Médecine de l'Université de Liège, Liège, Belgium.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (28 April 2009). ImmunoCAP© ISAC: interest in allergy diagnosis. Paper presented at Conférence du Cercle des jeunes chercheurs du CIRM, Liège, Belgium.

Cavalier, E. (2009). Vitamin D: interest in non bone pathologies. Paper presented at 5th Euregio Conference on Clinical Chemistry and Laboratory Medicine, Liège, Belgium.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (24 March 2009). Intérêt des allergènes recombinants: aspects biologiques. Paper presented at Jeudis de Fleurus, Haute Ecole Louvain en Hainaut, Fleurus, Belgium.

Gadisseur, R., & Cavalier, E. (02 March 2009). Microarrays destinés au diagnostic in-vitro des allergies. Paper presented at Glem de Biologie Clinique, Liège, Belgium.

Delanaye, P., Cavalier, E., Mariat, C., Maillard, N., Dubois, B., & Krzesinski, J.-M. (February 2009). Détection et estimation du niveau de la maladie rénale chronique. Revue Médicale de Liège, 64 (2), 73-78.

Gadisseur, R., & Cavalier, E. (30 January 2009). Microarrays for allergy. Paper presented at Symposium FOCUS Diagnostica, Anderlecht, Belgium.

Cavalier, E. (15 January 2009). Vitamine D : actualités sur les dosages - effets phosphocalciques et non phosphocalciques. Paper presented at Séminaires postgradués de Biologie clinique, Bruxelles, Belgium.

Cavalier, E., Carlisi, I., Chapelle, J.-P., Orfanos, P., Uzan, M., Falque, V., Delanaye, P., & Hachicha, M. (2009). Human anti-mouse antibodies interferences in Elecsys PTH assay after OKT3 treatment. Transplantation, 87 (3), 451-2. doi:10.1097/TP.0b013e31819575a1

Cavalier, E., Delanaye, P., Carlisi, I., Chapelle, J.-P., & Collette, J. (2009). An unusual interference in parathormone assay caused by anti-goat IgG: a case report. Clinical Chemistry and Laboratory Medicine, 47 (1), 118. doi:10.1515/CCLM.2009.015

Cavalier, E., Delanaye, P., Chapelle, J.-P., & Souberbielle, J.-C. (2009). Vitamin D: current status and perspectives. Clinical Chemistry and Laboratory Medicine, 47 (2), 120-127. doi:10.1515/CCLM.2009.036

Cavalier, E., & Souberbielle, J.-C. (January 2009). La vitamine D : effets « classiques », « non classiques » et évaluation du statut du patient. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 33, 7-16. doi:10.1016/j.mednuc.2008.10.001

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (2009). Low prevalence of chronic kidney disease in Far-East Asian populations: impact of the ethnicity factor? [letter to the editor]. Nephrology Dialysis Transplantation, 24 (9), 2952-3. doi:10.1093/ndt/gfp279

Delanaye, P., Cavalier, E., Lambermont, B., Canivet, J.-L., Preiser, J.-C., Garweg, C., Dubois, B., Morimont, P., Wiesen, P., Bataille, Y., Damas, P., & Krzesinski, J.-M. (2009). Mesure du débit de filtration glomérulaire aux soins intensifs basée sur l’iohexol : clairance plasmatique ou urinaire ? Poster session presented at 37ème congrès de la Société de Réanimation de Langue Française, Paris, France.

Delanaye, P., Cavalier, E., Maillard, N., Mariat, C., & Krzesinski, J.-M. (2009). Prévalence de la maladie rénale chronique par l’estimation du DFG dans une population de plus de 50 ans selon la formule MDRD versus la nouvelle formule CKD-EPI. Poster session presented at XI réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Toulouse, France.

Delanaye, P., Cavalier, E., Radermecker, R., Paquot, N., Depas, G., Chapelle, J.-P., Scheen, A., & Krzesinski, J.-M. (2009). Estimation of GFR by different creatinine- and cystatin-C-based equations in anorexia nervosa. Clinical Nephrology, 71 (5), 482-91. doi:10.5414/CNP71482

DELANAYE, P., Cavalier, E., RORIVE, M., Paquot, N., SCHEEN, A., & KRZESINSKI, J.-M. (2009). Estimation de filtration glomérulaire chez le patient obese: performances des équations basées sur la créatinine et la cystatine C. Poster session presented at 11e reunion commune de la Société Francophone de Dialyse (SFD) et de la société de Néphrologie (SN), Toulouse, France.

Delanaye, P., Cavalier, E., Rorive, M., Radermecker, R., Paquot, N., Scheen, A., & Krzesinski, J.-M. (2009). Estimation du debit de filtration glomérulaire chez le patient obese: performances des équations basées sur la créatinine et la cystatine C. Paper presented at réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Toulouse, France.

Delanaye, P., Cavalier, E., Rorive, M., Radermecker, R., Scheen, A., & Krzesinski, J.-M. (2009). Indexing glomerular filtration for body surface area is misleading in obese subjects: reductio ad absurdum. Poster session presented at World Congress of Nephrology, Milano, Italy.

Delanaye, P., Cavalier, E., Saint-Remy, A., Lutteri, L., & Krzesinski, J.-M. (2009). Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population. Scandinavian Journal of Clinical and Laboratory Investigation, 69 (3), 344-9. doi:10.1080/00365510802609856

DELANAYE, P., Mariat, C., CAVALIER, E., & KRZESINSKI, J.-M. (2009). Indexing Glomerular Filtration Rate for Body Surface Area: Myth and Reality. In E. Krüger & K. Hahn (Eds.), Nephrology Dialysis Transplantation (pp. 33-53). New York, United States - New York: Nova Science Publisher.

Delanaye, P., Mariat, C., Cavalier, E., & Krzesinski, J.-M. (2009). Indexation du debit de filtration glomerulaire par la surface corporelle : mythe et realite. Néphrologie et Thérapeutique, 5 (7), 614-22. doi:10.1016/j.nephro.2009.04.002

Delanaye, P., Mariat, C., Cavalier, E., & Krzesinski, J.-M. (2009). Errors induced by indexing glomerular filtration rate for body surface area: reductio ad absurdum. Nephrology Dialysis Transplantation, 24 (12), 3593-6. doi:10.1093/ndt/gfp431

Gadisseur, R., Cataldo, D., Collard, L., Chapelle, J.-P., & Cavalier, E. (2009). Allergie au venin d'hyménoptère et tests de laboratoires : de nouvelles approches pour la prise en charge des patients à haut risque de réaction sévère. Revue Médicale de Liège, 64 (11), 570-5.

Mistretta, V., Cavalier, E., Collette, J., & Chapelle, J.-P. (2009). Production des anticorps monoclonaux. Revue Médicale de Liège, 64 (5-6), 248-252.

Mistretta, V., Cavalier, E., Collette, J., Lutteri, L., & Chapelle, J.-P. (2009). Intérêt des anticorps monoclonaux dans le laboratoire d'analyses biomédicales. Revue Médicale de Liège, 64 (5-6), 257-263.

Teixeira, J., Denooz, A., Haleng, J., Cavalier, E., & Chapelle, J.-P. (2009). Evaluation of the Vitros 5600 Integrated System for Enzymatic determination of Creatinine in blood plasma.

Cavalier, E. (2008). Vitamin D: far beyond the bone metabolism. Paper presented at Werkgroep Biologen van Antwerpen, Antwerpen, Belgium.

Cavalier, E., Péroni, L., Abshoff, C., Lutteri, L., Chapelle, J.-P., Krzesinski, J.-M., & Delanaye, P. (November 2008). Etude analytique des trois trousses de cystatine C et impact sur les formules basées sur la cystatine pour l'estimation du DFG. Néphrologie et Thérapeutique, 4 (6), 399-400.

Cavalier, E. (2008). Bioformation ACORATA: Exploration biologique des pathologies osseuses. Paper presented at Bioformation ACORATA: Exploration biologique des pathologies osseuses, Paris, France.

Cavalier, E., & Souberbielle, J.-C. (October 2008). Vitamine D: effets « phosphocalciques » et « non-phosphocalciques ». Paper presented at 2ème symposium Bioclinique de l'ACOMEN: "Actualités sur le métabolisme phosphocalcique", Marseille, France.

Cavalier, E., Cormier, C., & Souberbielle, J.-C. (September 2008). Measurements of Vitamin D Do Not Necessarily Reflect What You Give to Your Patients. Journal of Bone and Mineral Research, 23, 196.

Cavalier, E., Delanaye, P., Carlisi, I., & Chapelle, J.-P. (September 2008). Analytical Validation of Diasorin Liaison and Roche Elecsys Methods for the Determination of Osteocalcin. Journal of Bone and Mineral Research, 23, 191.

Cavalier, E., Wallace, A. M., Knox, S., Mistretta, V., Chapelle, J.-P., & Souberbielle, J.-C. (September 2008). Circulating Concentrations of 25-Hydroxyvitamin D after a Single Oral Dose of 100.000 IU of Vitamin D2 or Vitamin D3. Journal of Bone and Mineral Research, 23, 212.

Cavalier, E. (2008). Nouveautés sur la vitamine D. Paper presented at Glem 1080, Brussels, Belgium.

Cavalier, E. (31 May 2008). Qualité optimale d’un prélèvement: Mieux connaître les facteurs pouvant modifier la qualité d’un résultat. Paper presented at Grande Journée de la SSMG sur la Biologie Clinique, Sainte-Ode, Belgium.

Cavalier, E. (15 May 2008). Vitamin D: current status and perspectives. Paper presented at New trends in clinical biology - Emerging Technologies and their Impact on Laboratory Medicine and Management, Brussels, Belgium.

Gilmaire, J., Descy, J., Haleng, J., Chapelle, J.-P., & Cavalier, E. (May 2008). Critical difference: from results to interpretation and its impact on patient care. Poster session presented at International Symposium "Brussels 2008" Société Belge de Chimie clinique, brussels, Belgium.

Bouüaert, C., Vanmeerbeek, M., Burette, P., Cavalier, E., Seidel, L., Blockx, S., Albert, A., & Giet, D. (February 2008). Déficit en vitamine D chez l'homme âgé vivant à domicile ou en institution en milieu urbain. Presse Médicale, 37 (2, Pt 1), 191-200. doi:10.1016/j.lpm.2007.07.012

Cavalier, E., Carlisi, A., Chapelle, J.-P., & Delanaye, P. (January 2008). False positive PTH results: An easy strategy to test and detect analytical interferences in routine practice. Clinica Chimica Acta, 387 (1-2), 150-152. doi:10.1016/j.cca.2007.08.019

Cavalier, E., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (2008). Analytical quality of calcitonin determination and its effect on the adequacy of screening for medullary carcinoma of the thyroid [letter to the editor]. Clinical Chemistry, 54 (5), 929-30. doi:10.1373/clinchem.2007.100636

Cavalier, E., Delanaye, P., Morreale, A., Carlisi, I., Mourad, I., Chapelle, J.-P., & Emonts, P. (2008). La carence en vitamine d chez les femmes enceintes en region liegeoise: un probleme meconnu. Revue Médicale de Liège, 63 (2), 87-91.

Cavalier, E., Rozet, E., Dubois, N., Charlier, C., Hubert, P., Chapelle, J.-P., Krzesinski, J.-M., & Delanaye, P. (2008). Performance of iohexol determination in serum and urine by HPLC: validation, risk and uncertainty assessment. Clinica Chimica Acta, 396, 80-85. doi:10.1016/j.cca.2008.07.011

Cavalier, E., Wallace, A. M., Knox, S., Mistretta, V., Cormier, C., & Souberbielle, J.-C. (2008). Serum vitamin D measurement may not reflect what you give to your patients. Journal of Bone and Mineral Research, 23 (11), 1864-5. doi:10.1359/jbmr.080608

Cavalier, E., Wallace, A. M., Mistretta, V., & Souberbielle, J.-C. (2008). Misdiagnosis of vitamin D insufficiency in subjects who received vitamin D2. Clinical Chemistry, 54 (6), 110.

Delanaye, P., Cavalier, E., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2008). New data on the intraindividual variation of cystatin C. Nephron. Clinical Practice, 108 (4), 246-8. doi:10.1159/000124327

Delanaye, P., Cavalier, E., Froissart, M., & Krzesinski, J.-M. (2008). Reproducibility of GFR measured by chromium-51-EDTA and iohexol [letter to the editor]. Nephrology Dialysis Transplantation, 23 (12), 4077-8; author reply 4078. doi:10.1093/ndt/gfn496

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (2008). Determining prevalence of chronic kidney disease using estimated glomerular filtration rate [letter to the editor]. JAMA: Journal of the American Medical Association, 299 (6), 631. doi:10.1001/jama.299.6.631-a

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (2008). Cystatin C, renal function, and cardiovascular risk [letter to the editor]. Annals of Internal Medicine, 148 (4), 323. doi:10.7326/0003-4819-148-4-200802190-00023

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (2008). Chronic kidney disease in Taiwan [letter to the editor]. Lancet, 372 (9654), 1950; author reply 1950-1. doi:10.1016/S0140-6736(08)61836-X

Delanaye, P., Cavalier, E., Krzesinski, J.-M., & Mariat, C. (2008). Cystatin C-based equations: don't repeat the same errors with analytical considerations [letter to the editor]. Nephrology Dialysis Transplantation, 23 (3), 1065; author reply 1065-6. doi:10.1093/ndt/gfm832

Delanaye, P., Cavalier, E., Maillard, N., Krzesinski, J.-M., & Mariat, C. (2008). Creatinine calibration in NHANES: is a revised MDRD study formula needed? [letter to the editor]. American Journal of Kidney Diseases, 51 (4), 709; author reply 709-10. doi:10.1053/j.ajkd.2007.12.041

Delanaye, P., Cavalier, E., Radermecker, R., Paquot, N., Depas, G., Chapelle, J.-P., Scheen, A., & Krzesinski, J.-M. (2008). Cystatin C or Creatinine for Detection of Stage 3 Chronic Kidney Disease in Anorexia Nervosa. Nephron. Clinical Practice, 110 (3), 158-c163. doi:10.1159/000166607

Delanaye, P., Cavalier, E., Saint-Remy, A., Dechenne, C., & Krzesinski, J.-M. (2008). Prevalence of chronic kidney disease in Province of Liège: critical comparison with the American NHANES study? Paper presented at Réunion de la Société Belge de Néphrologie, Leuven, Belgium.

Delanaye, P., Cavalier, E., Saint-Remy, A., Dechenne, C., & Krzesinski, J.-M. (2008). Prévalence de la maladie rénale au stade 3 selon l’équation MDRD : comparaison critique des données liégeoises (Belgique) et américaines (étude NHANES). Poster session presented at 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

Delanaye, P., Cavalier, E., Saint-Remy, A., Lutteri, L., Chapelle, J.-P., & Krzesinski, J.-M. (2008). Prévalence de la maladie rénale chronique par l’estimation du DFG avec une formule basée sur la créatinine versus la cystatine C. Poster session presented at 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

Delanaye, P., Krzesinski, J.-M., & Cavalier, E. (2008). Vitamin D treatment in chronic kidney disease: what we really need to know [letter to the editor]. Archives of Internal Medicine, 168 (18), 2045; author reply 2046. doi:10.1001/archinte.168.18.2045-a

Delanaye, P., Pieroni, L., Abshoff, C., Lutteri, L., Chapelle, J.-P., Krzesinski, J.-M., Hainque, B., & Cavalier, E. (2008). Analytical study of three cystatin C assays and their impact on cystatin C-based GFR-prediction equations. Clinica Chimica Acta, 398 (1-2), 118-24. doi:10.1016/j.cca.2008.09.001

Gadisseur, R., Collard, L., Cataldo, D., Chapelle, J.-P., & Cavalier, E. (2008). Can laboratory tests help to define the profile of desensitised patients or patients at high risk of severe reaction ? Allergy, 63 (Suppl. 88), 1773.

Mistretta, V., Delanaye, P., Chapelle, J.-P., Souberbielle, J.-C., & Cavalier, E. (2008). Vitamine D2 ou vitamine D3? Revue de Médecine Interne, 29 (10), 815-20. doi:10.1016/j.revmed.2008.03.003

Monfort, M., Delanaye, P., Chapelle, J.-P., & Cavalier, E. (2008). Calcium chez les patients hemodialyses : calcemie totale ou calcium ionise ? Le laboratoire doit-il systematiquement fournir au clinicien une valeur de calcemie totale corrigee obtenue par calcul ? Annales de Biologie Clinique, 66 (5), 573-6. doi:10.1684/abc.2008.0264

Piéroni, L., Delanaye, P., Abshoff, C., Lutteri, L., Chapelle, J.-P., Hainque, B., Krzesinski, J.-M., & Cavalier, E. (2008). Impact de la stabilité de la cystatine C sur la validité des mesures dans les études rétrospectives. Poster session presented at 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

Séronie-Vivien, S., Piéroni, L., Galteau, M.-M., Carlier, M.-C., Cavalier, E., Hanser, A.-M., & Cristol, J.-P. (2008). Evolution des modalités d'évaluation de la fonction rénale basée sur la créatinine entre 2005 et 2008: conséquences pour les biologistes. Annales de Biologie Clinique, 66 (3), 263-8. doi:10.1684/abc.2008.0226

Souberbielle, J.-C., Prié, D., Courbebaisse, M., Friedlander, G., Houillier, P., Maruani, G., Cavalier, E., & Cormier, C. (2008). Actualite sur les effets de la vitamine D et l'evaluation du statut vitaminique D. Annales d'Endocrinologie, 69 (6), 501-10. doi:10.1016/j.ando.2008.07.010

Lognard, M., Cavalier, E., Chapelle, J.-P., Lambermont, B., Krzesinski, J.-M., & Delanaye, P. (19 December 2007). Acetylcysteine and Enzymatic Creatinine: Beware of Laboratory Artefact! [letter to the editor]. Intensive Care Medicine, 34 (5), 973-974. doi:10.1007/s00134-007-0972-9

Cavalier, E. (2007). Vitamine D, métabolisme, dosage et utilité. Paper presented at Glem 1176 du Hainaut Occidental, Tournai, Belgium.

Cavalier, E. (2007). PTH élevée en ciel serein. Paper presented at Les Jeudis de Fleurus, Fleurus, Belgium.

Katsanos, K., Cavalier, E., Ferrante, M., Schnitzler, F., Katsaraki, A., Noman, M., Vermeire, S., Epameinondas, V. T., Rutgeerts, P., Chapelle, J.-P., & Van Assche, G. (December 2007). Intravenous iron therapy restores functional iron deficiency induced by infliximab. Journal of Crohn's and Colitis, 1, 97-105. doi:10.1016/j.crohns.2007.08.005

Gothot, A., & Cavalier, E. (2007). Nouveaux développements en allergologie: activation de basophiles par cytométrie de flux, CAST et Western-blot. Paper presented at Formation continue en Biologie Clinique, Liège, Belgium.

Cavalier, E. (2007). Bioformation Acorata: Exploration biologique des pathologies osseuses. Paper presented at Bioformation Acorata: Exploration biologique des pathologies osseuses, Paris, France.

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (September 2007). Impact des conditions préanalytiques sur le dosage de la PTH. Néphrologie et Thérapeutique, 3 (5), 192.

Cavalier, E., Delanaye, P., Carlisi, A., Krzesinski, J.-M., & Chapelle, J.-P. (August 2007). Stability of intact parathyroid hormone in samples from hemodialysis patients. Kidney International, 72 (3), 370-372. doi:10.1038/sj.ki.5002363

Cavalier, E., & Bouüaert, C. (2007). carence en vitamine D dans la population belge: Un vrai problème de santé publique? Paper presented at Formation continue en Biologie Clinique, Liège, Belgium.

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (June 2007). PTH stability : preanalytical conditios influences for Liaison (Diasorin). Clinical Chemistry and Laboratory Medicine, 45.

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (June 2007). Evaluation of heterophile antibodies interference on Liaison PTH (Diasorin). Clinical Chemistry and Laboratory Medicine, 45.

Cavalier, E. (24 May 2007). PTH in hemodialyzed patients. Paper presented at Innovations in Clinical Laboratory Management and Diagnosis, Grimbergen, Belgium.

Cavalier, E., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (April 2007). Analytical variation in plasma renin activity: Implications for the screening of primary aldosteronism [letter to the editor]. Clinical Chemistry, 53 (4), 803-804. doi:10.1373/clinchem.2006.083600

Cavalier, E., & Delanaye, P. (24 March 2007). Equations for GFR estimation: application and limits. Paper presented at 3rd Euregio conference of clinical chemistry and laboratory medicine, Vaals, Netherlands.

Cavalier, E., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (23 March 2007). MDRD equation for GFR estimation : analytical limitations. Paper presented at 10th International Symposium of Nephrology at Montecatini, Montecatini Terme, Italy.

Delanaye, P., Krzesinski, J.-M., & Cavalier, E. (20 March 2007). Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction [letter to the editor]. Circulation, 115 (11), 333. doi:10.1161/CIRCULATIONAHA.106.677815

Delanaye, P., Nellessen, E., Cavalier, E., Depas, G., Grosch, S., Defraigne, J.-O., Chapelle, J.-P., Krzesinski, J.-M., & Lancellotti, P. (15 March 2007). Is cystatin C useful for the detection and the estimation of low glomerular filtration rate in heart transplant patients? Transplantation, 83 (5), 641-644. doi:10.1097/01.tp.0000253746.30273.cd

Cavalier, E., Delanaye, P., Ferir, A.-M., Krzesinski, J.-M., & Chapelle, J.-P. (February 2007). Measurement uncertainty of creatinine in low values: Another good reason not to use the MDRD formula with low creatinine values. Clinical Biochemistry, 40 (3-4), 285-286. doi:10.1016/j.clinbiochem.2006.10.021

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (02 January 2007). Estimated glomerular filtration rate [letter to the editor]. Annals of Internal Medicine, 146 (1), 74-74. doi:10.7326/0003-4819-146-1-200701020-00020

Cavalier, E., Delanaye, P., Carlisi, A., Krzesinski, J.-M., & Chapelle, J.-P. (2007). Analytical validation of the new version of the Liaison N-Tact PTH assay. Clinical Chemistry and Laboratory Medicine, 45 (1), 105-107. doi:10.1515/CCLM.2007.017

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (2007). Stability of intact parathormone in hemodialyzed patients: a pragmatic study on Roche Elecsys assay. Poster session presented at Réunion de la Société Belge de Néphrologie, Brussels, Belgium.

Cavalier, E., Delanaye, P., Carlisi, I., Rogister, C., Mourad, I., Krzesinski, J.-M., & Chapelle, J.-P. (2007). High prevalence of vitamin D deficiency in pregnant women and new mothers in the area of Liège, Belgium. Poster session presented at 17th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Amsterdam, Netherlands.

Delanaye, P., Cavalier, E., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2007). Variabilité du débit de filtration glomérulaire, de la créatinine et de la cystatine C plasmatiques. Poster session presented at 9ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lyon, France.

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (2007). Impact of creatinine calibration in the MDRD equation on the epidemiology of renal failure. Paper presented at Réunion de la Société Belge de Néphrologie, Bruxelles, Belgium.

Delanaye, P., Krzesinski, J.-M., Cavalier, E., & Lambermont, B. (2007). The RIFLE criteria: are the foundations robust? [letter to the editor]. Critical Care Medicine, 35 (11), 2669; author reply 2669-70. doi:10.1097/01.CCM.0000288115.09689.3C

Goffinet, J., Bernard, P., Cavalier, E., & Chapelle, J.-P. (2007). Evaluation of the new BRAHMS-Biomerieux quantitative test for procalcitonin determination. Acta Clinica Belgica, 62 (6), 463-463.

Lognard, M., Cavalier, E., Chapelle, J.-P., Lambermont, B., Krzesinski, J.-M., & Delanaye, P. (2007). Acetylcysteine and enzymatic creatinine: take care for interference! Acta Clinica Belgica, 62 (6), 462-462.

Cavalier, E. (2006). Les interférences analytiques : les anticorps hétérophiles. Paper presented at Les Jeudis de Fleurus, Fleurus, Belgium.

Cavalier, E. (2006). Les interférences analytiques dans les dosages immunologiques. Paper presented at Séminaires de Médecine Nucléaire et de Tomographie à Positons, Liège, Belgium.

Cavalier, E. (November 2006). Glycémie délocalisée: Entretien avec le Dr Etienne CAVALIER. Biotribune Magazine, 19 (1), 33.

Delanaye, P., Cavalier, E., Chapelle, J.-P., Krzesinski, J.-M., & Froissart, M. (November 2006). Renal extraction of cystatin C [letter to the editor]. Nephrology Dialysis Transplantation, 21 (11), 3333-3333. doi:10.1093/ndt/gfl324

Cavalier, E. (26 October 2006). PTH: que dosons-nous réellement? Paper presented at 23ème Colloque CORATA, Bruges, Belgium.

Cavalier, E., & Maweja, S. (2006). Hyperaldostéronisme primaire: une cause fréquente et méconnue d'hypertension artérielle. Comment la diagnistiquer? Paper presented at Formation continue en Biologie Clinique, Liège, Belgium.

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (2006). PTH oxidation after a session of hemodialyze: myth or reality? Immuno-Analyse and Biologie Spécialisée.

Cavalier, E., Levaux, L., Carlisi, I., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (2006). VALIDATION ANALYTIQUE DE LA TROUSSE OCTEIA 25-HYDROXYVITAMINE D (IDS). Immuno-Analyse and Biologie Spécialisée.

Katsanos, K., Cavalier, E., Ferrante, M., Van Hauwaert, V., Henckaerts, L., Schnitzler, F., Katsaraki, A., Noman, M., Vermeire, S., Epameinondas, V. T., Rutgeers, P., Chapelle, J.-P., & Van Assche, G. (October 2006). The effect of I.V. iron sucrose therapy on erythropoietin and soluble transferring receptor levels in Crohn’s disease patients treated with Infliximab. Poster session presented at 14th European Gastroenterology week, Berlin, Germany.

Cavalier, E., Delanaye, P., Collette, J., Krzesinski, J.-M., & Chapelle, J.-P. (September 2006). Evaluation of different bone markers in hemodialyzed patients. Clinica Chimica Acta, 371 (1-2), 107-111. doi:10.1016/j.cca.2006.02.029

Delanaye, P., Cavalier, E., Krzesinski, J.-M., & Chapelle, J.-P. (August 2006). Why the MDRD equation should not be used in patients with normal renal function (and normal creatinine values)? [letter to the editor]. Clinical Nephrology, 66 (2), 147-148. doi:10.5414/cnp66147

Cavalier, E., & Valdes Socin, H. G. (2006). Pathologie de la parathyroïde : aspects cliniques et biologiques. Paper presented at Les Jeudis de Fleurus, Fleurus, Belgium.

Krzesinski, J.-M., Delanaye, P., Bovy, C., & Cavalier, E. (2006). Place de la Biologie Clinique dans l'évolution de l'insuffisance rénale et de ses complications. Paper presented at Formation continue en Biologie Clinique, Liège, Belgium.

Delanaye, P., Cavalier, E., Chapelle, J.-P., & Krzesinski, J.-M. (April 2006). Importance of the creatinine calibration in the estimation of GFR by MDRD equation [letter to the editor]. Nephrology Dialysis Transplantation, 21 (4), 1130-1130. doi:10.1093/ndt/gfl038

Cavalier, E., Carlisi, A., & Chapelle, J.-P. (2006). Validation analytique de l'ImmunoCap 250 (Sweden Diagnostics). Annales de Biologie Clinique, 64 (1, Jan-Feb), 91-4.

Delanaye, P., Cavalier, E., Radermecker, R., Paquot, N., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2006). Estimation du débit de filtration glomérulaire par les formules basées sur la créatinine et la cystatine C en cas d’anorexie mentale. Paper presented at 8éme réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lille, France.

Delanaye, P., Cavalier, E., Radermecker, R., Rorive, M., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2006). Plasma cystatin C for the detection of renal failure in obese patients. Poster session presented at 43ème Congress of ERA-EDTA, Glasgow, United Kingdom.

Delanaye, P., Nellessen, E., Grosch, S., Depas, G., Cavalier, E., Defraigne, J.-O., Chapelle, J.-P., Krzesinski, J.-M., & Lancellotti, P. (2006). Creatinine-based formulae for the estimation of glomerular filtration rate in heart transplant recipients. Clinical Transplantation, 20 (5, Sep-Oct), 596-603. doi:10.1111/j.1399-0012.2006.00523.x

Meex, C., Poncin, J., Chapelle, J.-P., & Cavalier, E. (2006). Analytical validation of the new plasma calibrated Accu-Chek (R) Test Strips (Roche Diagnostics). Clinical Chemistry and Laboratory Medicine, 44 (11), 1376-1378. doi:10.1515/CCLM.2006.249

Cavalier, E. (25 November 2005). PTH : what are we really assaying ? Paper presented at Focus Conference on Endocrinology and Tumour markers, Brussels, Belgium.

Chapelle, J.-P., & Cavalier, E. (14 September 2005). Traitement des plaintes dans un système d'assurance qualité: l'expérience du laboratoire de Biologie clinique. Paper presented at Symposium: la qualité dans les laboratoires en Belgique, Liège, Belgium.

Meex, C., Cavalier, E., Poncin, J., & Chapelle, J.-P. (May 2005). Analytical validation of the new plasma calibrated Accu-Check test strips (Roche Diagnostics). Poster session presented at 28th National Symposium of the SBCC, Liège, Belgium.

Cavalier, E., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (2005). Comparison of liaison N-tact PTH (diasorin) and N-tact PTH SPIRMA (diasorin) in hemodialyzed patients [letter to the editor]. Clinical Chemistry and Laboratory Medicine, 43 (8), 890-891. doi:10.1515/CCLM.2005.151

Cavalier, E., Carlisi, I., Delanaye, P., Pazzaglia, G., Krzesinski, J.-M., & Chapelle, J.-P. (October 2004). Comparaison of liaison N-tact PTH (Diasorin) and N-tact PTH SP IRMA (Diasorin) in hemodialyzed patients. Poster session presented at 21ème Colloque CORATA, Paris, France.

Marcelis, M., Cavalier, E., Gielen, J., Delespaul, P., & Van Os, J. (August 2004). Abnormal response to metabolic stress in schizophrenia: marker of vulnerability or acquired sensitization? Psychological Medicine, 34 (6), 1103-1111. doi:10.1017/S0033291703001715

Marcelis, M., Cavalier, E., Gielen, J., Delespaul, P., & van Os, J. (2002). Metabolic stress as a paradigm to elucidate genotype-environment interaction in psychosis. Acta Psychiatrica Scandinavica, 105 (Suppl. 411), 91.

Cavalier, E., Melin, P., & De Mol, P. (May 1997). Validation of the Bactec 9240. Poster session presented at 8th ECCMID, Lausanne, Switzerland.